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Tissue engineering is proving a promising tool as an alternative to relying on donor availability in 
restorative tissue therapeutics. Tissue engineering concepts entail combining cells and materials in 
vitro to generate 3D parts that replicate in vivo tissue environments. Much focus has been spent on 
researching biopolymer hydrogels as scaffolds within tissue engineering constructs as there is vast 
potential in their tailorability to simulate the extracellular matrices within native human tissues. 
Although many features within hydrogels may be finely tuned when developing tissue engineering 
implants, such as water content, mechanical properties, and microarchitecture, current studies in this 
area are seldom able to recapitulate the physicochemical and mechanical gradients that are exhibited 
in human tissues, within a single construct. Moreover, the hydrogel precursor solutions used in 3D 
bioprinting tissue engineering constructs are usually manipulated towards enhancing either print 
fidelity (by increasing solution viscosity) or to preserve the viability of suspended cells (by decreasing 
the viscosity of precursor solutions). 3D bioprinted tissue engineering constructs therefore often fail 
to harbour both optimal print fidelity in conjunction with viable encapsulated cells thus leaving the 
intended tissue engineering ECM environment poorly reproduced. The work presented in this thesis 
addresses these problems and demonstrates that the success of a tissue engineering construct need not 
be compromised by the usual trade-off between print fidelity and cell viability and can in fact possess 
both of these features that are crucial to the function of the part. This technology uses a supporting 
gel bed within which multiple cell/hydrogel printing solutions are layered to keep the construct in 
shape prior to solidifying. The mechanisms behind the function of the supporting gel bed as a 
suspending agent were first analysed, showing that its shear-thinning behaviour allows material to be 
deposited within it followed by rapid restructuring to uphold the construct shape. A range of 
contrasting hydrogels and cell types were then 3D bioprinted into multiple layers and configurations, 
pushing the boundaries of what can usually be achieved when conventionally 3D printing low 
viscosity solutions onto a planar surface. As an example of the potential of this technique in becoming 
commonplace in the clinic, a chronic-depth skin equivalent was 3D printed, complete with 
hypodermis, dual compartment dermis and epidermis. The construct contained gradients in material 
chemistry, mechanical properties, microarchitecture, and cell phenotype, and served as an example 
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Chapter 1 – Introduction to Tissue Engineering 
1.1 Tissue Engineering 
 
The average lifespan of our ever-growing population has continued to rise ever since records began. 
In recent years, especially in more developed regions of the world, a decrease in mortality rate is 
attributed to enhancing medical intervention. However, with increased longevity comes a larger risk 
of age-associated tissue and organ failure and further therapeutic mediation is needed (Olson et al., 
2011). Organ and tissue transplantation or surgical reconstruction is often implemented in order to 
remedy this, whereby defective tissues are excised and replaced with the healthy tissue of a donor, 
yet overcoming immune rejection and the clinical demand for organ donors still remain critical 
challenges (Dzobo et al., 2018). Tissue engineering is a relatively new field of research which has 
seen tremendous progression towards the successful restoration, maintenance and augmentation of 
biological function within the human body (Chen & Liu, 2016). Newly emerging tissue engineering 
strategies have the potential to circumvent the limitations that are present in current conventional 
therapies when repairing human tissue. These strategies are less invasive in nature and offer an 
alternative to the growing demand for tissue and organ donors. Tissue engineering also provides a 
long term and cost-effective solution to the treatment or eradication of disease thus improving quality 
of life. As a consequence, tissue engineering has received much attention as an attractive approach 
toward tissue restoration  (Peltola et al., 2008). 
The phrase ‘tissue engineering’ (TE) as we know it today was first used in 1988 at a National Science 
Foundation workshop, employing the theoretical bases of engineering and life sciences toward further 
understanding of the functional mechanisms within healthy mammalian tissue. With this, the 
production of biological alternatives in order to restore non-healthy tissue could be explored (Lanza 
et al., 2013). The many disciplines which comprise tissue engineering include medicine, engineering, 
cellular biology and materials science and each component contributes to the optimisation of the final 
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engineered part (Howard et al., 2008). Recent advances in this area have allowed the production of 
more biologically and geometrically relevant constructs in vitro that closer mimic their intended in 
vivo environments, meaning that the boundaries and limitations that once stood in the way of tissue 
engineering are now beginning to diminish. Several approaches are now being used to address the 
prospect of organ replacement using tissue engineering principles. These include (but are not limited 
to) i) cell-seeding of a pre-made porous biodegradable scaffold, ii) the decellularization and 
recellularization of pre-existing extracellular matrix (ECM), iii) cell sheet engineering with self-
secreted ECM and iv) cell encapsulation within a supporting hydrogel matrix (Figure 1.1) (Do et al., 
2015; O’Brien, 2011; Tee et al., 2010). The most commonly practiced methods amongst these are the 
use of biopolymer materials as cell-loadable scaffolds. This technique involves the design and 
manufacture of biopolymer constructs for the replication of native ECM (within which cells naturally 










Figure 1.1 – A brief overview of current scaffolding approaches used in tissue engineering for implantation. 
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1.2 Native Tissue 
Within the human body, tissues are an organisation of cells that share a common embryonic origin 
and work together toward a specific bodily function. In order to achieve this specific function, tissue 
composition varies greatly down to the molecular level, comprising a multitude of different cellular 
and extracellular components and also varying in the degree in which these components are present 
(Andrew & Rawdon, 1987). The extracellular matrix (ECM) portion of tissues supports cells by 
supplying the biochemical and structural means needed for cellular attachment, proliferation, 
migration and differentiation. ECM itself is secreted and oriented by residing cells during 
microenvironment remodelling (Yue, 2014).  
There are four main tissue categories, each with their own defining function: epithelial, connective, 
nervous and muscle tissue. Subsequent ordering of hierarchical tissues forms organs and organ 
systems for the maintenance of the human body as a whole (Kular et al., 2014). Skin for example 









Figure 1.2 - Schematic diagram illustrating the four major types of tissue within the skin organ (adapted from 







1.2.1 Epithelial Tissue 
Epithelial tissues exhibit minimal ECM composition in contrast to other tissue types. They are 
constituted primarily of cells bound by a strong intracellular cytoskeleton which is attached to 
the basal lamina via specialised junctions (Alberts et al., 2002). Epithelial tissues line the outer 
skin (epidermis) as well as the cavities of compartmentalised internal structures and their 
predominant role in tissue function is to control the passage of water, solutes and cells from 
adjacent tissues. The basal lamina forms the interface between epithelial cell layers and 
connective tissues. Although epithelia have a nervous supply, they lack a venous blood supply 
and therefore rely on the diffusion of molecules from the blood vessels of underlying tissues. 
Due to the harsh external environments to which epithelia are faced, epithelial tissue homeostasis 
is a stringently regulated process in which epithelia are constantly renewed by stem cells 
(Blanpain & Fuchs, 2014). 
1.2.2 Connective Tissue 
Out of all the tissue types, connective tissue is most abundant in ECM with comparatively fewer 
cells that are predominantly in the form of fibroblasts. Connective tissue ECM varies vastly and 
is dependent upon the location at which it is synthesised and secreted (Alberts et al., 2002). 
Loose connective tissue (such as adipose tissue) is rich in ground substance made of 
polysaccharides that fill the voids between collagenous, elastic and reticular fibres and cells. 
Adipose tissue is also regarded as a specialised connective tissue due to the specialised nature 
of adipocytes that are present within these matrices (Nakajima et al., 1998). Dense connective 
tissues such as tendons, ligaments and dermis are comparatively more abundant in collagenous 
fibres than loose connective tissue. Some dense connective tissue structures , including bone, 
exhibit additional ECM components, such as inorganic calcium phosphate deposits, which 
contribute to their stiffness and their role in the protection of vital organs. Blood is also 
considered as connective tissue (Marieb & Hoehn, 2012).  
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1.2.3 Nervous Tissue 
Nervous tissue is defined by its excitability and its capacity to propagate electrical impulses 
(known as action potentials) which traverse between the central nervous system and the rest of 
the body. These signals are responsible for allowing internal and external stimuli to be relayed 
as information to the brain for an appropriate response to be effected by the body (Vecino & 
Kwok, 2016). The ECM in nervous tissue, which is secreted by neural cells, is rich in collagens 
and glycosaminoglycans (GAG) such as chondroitin sulphate (CS), heparan sulphate (HS) and 
hyaluronan (HA). These complexes play a part in neurogenesis, modulation of synaptic 
connections and pro-inflammatory responses in central nervous system (CNS) autoimmunity 
(Mueller et al., 2014; Yamaguchi, 2010).  
1.2.4 Muscle Tissue 
Unlike other tissue types, muscle has contractile capacity thus allowing the actuation of 
voluntary responses such as body movement, or involuntary responses including mechanical 
digestion and the systemic transport of blood. As with other tissues, their signature ECM 
conformations underlie their functional roles. Much of the variations in different muscle ECM 
can be attributed to the alignment of collagen fibres embedded within a proteoglycan matrix 
(Schuliga, 2015). Smooth muscle undergoes spontaneous regeneration through the division of 
pericytes (Berry, 1920). The human body cannot, however, regenerate cardiac muscle and 
following trauma and subsequent scar tissue formation, loses its contractile capacity. In addition, 
skeletal muscle has a limited regenerative capacity by the recruitment of satellite cells. If the 
damage to skeletal muscle exceeds the reparative potential of recruited satellite cells, muscle 
fibres are replaced with scar tissue during fibrosis and muscle function may be compromised 
(Purslow, 2008).  
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1.3 Tissue Engineering Constructs 
Some tissues are unable to undergo regeneration by the human body, prevented by limited vascular 
invasion within large defects, the collapse of surrounding tissue into the defect and excessive 
mechanical strain in reparative tissue within unstable fractures. As a consequence, there is a clinical 
need for the introduction of exogenous tissue engineering components in order to facilitate tissue 
repair (Yannas, 2014). Tissue engineering constructs are designed to mimic the tissues that they are 
destined to replace, featuring similar cellular and extracellular environments and subsequently 
degrading at the same rate as new tissue formation is established (Velasco et al., 2015). They are 3D 
in shape, providing a better representation of native tissues compared with 2D cell culture, which is 
unable to recapitulate complex in vivo environments and the spatial arrangements of cells and tissue 
ECM. Tissue engineering constructs often employ a triad of components including scaffold material, 
cells and media / culture conditions for the fabrication of engineered tissue mimics. These constructs 
may then be destined either for implantation or for research within systems such as drug-disease 








Figure 1.3 - Components of the tissue engineering triad: scaffold, cells and media / culture conditions constitute 




Scaffolding in tissue engineering refers to the material matrix from which the tissue mimic is 
fabricated. For the successful manufacture of a tissue engineering construct, the scaffold material 
must resemble the native tissue ECM of which it wishes to replicate (Chan & Leong, 2008). For 
instance, connective tissues such as adipose, tendons and ligaments contain an abundance of collagens 
and glycosaminoglycans that provide their structural properties. Therefore, when fabricating tissue 
engineering scaffolds that aim to mimic these tissues, the incorporation of collagenous and GAG 
components can generate connective tissue-like environments (Caliari et al., 2011). The scaffolds 
themselves play multiple roles in tissue augmentation and repair and may either be injected or 
transplanted within the body. They provide a framework within which exogenous cells and biological 
molecules can be delivered to the defect site whilst also providing a template within which 
neighbouring endogenous cells can attach, migrate and proliferate, thus guiding new tissue formation 
(Koch et al., 2009).  Moreover, the placement of an acellular scaffold within an open dermal wound 
has been seen to prevent premature closure, tissue contraction and scar formation (Wainwright & 
Bury, 2011). Using this technique, the surrounding cells are provided with anchorage in order to 
infiltrate the scaffold and healing can occur without the closure of the wound causing deformation. 
1.3.2 Cells 
When cellular mitotic activity within a tissue is impaired or inadequate, it may be necessary to 
introduce exogenous cells within the tissue system. Cells may be retrieved for incorporation within a 
tissue scaffold from several sources. Whilst xenogeneic cell isolation (from a different species) or 
allogeneic cell sources (from different members of the same species) may provide a larger pool of 
potential cell sources to be exploited at a lower cost, utilisation of these cells comes with a higher risk 
of disease transmission and immune rejection following transplantation (Boneva et al., 2001; Michler, 
1996). Alternatively, autologous cells isolated from the patient receiving tissue engineering therapy 
offers a more promising approach to successful cell transplantation as the likelihood of immune 
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rejection reduces drastically (Langer & Vacanti, 1993). The selection of autologous cells, however, 
is associated with donor site morbidity and in many cases, few cells can be harvested from the donor 
site, generating the need for time consuming culture and expansion of cells. Furthermore, the option 
of autologous cells in the case of diseased tissues and elderly patients might not always be appropriate 
(Heath, 2000). Despite these drawbacks, grafting and implantation using autologous cells and tissues 
is currently the most practiced method in tissue restoration. 
Another consideration in the selection of cells for integration within a tissue-engineering scaffold is 
in the election of differentiated or uncommitted cells. Using primary, differentiated cells in tissue 
constructs involves the isolation of cells that match those to be replaced within a tissue defect, i.e. 
extracting human dermal fibroblasts from a healthy patient’s dermis for culture within a dermal tissue 
construct. This method is convenient as there is no requirement for a differentiation process to be 
undertaken (Hench & Jones, 2005). Despite this, using differentiated cells is associated with donor 
site morbidity and limited availability and cells of this nature encompass a finite proliferative and 
biosynthetic capacity. Furthermore, primary cells, upon multiple passaging, have a tendency to de-
differentiate during ex vivo cultivation thus losing their appropriate phenotype (Fitzpatrick & 
McDevitt, 2015).  
1.3.2.1. Stem cells 
Perhaps the most promising cell types within tissue engineering are stem cells due to their potential 
to overcome the issues associated with committed cells. Their prolonged self-renewal capabilities and 
their ability to differentiate into cells that would otherwise fail to regenerate once committed make 
them of high interest. Three main types of stem cells are available, each with varying differentiating 
capacity: embryonic, adult and induced pluripotent stem cells (Chen et al., 2009). The developmental 
plasticity of human embryos makes them ideal sources for harvesting stem cells. Within the first 
divisions following fertilisation, embryonic stem cells exhibit totipotency (the ability to give rise to 
all cell types) and following this period are pluripotent in nature (having the ability to give rise to 
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many cell types) (Atala et al., 2008). Despite the attraction of having the largest differentiation 
capacity, they are derived from allogenic sources and are associated with many ethical concerns. In 
contrast, autologous, multipotent adult stem cells from that of a patient are available for isolation 
from a variety of tissues including the stroma of bone marrow, dental pulp, hair follicle and 
subcutaneous adipose (Hodgkinson, Yuan, & Bayat, 2009). The progeny of adult stem cells isolated 
from these regions display variable degrees of differentiation along mesodermal, endodermal and 
ectodermal phenotypic lineages (Figure 1.4).  
 
Figure 1.4 - Endodermal, mesodermal and ectodermal germ layers and their differentiated progeny (Kirschstein 
& Skirboll, 2001). 
Other than self-renewal, the role of adult stem cells is to replenish differentiated cell numbers 
following damage or apoptosis. The fact that they exist at low quantities within tissues, however, 
requires stringent differentiation procedures following extraction. An alternative source of stem cells 
termed ‘induced pluripotent stem cells’ (iPSCs) are thus being investigated, defined as pluripotent 
stem cells artificially derived from non-pluripotent stem cells (typically from adult progenitor cells). 
Initially researched in mice in 2006, this technique evolved in 2007 following the introduction of four 
genes (Oct-3/4, Sox2, c- Myc, and KLF4) into adult human dermal fibroblasts.  The morphology, 
proliferation, gene expression and epigenetic status of pluripotent cell-specific genes within iPSCs 
are subsequently concurrent with those of embryonic stem cells following gene transfer (Takahashi 
et al., 2007). Exploration into the use of iPSCs in order to overcome the present issues associated 
with stem cells is currently at the forefront of interest within tissue engineering. 
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The purification and homogenisation of cell populations by removal of unwanted cell types is of 
critical importance when being used in therapeutic intervention as contaminations of undifferentiated 
iPSCs and human embryonic stem cells are potentially capable of forming teratomas following 
injection. Moreover, regulatory T (Treg) cells are currently under study as potential candidates in 
Graft versus Host Disease (GvHD) treatment by promoting tolerance after allogenic cell 
transplantation, yet ironically share several surface antigens with alloreactive T cells, capable of 
eliciting GvHD in recipients. Cells can be separated based on their physical properties (such as cell 
density gradient centrifugation for isolation of leukocytes from whole blood) or biological properties 
(based on plastic adherence status for separating MSCs from bone marrow aspirates), however, 
surface antigen-based techniques, including flow cytometric sorting, are capable of generating the 
highest purity output possible and have been used for the isolation of CD34+ human adipose derived 
mesenchymal stem cells (ADSC) (Donnenberg et al., 2013; McIntyre et al., 2010). 
1.3.3. Media and culture conditions 
For the fabrication of a tissue engineering construct, in addition to the careful selection of scaffold 
material and encapsulation of cells, media and culture conditions are often optimised in order to direct 
the outcome of the final product. Whilst the scaffolding materials play a major part in determining 
cellular morphology and behaviour, additional supplements such as amino acids, growth factors, 
reagents and hormones can provide cells with the biochemical milieus often found in native tissues 
(Lee et al., 2011). By cultivation of mesenchymal stem cells within defined media, the proliferation 
and differentiation of multiple cell lineages may be achieved. For instance, when the compound 
isobutylmethylxanthine (IBMX) is introduced within mesenchymal stem cell (MSC) culture along 
with indomethacin and dexamethasone, PPARγ (peroxisome proliferator-activated 
receptors) activation is upregulated and adipogenesis is initiated (Scott et al., 2011). Alternatively, 
supplementing MSCs with β-glycerophosphate combined with ascorbic acid and dexamethasone at 
critical levels induces osteogenic gene expression by extracellular related kinase phosphorylation 
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(Langenbach & Handschel, 2013). The use of basic media containing essential amino acids is 
typically standard across most tissue engineering practices, providing cells with the metabolites that 
are essential in cell survival and proliferation (Todd, 2014).  
Tissue constructs may be further subjected to a modulated external environment in order to 
recapitulate the environments experienced by native tissues. By tailoring oxygen concentrations, 
hypoxic, normoxic and hyperoxic conditions may be simulated that reflect target tissue environments. 
Culturing keratinocytes at the air-liquid interface in a similar mechanism to how skin epidermis is 
propagated in vivo is one example of how oxygen modulation can be achieved. In other 
circumstances, application of mechanical loading portrays the forces endured by tendons and 
ligaments in vivo, thereby guiding cell phenotype into tenocyte and fibrocyte lineages (Benhardt & 
Cosgriff-Hernandez, 2009; Yazdani, 2016). Using the tissue engineering triad, the specifications for 
a tissue-engineering construct can be met. 
1.4 Specifications for a Tissue Engineering Construct 
Several key parameters need to be met in all tissue-engineering constructs so that the prospective 
implant is successfully integrated within human tissue. In general, constructs must be conducive to 
the in vitro propagation of cells in a way that the native tissue being replicated develops in vivo. The 
suitability of a construct for tissue engineering purposes is usually defined by the following: 
biocompatibility, biodegradability, mechanical properties and scaffold architecture (O’Brien, 2011) 
(Figure 1.5).  
1.4.1 Biocompatibility 
Perhaps the most important principle in the assembly of an effective cell-scaffold complex is 
biocompatibility. It is essential that cells infiltrate the tissue scaffold, assume normal function and 
eventually replace the supporting scaffold by secreting their own ECM without evoking the 













Figure 1.5 - Tailoring biocompatibility, scaffold architecture, biodegradability and mechanical properties in TE. 
tissue construct including cell source and scaffold material. Unless immunosuppressive therapy is 
administered upon transplantation of allogenic and xenogenic cells, the transfer of foreign antigens 
often elicits an inflammatory response within the host, causing rejection of the implanted part. 
Regarding scaffold material, natural material sources are usually favoured over the use of synthetic 
materials as they better resemble the chemical structures of native tissues (Ikada, 2006). 
1.4.2 Biodegradability  
Another consideration when designing a tissue engineering construct is the biodegradability of the 
material within a tissue scaffold. The sole purpose of the scaffold is to encourage cells to establish 
their own ECM network and thus eventually replace the engineered part (Tan & Marra, 2010). 
Material biodegradability should occur in tandem with the rate at which neo-tissue formation occurs 
at the site of implantation. Scaffold by-products should also be excreted from the body without 
impedance on normal bodily function (Brown et al., 2009). 
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1.4.3 Mechanical Properties 
Additional parameters that are key to the successful culture of a tissue engineering construct are the 
mechanical properties of the tissue equivalent. Cells are capable of surveying external mechanical 
influences via mechanotransduction and respond appropriately to such stimulation through 
mechanoreciprocity. Within mechanically static or compliant tissues such as the neural network, 
tissues exhibit low stiffness. In contrast, tissues that are exposed to a high degree of mechanical 
loading, including bone or skeletal muscle, exhibit ECM stiffness that is several orders of magnitude 
greater (Engler et al., 2006). Therefore, the behaviour of cells is inherently tissue-specific and is 
highly dependent upon the stiffness of the substrate in which they reside. Furthermore, in studies of 
mechanical influence on cell behaviour, adult lung cells of fibroblastic origin that have been grown 
on rigid substrates undergo myofibroblast differentiation and assume a contractile phenotype.  Cells 
retain these behaviours even when transferred to soft substrata, implying that cells retain memory of 
past mechanical environments (Humphrey et al., 2014). 
1.4.4 Scaffold Architecture 
Though mechanical properties are important, it is also imperative that a certain degree of porosity 
exists within the construct in order for cell infiltration, the establishment of vascular tissue and 
subsequent diffusion of waste products away from the tissue construct (Hollister, 2005). Within 
scaffolds containing little porosity, pore size and interconnectivity, cell growth and invasion is limited 
due to restricted space and minimal access of cell metabolites. For scaffolds exhibiting high porosity, 
pore size and interconnectivity, insufficient tethering reduces cell traction and limits cell migration 
(Loh & Choong, 2013). The critical balance of ambient porosity conditions is therefore essential for 
the fabrication of a tissue scaffold. Furthermore, surface topography also procures alternative 
mechanisms for cell-biomaterial interplay and regulates cell response. As previously seen, cells 
cultured on rougher surfaces are bound and constrained by high ridges and low valleys as opposed to 
widespread cells on smoother substrata that establish strong actin networks (Wu & Zhang, 2015). 
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1.5 Biofabrication, Additive Manufacturing and 3D Bioprinting 
In its first instance in 1994, the term ‘biofabrication’ was used towards the naturally occurring process 
of the biomineralisation of pearls, but in the world of tissue engineering is commonly related to the 
use of biological materials and cells using specific mechanisms for construction (Groll et al., 2016). 
Additive manufacturing (or additive layer manufacturing) is a set of technologies used to describe the 
build-up of 3D objects in a layer-by-layer fashion, and has been applied as a technique to achieve the 
manufacture of biofabricated constructs in tissue engineering. 3D bioprinting is an example of 
additive manufacturing, in that combinations of cells and materials are deposited in a subsequential 
manner to form 3D tissue or organ-like structures. These three terms, biofabrication, additive 
manufacturing and 3D bioprinting, are often used like-for-like within the literature, but for the sake 
of clarity, they indeed have slightly different definitions when referred to in different contexts (Van 
Kampen et al., 2019).  
1.6 Current Progress in Tissue Engineering 
Once a topic implicated with numerous hurdles, tissue engineering has seen monumental 
advancements towards tissue restoration within the past decade. Several major challenges associated 
with identifying renewable cell sources, tuning biomaterial properties and improving vascularisation 
and host responses have been addressed, allowing for more intricate and intelligently designed tissue 
constructs to be researched and utilised (Khademhosseini & Langer, 2016). Arguably, one of the most 
impressive technological advancements in recent years is the realisation of 3D printed implants. 
Multiple 3D printed scaffolds have been approved by the Food and Drug Administration (FDA) and 
European Medicines Agency (EMA) - all within the last 10 years (Dzobo et al., 2018). 3D printing 
and additive manufacturing have already seen the fabrication of custom-made medical implants 
including a bronchial splint (Zopf et al., 2013), a cranial plate (Di Prima et al., 2016) and an artificial 
knee (Koeck et al., 2011). Currently, efforts are focused on making the transition of tailor-made 3D 
bioprinted constructs, containing cells, from the laboratory to market. 
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1.7 Present Challenges in 3D Bioprinting and Tissue Engineering 
Due to the interdisciplinary nature of the tissue engineering field and the high degree of variation 
within tissues between patients, there are still many challenges that need to be addressed before tissue 
engineering patient-specific constructs becomes commonplace in the clinic. One of the biggest 
hurdles on the clinical translation of tissue engineered constructs is in the standardisation of 
bioprinting materials, techniques and software to reduce tissue engineering construct variances and 
to better predict patient outcome (Chandra, Soker, & Atala, 2020; Grounds, 2018).   
Although 3D bioprinters can be used to print patient-specific implants that conform specifically to 
the patient’s defect, one of the major difficulties in 3D bioprinting soft materials is in retaining 
construct resolution once deposited onto a planar surface. Some research has been undertaken in a 
bid to improve shape fidelity by using co-extrusion, crosslinking during printing and also broadening 
of the scaffold base. Other efforts have been made in a bid to rectify this issue by using high viscosity 
materials such as hydroxyapatite thus improving structure integrity (Kang et al., 2016). The 
mechanical properties of the matrix in which cells reside, however, have been seen to dictate cell 
phenotype and proliferation in mesenchymal stem cells (MSCs) (Huang et al., 2015), rendering this 
approach as unsuitable in culturing cells which require much softer substrates like adipocytes. 
Another problem with 3D bioprinting lies with the difficulty in integrating multiple layers of 
mechanically varying materials, preventing the production of multi-layer constructs with regional 
variations in mechanical features. This impacts on the in vitro fabrication of structures that mimic the 
complex environments within native tissue in vivo. The work presented in this thesis is aimed at 
addressing these problems to produce tissue engineering constructs that more appropriately replicate 





1.8 Research Rationale and Aims 
Biopolymer hydrogels are frequently used in tissue engineering scaffolds as they have 
physicochemical similarities to extracellular matrix (ECM). The anisotropic nature of ECM in both 
material and cellular composition, however, is particularly challenging to replicate. Therefore, 
to facilitate the creation of more native environments, techniques to integrate multiple materials with 
different chemical and mechanical behaviour into a single construct are of great interest. 3D 
bioprinting using Additive Layer Manufacturing (ALM) is one approach that has showed promise to 
create detailed constructs of defined shapes. Recently in our laboratories, we have developed a 
technique to create cell-laden constructs from low viscosity biopolymers with the potential to design 
distinctly anisotropic structures from multiple materials using suspended manufacture. This technique 
involves the employment of a sacrificial supporting medium that suspends the tissue construct as it is 
being fabricated, prior to solidification, extraction and subsequent culture of the tissue construct.  
Initially, the supporting medium used in suspended manufacture for tissue construct engineering was 
characterised. The potential of suspended manufacture was then investigated, combined with the use 
of a 3D bioprinter for upscale automation of tissue construct fabrication and thus seeing the evolution 
of Suspended Layer Additive Manufacturing (SLAM). Following this, the generation of multi-layer 
gradient constructs was explored in order to assess the feasibility of producing heterogeneous tissue 
constructs that are akin to native tissues. Finally, a tri-layer skin model was designed and 





1.9 Thesis Outline 
This thesis comprises an introductory section on tissue engineering, native tissue and the manufacture 
of tissue engineering constructs including current progress and present challenges to date (Chapter 
1). The research rationale and aims are also outlined within this section. 
A further two introductory chapters are presented to cover the common themes throughout the thesis. 
Chapter 2 focuses on the importance of biopolymer hydrogels as ECM mimics in tissue engineering. 
Their use in therapeutic applications is touched upon with a greater emphasis on their role in tissue 
engineering constructs. Six biopolymers in particular are discussed in detail, namely agarose, gellan 
gum, ɩ-carrageenan, pectin, alginate, and collagen. These materials are featured within the results 
chapters later in the thesis. The current roles and implications of these materials within tissue 
engineering are also highlighted and the significance of mechanical behaviours is discussed. 
In Chapter 3, 3D bioprinting is introduced with an emphasis on its role in the creation of tissue 
engineering constructs. The process of 3D bioprinting tissue constructs, from the design of the print 
file to structure fabrication, is discussed in detail. Furthermore, the utilisation of embedded printing 
techniques is explored with a specific interest in suspended manufacture and fluid gel formation – a 
common feature throughout the thesis results sections.  
Chapter 4 is the first of the results sections comprised of the analysis and characterisation of the 
supporting bed. In order to define the mechanisms of suspended manufacture and define print 
resolution, brightfield and scanning electron microscopy, particle size, particle volume fraction, 
rheological, resolution and diffusion studies were undertaken. An alternative approach using an 





The development of the Suspended Layer Additive Manufacturing method is presented in Chapter 5. 
Firstly, cell-laden tissue constructs are printed by hand, demonstrating the method viability. The 
construct fabrication process is then refined using a commercially available 3D bioprinter for the 
manufacture of a variety of structures using a range of cells and polymers.  
Following on from this work, Chapter 6 features the fabrication of multi-layered gradient constructs 
that are synonymous to those of native tissue environments. The organisation of cellular, micro-
architectural, mechanical and biochemical gradients within a single construct is demonstrated using 
a selection of cells and polymers in multiple configurations. These tissue constructs have the potential 
to replicate tissues by intelligently tailoring and designing construct microenvironments that mimic 
target tissues in vivo. 
In Chapter 7, the creation of tissue / organ-like structures by example of a multi-layered skin model 
is investigated. Models feature a subcutaneous layer complete with adipocytes, upon which a dual 
compartment dermis is integrated followed by a surface seeded keratinocyte layer. This section of 
work sees the design and development of a three-tier skin construct designed for therapeutic 
implantation within chronic non-healing wounds. Firstly, the extraction, isolation and culture of 
adipose derived mesenchymal stem cells (ADSC), human dermal fibroblasts (HDF) and human 
epidermal keratinocytes (HEK) from a human abdominoplasty is described. Tissue engineering skin 
constructs are meticulously designed and manufactured, featuring gradients in cell densities and 
phenotypes and material composition to direct the anisotropic ordering throughout the construct as 
displayed in native human skin tissues. Analysis of skin models was undertaken using histological 
and immunohistochemical staining, brightfield and scanning electron microscopy, shear rheology and 
by incorporation into an ex vivo porcine wound model. 
Finally, Chapter 8 provides a summary of the works featured within this thesis along with conclusions 
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Chapter 2 – Biopolymer Hydrogels in Tissue Engineering 
2.1 Biopolymers in Therapeutic Applications 
Biopolymers are polymeric substances derived or extracted from living organisms. They have become 
highly popular within the biomedical, agricultural and industrial disciplines within the last half 
century and are used in drug delivery, controlled pesticide release and food preparation applications. 
Due to their natural origins, many biopolymers elicit minimal host immune responses and exhibit 
biodegradable properties once incorporated into the human body, making them of high interest in 
therapeutic applications (Vert, 2001). Biopolymers can be processed in the form of sponges, films, 
electrospun fibres, nanoparticles and hydrogels and the selection of both biopolymer and processing 
strategy is crucial when incorporating into a therapeutic system. For instance, processing soft 
materials into films, sponges and nanoparticles can further reduce mechanical stability causing 
premature degradation  (Reddy et al., 2015). Also, using dense materials to form electrospun fibres 
can cause insufficient porosity for the facilitation of cell migration and media infiltration (Tiwari et 
al., 2016). Biopolymer hydrogels are often employed in tissue engineering constructs as their tuneable 
chemical and mechanical characteristics allow greater freedom and versatility over tissue model 
fabrication. As well as natural hydrogels, tissue constructs can also be synthesized from synthetic 
hydrogels such as polyamides and polyethene glycol, however they are typically less biocompatible. 
2.2 Biopolymer Hydrogels in Tissue Engineering Constructs 
Biopolymer hydrogels are water swollen polymeric materials that feature highly organised intrinsic 
networks. These materials are of particular interest when designing 3D tissue scaffolds and constructs 
as their microarchitecture and mechanical properties largely resemble native ECM (Park et al., 2010). 
A multitude of parameters including porosity and mechanical strength may be manipulated within 
biopolymer hydrogels by tuning polymer concentration, crosslinking density and by careful 
manipulation of key conditions during sol-gel transition.  
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Many biopolymer hydrogels undergo sol-gel transition, whereby a disordered solution containing 
randomly dispersed polymers assembles to form a well ordered network of polymer molecules thus 
creating a more stable structure (Rudé Payró & Llorens Llacuna, 2006). Some hydrogels achieve 
crosslinking via thermal means by appropriately raising or reducing solution temperature in order to 
trigger optimum sol-gel transition kinetics. Others require further initiation via ionotropic mediation, 
such as the addition of ions to charged biopolymers, or alternatively by assembly with an oppositely 
charged polymer through complex coacervation (Gasperini et al., 2014). Furthermore, by chemically 
crosslinking polymers, gelation is mediated through the formation of covalent bonds between the 
polymer and crosslinker and ultraviolet (UV) radiation can be used in order to initiate crosslinking in 
modified biopolymers containing methacrylates (Hoare & Kohane, 2008). The latter two routes of 
achieving gelation, however, exert much harsher external environments on tissue culture systems and 
are therefore not investigated any further within this thesis. 
2.2.1 Chemically Crosslinked Hydrogels 
2.2.1.1 Agarose 
Agarose is a natural polysaccharide that is purified from components of the cell walls of red algae 
(Rhodophyta). It is commonly used in biological applications as a diagnostic tool in the separation of 
DNA fragments in gel electrophoresis and has also more recently found a place in tissue engineering 
approaches – especially in cartilage repair (Kim et al., 2011). Agarose exists as a repeating 
disaccharide unit of β-D-galactose and anhydro-α-L-3,6 galactose (Figure 2.1A). The gelation 
mechanism that occurs when cooling agarose from a solution to a gel is a physical and thermo-
reversible crosslinking process. When the critical sol-gel temperature is exceeded (above 80 °C), 
agarose exists as random coils in deionised water. Upon cooling, these random coils rearrange 
forming single helices and transition into a highly ordered double helix structure once quiescently 









Figure 2.1 - A) The chemical structure of agarose containing 1,3 linked β-D-galactose and 1,4 linked anhydro-α-
L-3,6 galactose subunits. B) The thermal gelation mechanism of agarose: first stage exhibits random coils in an 80 
°C+ solution, random coils transition to single helices in the intermediate stage and form double helices in the final 
gel state upon cooling below 37 °C.  
2.2.1.2 Gellan gum 
Gellan gum (gellan) is an anionic polysaccharide produced from an aerobic fermentation by-product 
within the bacteria Sphingomonas elodea. The manufactured product is commonly available as either 
a high acyl or low acyl isoform, characterised by their potential to create a soft gel or a hard gel 
respectively (Miyoshi et al., 1996). Both isoforms are capable of undergoing the transition from 
random coils in a hot solution to a well-ordered gel containing double helices upon cooling and the 
addition of cations further establishes the creation of a stable hydrogel through the formation of 
junction zones (Matricardi et al., 2009).   
Gellan is an ideal candidate for the encapsulation of cells as the gelation mechanisms of gellan are 
gentle and have no adverse effects on cell viability. Gellan itself does not contain cell attachment 
moieties and can therefore be used as a cell carrier within tissue constructs or alternatively can 
undergo further modification by incorporation of arginyl-glycyl-aspartic acid (RGD) sequences that 
are conducive to the attachment of cells (Stevens et al., 2016). The chemical structures of the 
tetrasaccharide repeating units 2 D-glucose:1 D-glucuronic acid:1 L-rhamnose and the chemical 


















Figure 2.2 - Chemical structures of A) high acyl gellan and B) low acyl gellan. C) The ionotropic crosslinking 
mechanism for the gelation of gellan: first stage exhibits random coils in an 85 °C solution, helices form upon 
cooling in the intermediate stage and form double helices with the addition of cations in the final gel state. 
2.2.1.3 ɩ Carrageenan 
There are three principal members within the carrageenan family named iota (ɩ), kappa (κ) and lambda 
(λ) (Figure 2.3), all of which are extracted from red algae (Rhodophyta). Each isoform differs 
chemically based on the degree of sulphation and subsequently the characteristics of the gels also 
differ, with only ɩ and κ isoforms being capable of producing self-supporting gels (Chandrasekaran, 
1998). Iota carrageenan (which forms soft elastic gels) is made of an alternating sequence of β1-3 
linked and α1-4 linked D-galactose residues with one sulphate on every residue as opposed to per 
disaccharide repeat unit in κ carrageenan (which forms stiff, brittle gels). Gelation of ɩ carrageenan, 
as featured later in this thesis, is mediated through cooling of polymer solutions triggering the 
formation of intermolecular double helices and the addition of cations further increases polymer ionic 
strength (Piculell et al., 2011). Alternatively, salts within cell culture media are sufficient enough to 
initiate crosslinking within an ι carrageenan tissue construct (Mehrban et al., 2009).  
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Relatively little research has been done on the use of ι carrageenan in tissue engineering scaffolds 
compared with other polysaccharide hydrogels such as alginate, with contradictions in the available 
literature on the cytotoxicity of ι carrageenan on cells (Calvo et al., 2019; McKim et al., 2016). In 
other research, the potential of ι carrageenan as a material for cell encapsulation has been highlighted, 
exhibiting proliferation and even attachment of entrapped cells and suitable mechanical properties 






Figure 2.3 - Chemical structures of kappa (κ), iota (ɩ) and lambda (λ) carrageenan.  
2.2.1.4 Pectin 
Pectins are a family of complex carbohydrates extracted from plant cell walls including citrus peels 
and like agarose, gellan gum, ι carrageenan and alginate, they have a place in the food industry as 
food stabilisers, viscosity builders, emulsifiers and satiety increasers. The chemical composition of 
this negatively charged hydrocolloid consists of a 1,4-linked α-d-galacturonic acid backbone and 
occurs with varying degrees of methyl esterification (DE) with high (>50% esterified acid units) and 
low (<50% methyl ester groups) variants (Sudheesh Kumar et al., 2013) (Figure 2.4). Rhamnose 
residues appear at random intervals on the main chain causing a kink in the otherwise linear chain 
and side chains of arabinans and galactans also feature within pectin molecules (Morris et al., 2008). 
High methyl ester (HM) pectin gelation requires low pH and water activity by the addition of sugar 
and acid whereas low methyl ester (LM) pectin forms gels in the presence of divalent cations in the 
formation of the ‘egg box’ model.  
κ carrageenan ι carrageenan λ carrageenan 
n n n 
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In tissue engineering, there have been some reports of the use of pectin in scaffolds and constructs, 
but most often are incorporated with other materials. Examples include pectin blended with silk 
fibroin for skin tissue engineering (Türkkan et al., 2018), calcium phosphate for bone tissue 
engineering (Munarin et al., 2011) or modified to contain RDG complexes also for bone tissue 
engineering (Zhao et al., 2016). Pectin in conjunction with carboxymethylcellulose has also been 
demonstrated as a suitable candidate in the healing of partial thickness wounds in a rat model, with 
indications of ECM deposition, re-epithelialisation and promoting skin regeneration (Ninan et al., 
2014). 
 
Figure 2.4 - Gelation mechanism of A) high methoxyl (HM) and B) low methoxyl (LM) pectin.  
2.2.1.5 Alginate 
Alginate is a negatively charged polysaccharide and is mainly extracted either from the cell walls of 
brown algae such as Laminaria and Ascophyllum species or from bacterial exopolysaccharide 
including Pseudomonas and Azotobacter. Alginates can vary based on the ratios of which the uronic 
acid residues (1-4′)-linked β-d-mannuronic acid (M blocks) and α-l-guluronic acid (G blocks) are 
present. Copolymerisation of M and G blocks form linear blocks (GM blocks) (Aramwit, 2016) 
(Figure 2.5). Alginates with a high content of G blocks are associated with the formation of stiffer 
gels than those with higher M content as the induction of crosslink formation is mediated by 
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interactions between divalent cations and carboxylic acid groups within the G blocks (Park et al., 
2009). Alginates also assume the ‘egg box’ structure when crosslinked through a similar mechanism 
to the gelation of pectin (Gotoh et al., 2004). 
Alginate is capable of absorbing water and body fluids up to 20 times its mass and is often employed 
in many commercially available wound dressings, such as AlgiDERM, for the maintenance of moist 







Figure 2.5 - Chemical structure of alginate containing linear blocks α-L-guluronate (G) and β-D-mannuronate (M) 
with a variation in composition and sequence.  
2.2.2 Physically Crosslinked Hydrogels 
2.2.2.1 Collagen 
Collagen is present in all connective tissues and is therefore one of the most extensively studied 
protein hydrogels within the tissue engineering field. Made predominantly by fibroblasts, there are 
29 distinct collagen variants which have been identified and all display a left handed triple helix 
structure (Parenteau-Bareil, Gauvin, & Berthod, 2010). Each collagen molecule consists of an 
assembly of three α chains that are packed into a tight formation. Each α chain is composed of more 
than a thousand amino acids following the sequence Gly-X-Y-, where the X and Y locations are most 
often occupied by proline and 4-hydroxyproline (Prockop, 1995) (Figure 2.6). Type I collagen exists 
in fibrils in its polymerised form at neutral pH, is distributed throughout bone, skin, tendons ligaments 
and cornea and represents 90% of total collagen in the human body (Alberts et al., 2002).  
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Figure 2.6 - Chemical structure of collagen type I. A) Primary amino acid sequence, B) secondary left-handed helix 
and C) tertiary right-handed triple-helix structure. 
Factors that control the polymerisation process for the formation of a collagen gel matrix include 
temperature, pH, ionic strength and concentration. Furthermore, the addition of more crosslinking 
agents can also affect fibrillogenesis (Antoine et al., 2014). The final outcome of the collagen gel 
when processed under a variation of these conditions can display differences in gel mechanics and 
fibre structure, with reports of higher pH and lower gelation temperatures producing more 
mechanically robust gels with increased collagen fibril packing and decreased fibre diameter (Achilli 
& Mantovani, 2010).  
2.3 Characterising Biopolymer Mechanical Properties  
The mechanical characterisation of biopolymer hydrogels is imperative in their utilisation within 
tissue engineering scaffolds and constructs. It provides critical information on the hydrogel’s 
mechanical behaviour during printing and handling, integrity following gelation and can aid in 
describing potential relationships between hydrogel stiffness and cell behaviour. These data are 
invaluable when comparing the mechanical milieus within candidate biopolymer scaffolds to those 
found in native tissues. Rheology is one method that is used to assist in characterising the mechanical 




rheological terminology is presented in order to outline how these materials may be studied as 
featured within the results section of this thesis. 
2.3.1 Rheology 
The term rheology comes from the Greek words “rheo” (meaning to flow) and “logos” (meaning 
study) and is the science of deformation of matter in response to an applied mechanical force (Struble 
& Ji, 2001). The effect of the force applied is represented by the materials’ liquid or solid like 
behaviour – as denoted numerically by viscosity and viscoelasticity. Most materials are not 
exclusively liquid or solid and exhibit an intermediate characteristic of both under a given applied 
stress. However, the Newtonian liquid and Hookean solid models serve to represent the extreme ends 
of the scale. Elastic “solid-like” matter is seen to fracture upon an applied influential force whereas 
viscous “liquid-like” matter is seen to flow and it is the degree to which matter fractures or flows 
from which rheological behaviour may be determined (Kavanagh & Ross-Murphy, 1998). 
Stress can be applied in three ways in order to determine the moduli of a material, i) 
compression/tension, ii) bulk compression and iii) shear (Figure 2.7). Compression and tension 
testing are used to determine the Young’s modulus (E, (Pa)) of a material and is quantified by dividing 
perpendicular stress by strain (Mohammed H. Mahdi, 2016). Bulk testing is seldom practised on soft 
materials such as biopolymer hydrogels, however this method incorporates the application of isostatic 
compression divided by the volumetric strain for calculation of the bulk modulus (K, (Pa)) (Biron, 
2015). Finally, shear modulus (G, (Pa)) is measured by applying a lateral shear upon a sample’s 
surface and is a more suitable approach to measuring the mechanical characteristics of samples that 




Figure 2.7 - Schematic illustration of longitudinal, lateral and isotropic deformation for moduli measurement. 
2.3.1.1 Shear rheology 
In the case of shear rheology, the force applied to the material is described either in terms of shear 
stress, measured by force applied per unit area (Equation 2.1), shear strain, defined as a ratio of 
extension per unit length (Equation 2.2) or shear rate, calculated by the change in strain over the 
change in time (Equation 2.3). 
𝑆ℎ𝑒𝑎𝑟 𝑠𝑡𝑟𝑒𝑠𝑠 𝜎 (𝑃𝑎) =  
𝑓𝑜𝑟𝑐𝑒 𝐹 (𝑁)
𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎 𝐴 (𝑚2)
   Equation 2.1 
𝑆ℎ𝑒𝑎𝑟 𝑠𝑡𝑟𝑎𝑖𝑛 𝛾 =
𝑑𝑒𝑓𝑜𝑟𝑚𝑎𝑡𝑖𝑜𝑛 𝑢
ℎ𝑖𝑔ℎ𝑡 𝑑
     Equation 2.2 
𝑆ℎ𝑒𝑎𝑟 𝑟𝑎𝑡𝑒 ?̇?(𝑠−1) =  
𝑐ℎ𝑎𝑛𝑔𝑒 𝑖𝑛 𝑠𝑡𝑟𝑎𝑖𝑛 𝛿𝛾 
𝑐ℎ𝑎𝑛𝑔𝑒 𝑖𝑛 𝑡𝑖𝑚𝑒 𝛿𝑡 (𝑠)
   Equation 2.3 
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The shear mechanical behaviour of a material may be quantified as a function of material flow or 
deformation. The degree to which a material resists flow upon an applied force is defined by viscosity 
and is important in tissue engineering biopolymer scaffolds during biopolymer solution preparation 
and handling. Deformation of matter, on the other hand, deals with how a sample behaves before it 
flows and determines sample properties in terms of viscoelasticity (Lyklema, 2005).   
2.3.1.1.1 Measuring viscosity 
Viscometric tests produce analytical data on material viscosity following the application of shear. 
Here, a sample is loaded onto a flat lower plate and an upper cone plate rotates uni-directionally, over 
a set range of shear rates, across the sample’s surface. The cone creates a uniform shear across the 
whole of the sample unlike a parallel plate and the range of shears used within the test are used to 
replicate the range of shear forces experienced by the material during handling. For example, very 
low shear rates of ~0.001s-1 simulate the shear forces experienced by a material during storage and 
can indicate sample quality and stability. Alternatively, high shear rates of ~100s-1 can simulate higher 
shear forces such as dispensing and applying a colloidal hand cream (Malvern Panalytical, 2016). 
Apparent viscosity is thus calculated by the shear stress divided by the shear rate (Equation 2.4). 
𝐴𝑝𝑝𝑎𝑟𝑒𝑛𝑡 𝑣𝑖𝑠𝑐𝑜𝑠𝑖𝑡𝑦 ƞ (𝑃𝑎 𝑠) =  
𝑆ℎ𝑒𝑎𝑟 𝑠𝑡𝑟𝑒𝑠𝑠 𝜎 (𝑃𝑎) 
𝑆ℎ𝑒𝑎𝑟 𝑟𝑎𝑡𝑒 ?̇? (𝑠−1)
   Equation 2.4 
There are three general flow behaviours of a sample when measuring viscosity: Newtonian, shear 
thinning (pseudoplastic) and shear thickening (dilatant) (Figure 2.8). For Newtonian fluids such as 
silicone oil, the viscosity is constant and equal to the Newtonian viscosity of the fluid, however for 
non-Newtonian fluids, the viscosity of the material is shear rate dependent. As viscosity is also time 
dependant, shear-thinning materials such as polymers and shear-thickening materials including 
cornflour often exhibit a hysteresis loop. Here, upon the removal of shear, polymer chain re-
entanglement is not proportional to polymer dis-entanglement – a phenomenon known as thixotropy 







Figure 2.8 - Flow behaviour of materials when measuring sample viscosity: Newtonian, shear thinning 
(pseudoplastic) and shear thickening (dilatant). 
Factors that influence the viscosity of a polymer include molecular weight, polymer concentration 
and particle size. Polymers with a higher molecular weight have a larger intrinsic viscosity 
(contribution of viscosity to a solution) and stronger forces between intermolecular entanglements, 
which are causative of more viscous properties (Kasaai et al., 2000).  
From these data, information on the material at rest may also be ascertained by observing yield stress 
and zero shear viscosity. Samples with a yield stress exhibit an ever-increasing viscosity as shear rate 
approaches zero meaning the material is solid like and non-flowing when stationary. This is important 
in materials such as paint, in that emulsions have good stability during storage and will shear thin 
upon a given applied shear to allow spreading before restructuring to prevent drippage from surfaces. 
Materials with zero shear viscosity exhibit a plateau as the shear rate approaches zero and indicates 
that the material is liquid like when stationary. Viscosity tests using shear rheology can measure 
material characteristics by applying a single shear rate or subjecting to a range of shear rates (Cheng, 
1986). These data are invaluable, especially within industrial processes, in designing materials for 
different printing platforms which require specific ranges of viscosities to allow dispensing. 
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2.3.1.1.2 Measuring viscoelasticity 
A large proportion of materials exhibit an intermediate of solid-like and liquid-like behaviour, which 
can be quantified simultaneously by measuring viscoelasticity. Using oscillating shear rheology, a 
sinusoidal stress (or strain) is introduced upon a sample located between an oscillatory upper plate 
and a static bottom plate. The applied sinusoidal stress is conducted through the sample and either 
dissipated by friction in viscous materials or transmitted in elastic materials (Deshpande, 2018). By 
using the values of input shear stress and measured strain, the complex modulus (G*) (and thus the 
material stiffness) can be calculated (Equation 2.5). 
𝐶𝑜𝑚𝑝𝑙𝑒𝑥 𝑚𝑜𝑑𝑢𝑙𝑢𝑠 𝐺∗(𝑃𝑎) =  
𝑆ℎ𝑒𝑎𝑟 𝑠𝑡𝑟𝑒𝑠𝑠 𝜎 (𝑃𝑎)
𝑆ℎ𝑒𝑎𝑟 𝑠𝑡𝑟𝑎𝑖𝑛 𝛾
   Equation 2.5 
Different types of material display different phase angles between the applied and measured 
sinusoidal signal and can be used to determine viscoelasticity. Materials that demonstrate purely 
elastic behaviour are said to have a stress and strain that are ‘in phase’ with a phase angle of zero, 
whereas purely viscous materials have a stress and strain that are one quarter of a cycle ‘out of phase’ 
and therefore have a phase angle of 90 ° (Malvern Panalytical, 2016) (Figure 2.9).  
 
Figure 2.9 - Characterisation of elastic ‘in phase’ and viscous ‘out of phase’ materials. 
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When defining elastic (storage - Gʹ) and viscous (loss - Gʺ) moduli separately, storage modulus is 
calculated using the Sin function whereas loss modulus is calculated using the Cos function 
(Equations 2.6 and 2.7). If the phase angle is less than 45 °, Gʹ > Gʺ and the sample is more solid 
like, whereas if the phase angle is greater than 45 °, Gʹ < Gʺ and the sample is more liquid like. 
𝑆𝑡𝑜𝑟𝑎𝑔𝑒 𝑚𝑜𝑑𝑢𝑙𝑢𝑠 𝐺ʹ (𝑃𝑎) =  
𝑆𝑡𝑟𝑒𝑠𝑠 𝜎 (𝑃𝑎) 
𝑆𝑡𝑟𝑎𝑖𝑛 𝛾
 𝐶𝑜𝑠𝛿   Equation 2.6 
𝐿𝑜𝑠𝑠 𝑚𝑜𝑑𝑢𝑙𝑢𝑠 𝐺ʺ (𝑃𝑎) =  
𝑆𝑡𝑟𝑒𝑠𝑠 𝜎 (𝑃𝑎) 
𝑆𝑡𝑟𝑎𝑖𝑛 𝛾
 𝑆𝑖𝑛𝛿   Equation 2.7 
There are two parts of the oscillation that can be controlled in order to measure different parameters 
of viscoelasticity: oscillation amplitude and oscillation frequency. In general, amplitude stress (or 
strain) sweeps are first conducted in order to determine the linear viscoelastic region (LVR) of a 
sample (Figure 2.10). Here, the amount of stress required to break a material can be ascertained, 
indicating the stability of a colloid. Data is acquired at constant frequency and Gʹ is typically more 
sensitive to the LVR. Shear stresses within the LVR measure small deformations in a sample whereas 
shear stresses that exceed the LVR measure large deformations and cause the sample to fracture. 












By recording Gʹ and Gʺ moduli over a range of frequencies under a set shear stress that falls within 
the LVR, a fingerprint spectrum of the material can be obtained. The material phase angle at rest (0 
Rad s-1) is then used to classify samples into one of three general behaviours: viscoelastic solid (δ = 
0 °), gel (δ is independent of frequency) or viscoelastic liquid (δ = 90 °) (Figure 2.11).  
 
 
Figure 2.11 - Frequency sweeps for the determination of viscoelastic solid, gel and viscoelastic liquid behaviour of 
a material. 
During a frequency sweep, low frequencies are used to measure longer timescales whereas high 
frequencies are used to measure more rapid successions of oscillatory shear. Viscoelastic solids are 
defined by a dominance of Gʹ over Gʺ at low frequencies and become more liquid-like as frequency 
increases. Alternatively, viscoelastic liquids exhibit a dominance of Gʺ over Gʹ at low frequencies 
and become more solid like as frequency increases. Gels on the other hand exhibit no dependency on 
angular frequency. Using these principles, play putty is classified as a viscoelastic liquid in contrast 
to hand cream, which is characterised as being a viscoelastic solid. 
2.3.2 Assessing Polymer Rheology to Determine Suitability within Tissue Engineering Constructs 
When carrying out rheological measurements on polymers as potential tissue engineering resources, 
temperature is another parameter that should be assessed. The viscoelasticity of a sample can be 
analysed under a set shear rate over a range of temperatures in order to determine gelation kinetics 
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within polymers that thermally undergo sol-gel transition. Temperature can also be controlled and set 
to a physiologically relevant value during an amplitude stress sweep in order to determine polymer 
suitability within a tissue scaffold or construct destined for implantation. Ultimately, shear rheology 
is an effective way of determining not only the suitability of materials within tissue engineering 
implants, but also on the materials during handling and printing. Without the feasibility of 3D 






























Chapter 3 – 3D and Embedded Bioprinting 
3.1 Hydrogel Based 3D Bioprinting Systems 
Three-dimensional (3D) printing is an additive layer manufacturing (ALM) process in which natural 
(including biopolymer hydrogels) or synthetic material is layered for the construction of a 3D model. 
The potential of 3D printing has been realised within the engineering, manufacturing and medical 
sectors and is currently seeing an evolving extension of applications further afield. More specifically, 
3D bioprinting is used to design cell-laden constructs of defined shape which are either destined for 
implantation or for in vitro testing (Grogan et al., 2012). Biopolymer hydrogels will be the focus in 
this thesis due to their printability and their potential in mimicking native human tissue matrices. 
There are three main methods in which biopolymers may be 3D bioprinted based upon the type of 
bioprinter used for construct fabrication: i) laser assisted, ii) inkjet and iii) micro-extrusion (Figure 
3.1). Choosing the appropriate printer depends predominantly on the nature of the scaffolding 
material which is to be printed (Murphy & Atala, 2014). Laser assisted bioprinters (used in a method 
commonly known as laser-induced forward transfer) are the most attractive in respect to cell viability 
and they also exhibit the most desirable print resolution at the microscale level, yet are also the most 
costly and time consuming during print preparation (Guillemot et al., 2010). These types of printer 
operate by focusing laser pulses onto an adsorbing layer of glass ribbon that generates a high-pressure 
bubble, thus propelling the bioink towards a collector substrate. Inkjet printers are a suitable method 
of 3D bioprinting when dealing with very low viscosity materials (3.5–12 mPa/s) and they perform 
with admirable preparation and print timescales. They operate on either a thermal or acoustic basis, 
creating bioink droplets through electrical heating of the printhead producing air pressure pulses, or 
using vibrations for alternating current (AC) propagation in piezoelectric crystals. These are the 
cheapest and most predominantly used bioprinters and were originally adapted from 2D ink-based 




Figure 3.1 – Current 3D bioprinting methods used for dispensing hydrogel bioinks (Malda et al., 2013). 
Pneumatic based bioprinters use an automated robotic arm which controls extrusion of material over 
X, Y and Z axis coordinates. Compressed air is supplied to a cartridge whose piston extrudes material 
through a nozzle and material is deposited onto a Z-stage collector. These techniques offer greater 
cell density capabilities over a larger range of material viscosities and gelation methods. Within many 
micro-extrusion based units, deposited material can be crosslinked by adjusting temperature, 
introducing crosslinking agents or subjecting the 3D model to UV radiation (Murphy & Atala, 2014). 
The technology employed in this thesis is focused on robotic, pneumatic, micro-extrusion printing. 
3.2 3D Bioprinting Process using Pneumatic Extrusion 
Like other 3D biofabrication methods, pneumatic extrusion-based printing starts with a model 
preparation stage and the generation of a 3D print file for the printer to replicate. A 3D model may 
be obtained using medical imaging techniques or by fabrication within computer automated design 
(CAD) software. The 3D model is then translated into a series of printable layers using coding 
language as instructions for the printer to follow. Depending on the type of file that the printer 
processor reads, the file may undergo conversion into another file format. The bioink is formulated 
by mixing cells and material and a range of printing parameters may then be adjusted in order to 
optimise the generation of the final printed part during the construct fabrication stage. The construct 
may then undergo further propagation before being used for its intended application (Figure 3.2) 




Figure 3.2 – Chronological stages for the design and production of a 3D bioprinted construct for tissue engineering. 
3.2.1 Model Preparation 
Preparing to 3D bioprint a tissue construct is constituted mainly of two parts, namely i) imaging data 
acquisition and ii) 3D model reconstruction. The use of either medical imaging or computer aided 
design (CAD) software produces anatomic data which can then be transformed into a readable 
language which complies with 3D bioprinter operation (Vijayavenkataraman et al., 2018).  
3.2.1.1. Imaging 
Before 3D bioprinting can commence, it is important to interpret the target tissue architecture in order 
to fully capture the structure’s dimensions and to enhance the scaffold’s performance as an implant 
or tissue model. The selection of imaging software can be tailored to specific situations appropriately, 
in that computed tomography (CT) is more suitable in imaging hard tissues such as bone and tumour, 
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whereas MRI imaging is more appropriate for the assessment of soft tissue (Chua & Yeong, 2014). 
Further considerations into imaging choice include target tissue accessibility, resolution and exposure 
to potentially harmful radiation (Ballyns & Bonassar, 2009; Nam et al., 2014). 
3.2.1.2 3D modelling and slicing 
Following imaging data acquisition, 3D models may be subjected to further modification via the 
introduction of internal contours, pores and channels in order to facilitate cell attachment, 
proliferation, nutrient flow and subsequently, tissue maturation (Ozbolat et al., 2012). Scaffold design 
may also be initiated during the 3D modelling step using CAD software, such as SOLIDWORKS®, 
as opposed to using medical imaging software. These 3D models are usually presented in 
stereolithography (STL) file format which describes surface geometry using a series arrangement of 
surface tessellations for complete build-up of the whole structure (Kai et al., 1997). It is also at this 
point that certain printing parameters may be selected, such as the infill pattern, infill density, printing 
speed, printing temperature and the inclusion of overhang-supporting material. 
Once the geometry surface has been defined, models undergo manufacturing through slicing software 
such as Slic3r. This type of processing renders the model in a stack of horizontal layers which the 3D 
bioprinter uses to extrude material following the principles of additive layer manufacture (ALM). In 
some cases, it is necessary to convert the file into G-code file format for language compatibility 
between the file and the printer. The G-code comprises a series of instructions manifested as letters 
and numbers that assign a printer function (Rajapakse et al., 2018). These functions range from 
directing valve opening and closing times in order to orchestrate material extrusion, to determining 
nozzle location at pre-defined coordinates. For example, the code ‘M760’ opens the valve for 
printhead 1 and the code ‘G1 X1.236 Y4.611 E0.01212 ; perimeter’ linearly moves the extruder to 
these X, Y and Z coordinates when using the INKREDIBLE 3D bioprinter (Cellink, Sweden). Once 
the 3D model has been created and the print path fully defined, bioinks may be formulated, print 
parameters may be selected and construct fabrication can commence. 
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3.2.2 Construct Fabrication 
During the processing stage of 3D bioprinting using biopolymer hydrogels, construct fabrication is 
undertaken. Initially, the bioinks are formulated by mixing the relevant materials and cell types that 
are appropriate as intended tissue mimics. The bioinks are then loaded into the printer cartridges and 
the printer is calibrated in order to achieve maximum attainable resolution whilst also preserving cell 
viability.  
3.2.2.1 Bioink preparation 
Once the appropriate materials and cells that replicate target tissue ECM have been identified, as 
directed by the specifications of a tissue engineering construct, the components are mixed for bioink 
formulation. While practicing sterile techniques, biopolymer materials are processed using specific 
concentrations and precise formulation methods in order to limit batch-to-batch variability between 
solutions. Culture of cells is also undertaken until an ample population is obtained for suspension 
within biopolymer solutions at pre-defined densities. A number of polymers and cell types can be 
mixed within a single bioink or, alternatively, a number of cartridges containing different bioink 
formulations may be installed within the bioprinting setup so that the complex heterogeneous nature 
of native tissue may be captured within a single construct (Gungor-Ozkerim et al., 2018). 
3.2.2.2 3D Bioprinting 
During the 3D bioprinting step, the fabrication of the tissue construct is realised. Initially, the printer 
Z-stage collector platform and X,Y robotic arm (with inserted cartridge and nozzle) are calibrated so 
that the dispensing coordinates are in reference with the collector platform on which the bioink will 
be dispensed. This step accounts for different needle lengths that are inserted within the cartridge 
holder and thus the positioning of the robotic arm respectively. The extrusion pressure is then selected 
for each bioink so that an appropriate flow rate is achieved. Printing is then initiated upon selection 
of the 3D model and the part is printed, layer by layer, according to the G Code (Cellink, 2020). 
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3.2.3 Construct Propagation 
Culturing of tissue engineering constructs is as important as the 3D bioprinting process in that the 
conditions to which a 3D construct is exposed can define the success of the part. The propagation of 
a construct is also dependent on the intended application of the construct. In some instances, 
bioreactors allow semi-automated cell and tissue culture by the maintenance of specific 
physicochemical culture parameters as well as physical conditioning of developing tissues (Wendt et 
al., 2009). The tissue mimic is subjected to specific biochemical and physical cues to replicate the 
environments experienced within either healthy or diseased tissue for a time period that is suitable 
until the 3D model is fit for purpose. 
3.2.4 Application  
The four main 3D bioprinting applications include drug discovery, cosmetics testing, tissue 
regeneration and medical devices (Vijayavenkataraman et al., 2018). Drug screening on biomimetic 
constructs versus 2D models provide better results based on their ability to mimic the spatial and 
chemical attributes of native tissues (Peng et al., 2017). Bioprinting models for cosmetic testing, on 
the other hand, is mainly practiced in order to bypass animal testing in the first instance 
(Vijayavenkataraman et al., 2016). For tissue regeneration purposes, 3D bioprinting is used to 
produce artificial tissues such as skin, bone, cardiovascular tissue and cartilage in an attempt to 
overcome organ donor shortages. Finally, 3D models destined as medical devices have been used in 
applications such as in the prevention of biofilm formation (Sandler et al., 2014), as stents (Cabrera 
et al., 2017) and in dental restoration practises (Dawood et al., 2015). 
 
3.3 Addressing the Challenges in 3D Bioprinting 
Out of all the bioprinting modalities, micro-extrusion based printers are the only platforms that can 
achieve human-scale tissues due to the continuous flow of bioink and large deposition rate 
(Vijayavenkataraman et al., 2018). There are two main issues that are associated with the use of 
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bioprinters, however, firstly being able to achieve optimum print fidelity of a scaffold whilst secondly 
preserving cell viability. High viscosity bioinks are often employed in order to tackle the issues 
associated with print fidelity for micro-extrusion printing, although cell viability can be somewhat 
compromised using this method (Peltola et al., 2008). Likewise, low viscosity bioinks better 
perpetuate cell viability at the cost of compromising print fidelity. Several printing variables may be 
adjusted in order to overcome these issues by optimising the material parameters (including gelation 
and hydrogel properties), print parameters (including nozzle gauge, print pressure and print speed) 











Figure 3.3 – Optimisation of print parameters that are critical for successful biofabrication in tissue engineering. 
3.3.1 Material Parameters 
During tissue construct fabrication, materials for incorporation into a bioink are often elected based 
upon their suitability as a target tissue ECM mimic. Print parameters are then tailored in order to 
accommodate material printability and subsequent gelation of the construct. That being said, it is also 















optimisation accordingly. The main hydrogel properties that affect printing specifications are 
threefold – chemical constituents, molecular weight and concentration (the latter two properties 
contributing to material viscosity) (Kyle et al., 2017).  
With regards to the chemical properties of a printing material, different material chemistries require 
specific crosslinking mechanisms which can impact on biofabrication window time. It is paramount 
that the printed construct geometry is consistent with the geometry of the 3D model whilst also 
maintaining cell viability. In order to achieve this, in situ gelation is often initiated, whereby material 
is crosslinked as it is printed, layer by layer, in order to achieve maximum print fidelity. This 
technique is useful when the time to generate the overall print is lengthy, when the viscosity of the 
bioink solution is low, and when gelation mechanisms are slow, yet is limited to the manufacture of 
single materials as biopolymers are difficult to integrate once gelled (Galarraga et al., 2019). 
3.3.2 Print Parameters 
Once suitable material parameters have been selected, printer operating modalities can be optimised 
for tissue construct fabrication using micro-extrusion-based printing. Amongst these modalities are 
print speed, print pressure, nozzle gauge and extrusion flow rate and each criterion directly impacts 
upon each other as well as print fidelity and cell viability within a printed construct. It is generally 
the consensus that print speed is the first parameter to be tailored as it is most dependent upon the 
material being printed. However, when the bioink being extruded is stable following deposition, 
slicing software can automatically calculate print speed based on input nozzle gauge so that a line 
width between 20% – 50% larger than the needle aperture is achieved. This is so that, for extrusion 
of high viscosity polymers without any supporting apparatus, over-extrusion and increase in layer 
height or under-extrusion and discontinuous layer deposition can be prevented (Carrier, 2018). 
Hydrogels exhibiting low viscosity require more rapid print speeds in favour of completing structure 
fabrication before the printed part loses its structural integrity.  
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Selecting nozzle gauge can often be a trade-off between print resolution and exposure of bioinks to 
shear stresses. Larger nozzle apertures can reduce nozzle induced stresses on bioinks due to a 
reduction in polymer flow resistance yet jeopardises print resolution. Conversely, smaller nozzle 
diameters achieve better resolution but can compromise the viability of a bioink’s cell cargo. The 
delicate balance between resolution and shear stress is further apparent when tuning print pressures 
in pneumatic extrusion. High print pressures can result in poor resolution and exertion of shear 
stresses on cells, whereas low print pressures cause disruptions in polymer flow yet with less 
negligible effects on cell viability (Webb & Doyle, 2017). Nozzle gauge and print pressure, in 
addition to viscosity, determine polymer flow rate and must also work in conjunction with print speed.  
3.3.3 Collector Platform 
Within conventional bioprinting systems, bioinks are deposited onto a z-stage collector platform 
during additive layer manufacture of a scaffold or construct. Some scaffolds incorporate additional 
supporting features which are built-in within the 3D model and are later severed from the part 
following reinforcement by gelation. The extra scaffolding material is used to support overhanging 
features that would not otherwise be printable in 3D. It is only relatively recently that research 
directed into the use of a supporting sacrificial matrix has been investigated.   
3.4 Embedded Bioprinting 
Embedded bioprinting is defined by a range of techniques that use a secondary substrate for the build-
up of complex hydrogel structures. Using embedded bioprinting, one is not subjected to the usual 
constraints found in conventional methods when printing onto a planar surface and instead, the 
fabrication of intricate shapes can be realised with greater success. This technique is conducive to the 
production of constructs featuring overhanging or hollow structures which would otherwise collapse 
without the supporting matrix resulting from gravitational forces. Within the literature, one of the 
first reports of using a secondary substrate in additive layer manufacture dates back to 2011. Wu et 
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al., (2011) documented using a modified Pluronic F127 reservoir into which an unmodified Pluronic 
F127 fugitive ink was deposited for the manufacture of microvascular networks. This approach 
generated a perfusable network within the supporting reservoir which would later be 
photocrosslinked. The fugitive phase was subsequently liquefied under vacuum at 4 °C leaving an 
embedded vascular structure.  
Since this method of forming the final part within the reservoir phase, it has become more 
commonplace to print a retrievable tissue construct within a sacrificial supporting matrix. Support 
materials such as a carbopol granular medium (Bhattacharjee et al., 2015) and a gelatin slurry (Hinton 
et al., 2015) have both been used to this effect for the generation of complex, self-supporting freeform 
structures using the printing materials PDMS, alginate, collagen and fibrinogen.  Despite significant 
efforts, these manufacturing processes have fallen short of generating constructs with regional 
variations in mechanics, material chemistry and cell phenotypes, require stringent temperature 
constraints to prevent the support bed from prematurely liquefying under cell culture conditions and 
prove difficult in liberating the final product from the supporting matrices. An alternative method 
known as Suspended Manufacture has since been coined which meets the criteria of achieving multi-
layer hydrogel structures that are akin to native human tissues, under ambient conditions, with relative 
ease and accurate shape-specificity. 
3.4.1 Suspended Manufacture 
Suspended manufacture is a process in which cell laden biopolymer solutions are extruded into a 
bed of micrometre-sized agarose gel particles that provide sufficient support to prevent the 
structure collapsing under its own weight. Once construct printing is complete, it may be solidified, 
extracted from the supporting gel bed and cultured for its intended use (Figure 3.4). This technique 
has proven successful in a previous study with Moxon et al., (2017) whereby cell laden gellan was 
extruded by hand into a supporting fluid gel bed to create an osteochondral plug which was later 







Figure 3.4 – Suspended manufacture process. A) Bioink containing polymer and cells is loaded into a dispensing 
cartridge and agarose fluid gel is poured into a container to form the supporting bed. B) The bioink solution is 
extruded within the supporting gel. C) Multiple other bioinks with differing polymer chemistries and encapsulated 
cell phenotypes may be extruded atop the previous extrude. D) Crosslinking solution is used to solidify charged 
polymers. E) The construct is extracted and 3D cultured until maturity is reached. F) The tissue construct is ready 
for its intended use, either for implantation or drug-disease / cosmetics modelling. 
This technology enables the printing of constructs from low viscosity precursor solutions with greater 
complexity and shape specificity without limitation over build direction, supports or overhangs. It is 
the inherent behaviour of the fluid gel particles themselves that allows the success of suspended 
manufacture. 
3.4.1.1 Fluid gels 
Fluid gels are characterised by their self-supporting ability at rest and will subsequently flow upon 
the application of shear. They are generated when a shear force is applied during the gelation process 
of a polysaccharide hydrogel. The end-product of this technique consists of micrometre sized gel 
particles within a liquid continuous phase as opposed to a bulk, firm gel following quiescent gelation 
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(Figure 3.5). The weakly interacting structure of fluid gels that allows this temporary flow and 
spontaneous reformation phenomenon has been exploited within the food industry as they are 
renowned for their flavour release and pleasant mouthfeel properties. Several examples of fluid gels 
have been documented in the literature, including gellan (Sworn et al., 1995), alginate (Fernández 
Farrés & Norton, 2014), κ-carrageenan (Mahdi, 2016), agar (Fernández Farrés et al., 2014) and 
agarose (Moxon et al., 2017). In this thesis, agarose has been used in fluid gel formulation as it 
requires thermal gelation kinetics at high temperatures and is relatively neutral, meaning that culture 










Figure 3.5 – Schematic diagram of the quiescent gelation of a firm gel and sheared gelation of a fluid gel. 
The proposed underlying mechanism for agarose fluid gel formation in particular is described by a 
nucleation and growth process, in that particle growth is dependent upon the shear environment 
experienced by the solution (Norton et al., 1999). During cooling of an agarose solution, an increase 
in viscosity is attributed to aggregation of ordered domains during what is known as a spinodal 
decomposition event, causing phase separation during molecular ordering. Under shear, the potential 
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nucleation sites are disassociated from one another, limiting the molecular ordering to within distinct 
fluid gel particles. The extent of particle growth is in turn dictated by the magnitude of the shear force 
applied to the agarose solution, where polymer chains are recruited from the surrounding un-gelled 
matrix and the particles are also physically forced to aggregate by shear flow forces. This enables the 
modulation of the hydrogel’s physical attributes without changing the chemical properties at the 
molecular level.  
The particles formed by sheared gelation display a higher polymer density at the core of the particle 
with a descending gradient to the outer edge, ascribed by the weak intermolecular tension at the gelled 
and non-gelled polymer interface and the increased flow field at the particles’ surface (Fernández 
Farrés et al., 2014b). Within these lower density regions at the particles’ surface exist fewer helical 
domains and aggregates, leading to the evolution of particle hairs. Varying polymer concentration 
and applied shear during fluid gel formation have also been seen to generate rheological variances 
(Dong et al., 2009). Within a high concentration agarose solution, as the particles are being formed 
under a sufficient shear rate, the higher population of disordered coils within the solution is causative 
of higher viscosity solutions. This results in an increase in local shear stresses on the particles within 
the system, thus reducing the potential of aggregation and nucleation of neighbouring particles and 
generating a larger variance in particle size populations. 
To successfully support the printed structures during suspended manufacture, the agarose fluid gel 
bed should sufficiently flow to allow deposition of the printed material, yet also demonstrate ample 
structural integrity following deformation and a capacity to self-heal. It is therefore crucial that an 
understanding of the mechanisms underlying fluid gel formation and the behaviour of the fluid gel 
post-formulation is clearly outlined. The first of the results chapters deals with the preparation and 
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Chapter 4 – Characterisation of the Supporting Fluid Gel Bed 
4.1 Introduction 
An extensive number of reports have recently been made on fabricating complex, 3D bioprinted, cell-
laden hydrogels. Numerous approaches towards this end have been described, however, given the 
nature and fragility of the liquid precursors, the most successful approaches employ a supporting 
particulate gel phase (Senior et al., 2019). Using this supporting feature, the fragile part is protected 
during printing and the 3D model features are maintained in the liquid form prior to gel initiation. 
Without such, one must incorporate high viscosity materials and rapid gelation mechanisms as well 
as a broad geometrical base and built-in supports for overhanging structures for the successful 
realisation of a 3D biofabricated construct (Cooke et al., 2018). 
The characteristics of the supporting gel bath are key in creating model tissue replicas by ensuring 
shape-specificity whilst also maintaining the viability of its cell cargo. The supporting matrix must 
have the ability to uphold the deposited material without the need to modify the 3D model in order to 
ensure that an accurate representation in shape geometry is achieved (Highley et al., 2015). Moreover, 
the support must allow the layered deposition of multiple bioinks if one wishes to fabricate anisotropic 
tissue-like structures (Moxon et al., 2017). Following material extrusion within the support bath 
which causes subsequent deformation, the gel must exhibit rapid recovery in order to preserve 3D 
print fidelity and to prevent the formation of voids within the support matrix as a result of needle and 
bioink-induced shear (Rocca et al., 2018). It is also essential that fabricated constructs can be cross-
linked and liberated from the support bed without impedance on cell culture-conducive conditions. 
Lastly, the supporting medium within which bioinks are deposited must demonstrate 
biocompatibility, eliciting no adverse effects on encapsulated cells and having no chemical interaction 
with the tissue construct. 
49 
 
Fluid gels made from agarose and generated under specific conditions can fulfil these criteria. They 
have shear-thinning capabilities that allow extrusion of material between particle interstices and allow 
rapid restructuring upon the removal of shear (Senior et al., 2019) (Figure 4.1). They allow the 
suspension of a large range of polymers and crosslinking strategies, having no interaction upon the 
addition of ions that solidify suspended charged polymers and are also conducive to cell culture media 
and temperatures. This natural polymer is also biocompatible, attributed to its natural origins, net 
neutral charge and non-cytotoxicity and also lacks non-specific adsorption of biomolecules and 
cellular attachments to the gel matrix in unmodified gels (Fernández-Cossío et al., 2007; Keren, 2003; 







Figure 4.1 – Shear-thinning and self-healing agarose fluid gel bed in suspended manufacturing (adapted from Jeon 
et al., 2019).  
Despite the apparent similarities between supporting particulate beds that have been reported in the 
literature, the way in which particles are generated strongly influences particle interaction and has a 
definitive effect on suspended product quality. Using an agarose fluid gel bed as a supporting matrix 
has previously been validated by Moxon et al., (2017) who printed an osteochondral unit by hand. 
Some analysis on the characterisation of the agarose fluid gel as a suspending matrix was undertaken 
by studying rheological behaviour and particle microscopy.  
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In this chapter, to gain a better understanding of the mechanisms underlying suspended 
manufacturing, the physical characteristics of the supporting fluid-gel matrix were explored. Initially, 
the mechanical characterisation of agarose fluid gels was explored by shear rheology. A secondary 
fluid gel formulation regime was also studied by dilution of freshly prepared agarose fluid gels to 
given concentrations, demonstrating the critical importance of formulation technique on the 
behaviour of the supporting matrix. Assessment of particle size distribution, morphology and volume 
fraction by using particle sizing, brightfield and scanning electron microscopy and centrifugation 
techniques further consolidates agarose fluid gel behaviour, providing additional insight into 
suspended manufacturing function.  
4.2 Methods 
4.2.1 Agarose gel formulation 
Fresh agarose fluid gels (type I low EEO, purchased from Sigma-Aldrich, Dorset, UK) were prepared 
by autoclaving solutions of agarose mixed with deionised water (121°C temperature and 1.4 bar 
pressure) (Prestige Medical™ bench top autoclave) at concentrations of 0.25%, 0.50%, 0.75% and 
1.00% w/v and cooling to 25 °C under a constant shear of 700 rpm using a magnetic stirrer.  
Diluted agarose fluid gels were formulated by the addition of deionised water to freshly prepared 
agarose fluid gels at 1.00% w/v to make subsequent concentrations of 0.25%, 0.50% and 0.75% w/v 
agarose. 
Quiescent agarose firm gels were made by quiescently cooling autoclaved agarose solutions to 25 °C 
absent of shear to give final concentrations of 0.25%, 0.50%, 0.75% and 1.00% w/v.  
4.2.2 Shear rheology 
All rheological testing was undertaken in triplicate using a Bohlin Gemini rheometer (Malvern 
Panalytical, UK) fitted with a 2°/55 mm cone and plate geometry at 25 °C. 
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4.2.2.1 Amplitude sweeps 
Amplitude sweeps were carried out to compare and characterise the liner viscoelastic region (LVR) 
of fresh and diluted fluid gels. G′ and G″ moduli (Pa) were measured with an increasing shear stress 
from 0.1 to 100 Pa and a constant angular frequency of 10 rad s-1. 
4.2.2.2 Frequency sweeps 
Frequency sweeps were performed to characterise the viscoelastic behaviour of fresh and diluted fluid 
gels. Gʹ and G″ moduli (Pa) were measured with increasing oscillatory frequencies from 0.1 to 100 
rad s-1 at a constant strain of 0.05%. 
4.2.2.3 Shear ramps 
Shear ramps were conducted to characterise the viscosity of fresh and diluted fluid gels. Viscosity 
(Pa s) was measured with an increasing shear rate of 0.01 to 100 s-1. 
4.2.3 Particle size distribution 
Particle size distribution within fresh agarose fluid gels was examined using a Malvern Mastersizer 
2000. Fluid gel samples of 0.25%, 0.50%, 0.75% and 1.00% w/v were diluted in deionised water 
followed by agitation at 2450 rpm using a small volume sample dispersion unit (Hydro 2000 SM) in 
order to give a homogenous dispersion of particles prior to particle sizing analysis. A refractive index 
of 1.42 and 1.33 was used for agarose and deionised water, respectively.  
4.2.4 Brightfield microscopy 
For visualization of the particulate structure within fluid gels, small samples of 0.25%, 0.50%, 0.75% 
and 1.00% concentration were loaded onto microscope slides and mounted with a cover slip before 




4.2.5 Particle volume fraction 
For the determination of fluid gel particle volume fractions, agarose fluid gel samples at 
concentrations of 0.25%, 0.50%, 0.75% and 1.00% were centrifuged at a given range of centrifugal 
forces (RC5C Sorvall Instruments-Dupont, Wilmington, DE) in order to separate fluid gel particles 
from the continuous aqueous phase. The solid phase volume of the fluid gel following centrifugation 
(φFG) was then calculated as a fraction of the mass of sedimented solid (MFG.s) compared with the 
total pre-centrifuged fluid gel (MFG.0) as displayed below (Equation 4.1). 
          φFG =  
𝑀𝐹𝐺.𝑠
𝑀𝐹𝐺.0
                                          Equation 4.1 
In order to account for the fluid released from the particles themselves during the centrifugation 
process, quiescent agarose bulk gels of identical concentrations were also centrifuged. The solid phase 
volume of the quiescent bulk gel following centrifugation (φQG) was then calculated as a ratio of the 
mass of sedimented solid (MQG.s) compared with the total pre-centrifuged quiescent bulk gel 
(MQG.0) as reported in Equation 4.2. 
                                            φQG =  
𝑀𝑄𝐺.𝑠
𝑀𝑄𝐺.0
                                        Equation 4.2 
The fluid expelled from fluid gel particles due to particle compressibility can therefore be expressed 
as 1 – φQG. 
Finally, a third contributor to liquid expulsion can be attributed to gel relaxation - also known as 
syneresis (φsyn). This was quantified as the mass of the fluid released from quiescent gels following 
a 72-hour period divided by the total original mass of quiescent bulk gels for given concentrations. 
The fluid gel particle volume fraction for a given polymer concentration and centrifugal force may 
then be ascertained according to Equation 4.3. 
                                                𝛷𝐹𝐺 = 𝜑𝐹𝐺 + [(1 − 𝜑𝑄𝐺) − 𝜑𝑠𝑦𝑛]             Equation 4.3 
53 
 








Figure 4.2 - Schematic illustration of the phases within agarose particulate fluid gels and quiescent bulk gels post-
centrifugation. 
4.2.6 Lyophilisation 
Samples of 0.50% agarose fluid gel and quiescent bulk gel, as well as solid and supernatant phases 
of both centrifuged fluid gel and bulk gel, were subjected to lyophilisation. Freshly prepared 1.00% 
agarose and 0.50% diluted agarose fluid gels were also freeze-dried. Samples were frozen at -80 ºC 
for 24 hours and then a 72 hour freeze drying cycle was implemented at -76 ºC and 0.0010 mbar 
(Christ ALPHA 2–4 LD plus). Dry samples were stored in a desiccator for the preservation of aridity.  
4.2.7 Scanning Electron Microscopy (SEM)  
Lyophilised agarose fluid gels (fresh 0.50%, 1.00% and diluted 0.50%), quiescent bulk gel (0.50%), 
and solid and supernatant phases of centrifuged fluid gel were sputter coated with gold using a 
Quorum SC7620 sputter coater under a low bleed of argon. The internal networks of the materials 
were then studied using a field emission scanning electron microscope (FEI Quanta 250 SEM) 
operated in high vacuum mode at an accelerated electron energy of 10 kV. Several images were 




4.3.1 Amplitude sweeps 
Amplitude sweeps were conducted to ascertain the linear viscoelastic region (LVR) and therefore the 
critical stress at which intermolecular associations are forced to collapse in samples of agarose that 
were freshly prepared (F) and diluted from a pre-formulated stock of 1.00% agarose (D). As 
concentration descended, elastic (G′) and viscous (G″) moduli decreased across both formulation 
regimes (Figure 4.3). Diluted samples exhibited reduced G′ and G″ moduli in comparison to the 
corresponding concentrations of agarose that were freshly prepared. This caused a reduction in the 
length of the LVR resulting in polymer network deformation at lower shear stresses. Table 4.1 
highlights and compares the key initial elastic and viscous moduli along with the contrast in LVR 









Figure 4.3 - Amplitude sweeps displaying elastic (G′) and viscous (G″) moduli of A) 1.00% w/v agarose stock and 
the comparison of moduli between freshly prepared (F) and diluted from stock (D) in B) 0.75% C) 0.50% and D) 























































































Table 4.1 – Comparison of freshly prepared agarose with agarose diluted from 1.00% stock on initial Gʹ and 
stress where Gʹ = Gʹ. 
 
4.3.2 Frequency sweeps 
Small deformation oscillatory rheology within the linear viscoelastic region (LVR) was performed 
on agarose fluid gels to determine a mechanical spectrum. This revealed that gels of all concentrations 
and formulation regimes were moderately frequency dependent (Figure 4.4), suggesting 
characteristics of a structured fluid with a dominance of solid (Gʹ) over liquid behaviour (Gʺ) across 
the frequency range tested. It was apparent that as concentration decreased, there was a subsequent 
decrease in elastic and viscous moduli in both freshly prepared and diluted agarose fluid gel regimes. 
Frequency sweeps also gave evidence that preparing diluted (D) compared with fresh (F) agarose 
fluid gels at corresponding concentrations reduces the elastic and viscous moduli. Furthermore, 
diluting agarose seems to have a much more profound effect on moduli in higher concentrations in 
comparison to low, with a variation in G′ between F and D of 1142, 320 and 45 Pa in 0.75%, 0.50% 






Description of Agarose Initial Gʹ (Pa) Stress where Gʹ = Gʹʹ (Pa) 
1.00% Stock  1164.33 74.55 
0.75% (F) 658.50 27.34 
0.75% (D) 128.63 4.19 
0.50% (F) 75.68 4.42 
0.50% (D) 40.03 3.16 
0.25% (F) 16.70 1.23 













Figure 4.4 - Frequency sweeps displaying elastic (G′) and viscous (G″) modulus of A) 1.00% w/v agarose stock and 
the comparison of moduli between freshly prepared (F) and diluted from stock (D) in B) 0.75%, C) 0.50% and D) 
0.25% w/v agarose over a frequency of 0.1 to 100.0 Rad s-1. 
 
4.3.3 Shear ramps 
Upon analysis of freshly prepared and diluted agarose using shear ramp parameters, it is visible that 
increasing shear rate causes a decrease in viscosity in all cases (Figure 4.5). The viscosity of each 
fluid gel (both freshly prepared and diluted) also decreases as concentration descends. Additionally, 
diluted agarose samples exhibit lower viscosities compared with freshly prepared agarose at 
equivalent concentrations over identical shear rates. These results are in concordance with Figures 
4.3 and 4.4 in that diluted agarose presents weaker fluid gels compared with agarose which was 


































































































Figure 4.5 - Viscosity (Pa s) of A) 1.00% w/v agarose stock and the comparison of viscosity between freshly 
prepared (F) and diluted from stock (D) in B) 0.75%, C) 0.50% and D) 0.25% agarose over a shear rate of 0.01 to 
100.00 s-1. 
4.3.4 Particle size distribution 
To decipher the optimum fluid gel formulation for printing, fluid gels were prepared at different 
concentrations of 0.25% – 1.00% w/v agarose and the particle sizes were quantified.  
The span was calculated in order to represent the width of particle size distribution, where the smaller 
the span, the narrower the distribution becomes. Span is calculated as per Equation 4.4, where 
𝑑(0.9), 𝑑(0.1) and 𝑑(0.5) is the size of particle (µm) below which 90%, 10% and 50% of the sample 
lies, respectively. Here, a rise in the span of particle size distributions is featured as fluid gel 



















































































       
𝑑(0.9)−𝑑(0.1)
𝑑(0.5)
                                        Equation 4.4 
The volume weighted mean D [4, 3] (also known as the De Brouckere mean diameter or mass moment 
mean) is analogous to the moment of inertia with a volume or mass dependence, therefore indicating 
particle size distribution in terms of volume (Equation 4.5, where 𝑑 is particle size (µm)). For agarose 
fluid gels of increasing concentration, the volume weighted mean was also seen to increase.  
               
∑𝑑4
∑𝑑3
                                                Equation 4.5 
Likewise, the median of the volume distribution (also termed 𝑑 (0.5)) and sizes of particles within 
which 90% of the population distribution lie below (also termed 𝑑 (0.9)) showed a general increase 
with increasing polymer concentration. Distribution of particle sizes within lower polymer 
concentrations display a more Gaussian trend as reported by the bell-shaped curves, where mean and 
median coincide. Higher concentrations of fluid gels, on the other hand, exhibit dual populations in 
particle diameter prevalence, as attributed by the double bell-shaped curves and larger span sizes. 
Uniformity, as measured by the absolute deviation from the median, is calculated as indicated in 
Equation 4.6, whereby 𝑑(0.5) is the median size of the distribution and 𝑑𝑖 and 𝑥𝑖 are respectively 
the mean diameter of, and result in, size class 𝑖. 
 
       
∑𝑥𝑖 𝑑(0.5)− 𝑑𝑖
𝑑(0.5) ∑ 𝑥𝑖
                                      Equation 4.6 
In agreement with the previous data, as polymer concentration increases, uniformity decreases. 
Finally, the size of the smallest and largest particles within agarose fluid gels generally increases with 
increasing concentration, with exception of the highest concentration of 1.00% which is preceded by 
that of 0.75%. 
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Figure 4.6 - Particle size distribution within agarose fluid gels produced at concentrations of 0.25%, 0.50%, 0.75% 
and 1.00% w/v under 700 rpm agitation. 
 
Table 4.2 – Particle size span, volume weighted mean (D [4, 3]), median of the volume distribution (𝒅(𝟎. 𝟓)), size 
of particle below which 90% of the population lie (𝒅(𝟎. 𝟗)), uniformity and particle size range in agarose fluid gels 
varying from 0.25 – 1.00% w/v concentration (green and red are lowest and highest values respectively). 
 Agarose fluid gel concentration (%) 
Measurement 0.25 0.50 0.75 1.00 
Span (AU) 0.74 0.97 3.65 3.81 
D [4, 3] (µm) 33.93 49.40 123.77 124.45 
𝒅(𝟎. 𝟓) (µm) 32.81 43.38 73.97 72.82 
𝒅(𝟎. 𝟗) (µm) 46.84 74.07 305.67 302.77 
Uniformity (AU) 0.23 0.31 1.01 1.18 




















0.25% 0.50% 0.75% 1.00%
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4.3.5 Brightfield microscopy 
For the inspection of individual agarose fluid gel particles, particle morphology was determined using 
brightfield microscopy. Fluid gels of all concentrations (0.25% - 1.00% w/v) exhibited ‘hairy’ inter-
particle associations presenting a ‘beads on a string’ model (Figure 4.7). As concentration increased, 
the heterogeneity in particle morphology and size distribution also increased in agreement with 
particle sizing analysis.  
 
Figure 4.7 – Brightfield micrographs of agarose fluid gel particles at concentrations of A) 0.25%, B) 0.50%, C) 




4.3.6 Particle volume fraction 
Fluid gels consist of a suspension of gelled particles within a continuous medium. To understand the 
influence of concentration on particle volume fraction, fluid gels were subjected to a range of 
centrifugal forces. Solid phase volume fractions within fluid gels (φFG) and quiescent gels (φQG) 
were determined under four increasing modes of centrifugation (5000, 17,500, 30,000 and 47,800 g). 
It was deduced that 0.50% quiescent gel solid phase fractions were 1.14, 1.21, 1.26 and 1.33 times 
larger than those of their fluid gel counterparts for each increasing centrifugal force (Figure 4.8A). 
Increasing centrifugal force, therefore, only had a slight effect on solid phase volume fractions 
between both quiescent and fluid gel preparations. Particle volume fractions account for the fluid lost 
to within the supernatant that is attributed to particle compressibility and gel relaxation. The particle 
volume fractions for the lowest given centrifugal force of 5000 g were 0.76, 0.88, 0.92 and 0.92 for 
agarose concentrations of 0.25%, 0.50%, 0.75% and 1.00% respectively (Figure 4.8B). For the 
highest applied centrifugal force of 47,800 g, particle volume fractions were 0.78, 0.83, 0.86 and 0.88. 
It can thus be determined that fluid gel particle volume fraction is dependent on concentration. 
Figure 4.8 – Relationship of relative centrifugal force (RCF) on A) phase volumes within 0.50% agarose gels and 





4.3.7 Scanning Electron Microscopy (SEM) 
Scanning electron microscopy (SEM) was performed in order to compare the microstructures of 
agarose gels when prepared under defined conditions. Lyophilised 0.50% agarose quiescent and fluid 
gels differ in that quiescent gels are comprised of thin, film-like sheets whereas fluid gels display an 
interconnected porous network (Figures 4.9A and B). The solid fraction (SF) of the gels were 
quantified as a percentage of dry weight versus total weight and were calculated at 0.49% and 0.42% 
respectively.  
Following centrifugation, the particle fraction (PVF) and supernatant of 0.50% agarose fluid gels 
were also lyophilised and imaged using SEM (Figures 4.9C and D). The consistency of freeze dried 
PVF was like that of polyethylene foam and particle hairs could be seen at the microscale, consistent 
with particles imaged using brightfield microscopy. Given that the supernatant was removed prior to 
lyophilisation, the solid fraction was larger than that of fluid gels, measuring at 1.27%. In contrast, 
the supernatant exhibited a cotton wool-like appearance that was light and sparse, represented by the 
solid fraction of 0.02%. 
To characterise the microstructural differences of freshly prepared and diluted agarose fluid gels, both 
freshly prepared 1.00% w/v and 0.50% diluted fluid gels prepared from a 1.00% stock were 
lyophilised and imaged using SEM (Figures 4.9E and F). Fluid gels prepared at 1.00% w/v presented 
a thick mesh-like network in comparison to the less inter-connected network seen in agarose fluid 
gels prepared at 0.50% w/v. When fluid gels are prepared following dilution to 0.50% w/v from a 






Figure 4.9 – Scanning electron micrographs showing the microarchitecture of freeze-dried agarose gels. A) 0.50% 
quiescent gel, B) 0.50% fluid gel, C) 0.50% centrifuged fluid gel particle fraction, D) 0.50% centrifuged fluid gel 





Biopolymer hydrogels such as agarose are valuable resources in tissue engineering applications due 
to their tuneable microarchitectures and mechanical properties. When 3D bioprinting a desired shape, 
the complexity, resolution and dimensional accuracy of the product is influenced by the material that 
is being printed and also the platform or supporting network into which the bioink is extruded. 
However, many implications arise when 3D bioprinting scaffolds onto a solid, planar surface. This 
technique is limited to printing relatively basic designs with the use of only high viscosity materials 
that require curing in-situ. Another method by the name of suspended manufacturing uses a 
supporting particulate bed for the creation of distinguished bioprinted scaffolds. The suspended 
manufacturing method in supporting a construct has proven a reputable solution to the flowing and 
deformation of scaffold architecture and has been likened to the way in which the amniotic fluid 
cradles a developing foetus (Moxon et al., 2017).  
Both natural (polysaccharide and protein) and synthetic gelling polymers can form fluid gels. The 
resultant gel properties when produced under a given shear field create a fluid or paste-like 
consistency as opposed to quiescent, bulk gels formed through traditional static cooling. Rheological 
analysis was used to assess the viscoelastic qualities which manifest within agarose fluid gels over 
set ranges of shear stresses, shear rates and oscillatory frequencies. These parameters are 
representable of the forces experienced by the gel during extrusion and handling. Particular attention 
was given to assessing the differences between agarose gels that were freshly prepared (F) to a given 
concentration or diluted (D) to a corresponding concentration from 1.00% w/v stock in order to 
demonstrate the critical importance of the fluid gel formulation method. 
On first analysis, with a decreasing concentration of agarose comes a reduction in yield stress and 
viscoelastic strength in both freshly prepared and diluted samples over a range of set shear stresses 
(Figure 4.3). Additionally, a decrease in G′ and G″ over identical oscillatory frequencies occurs as 
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agarose concentration decreases and viscosity decreases over set shear rates as concentration is 
reduced (Figure 4.4 and 4.5). The decrease in polymer concentration results in weaker gels due to a 
reduction in particle density and a simultaneous decrease in particle-particle interactions. In addition 
to this, hydrogels of lower concentrations exhibit lower viscosities as they contain fewer crosslinks 
and a higher mesh size (Annabi et al., 2010; Zhang et al., 2017). Upon comparison of freshly prepared 
fluid gels with those diluted from a 1.00% w/v stock, preparation methods have a large impact on 
fluid gel mechanical behaviour. When samples were diluted to 0.75%, 0.50% and 0.25%, it was 
apparent that this preparation method resulted in gels with lower mechanical strengths compared with 
fluid gel samples that were freshly prepared to corresponding concentrations. This effect was more 
noticeable in the higher concentrations in contrast to lower concentrations, in that there was a larger 
difference in initial viscosity between fresh and diluted samples in 0.75% agarose than in 0.50% and 
0.25% concentrations, respectively.  
It has previously been reported that fluid gels of different concentrations contain a diverse range of 
particles. One main difference between freshly prepared and diluted agarose fluid gels when 
formulating to equivalent concentrations must therefore be particle size and morphology. To 
understand the connection between concentration and particle distribution, one must therefore analyse 
the particles within a range of fluid gel concentrations. At concentrations above 0.50%, there was the 
emergence of a dual particle size population (Figure 4.6). In these higher concentration fluid gels, 
the greater heterogeneity in particle size causes localized areas of increased viscoelasticity, thus 
generating a secondary population of particles of smaller size as well as allowing other particles to 
agglomerate and grow to equilibrium, unaffected by local shear. As 1.00% w/v agarose fluid gels 
generate a secondary, larger particle population under shear, the formulation of a diluted fluid gel to 
0.50% w/v concentration involves the transfer of larger agarose particles. Given that larger particles 
have a much smaller surface area to volume ratio (Norton et al., 1999), particle-particle interactions 
are not as profound compared with gels freshly formulated to equivalent concentration with a larger 
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abundance of smaller particles. This would subsequently cause diluted agarose fractions to be less 
viscous compared to the freshly prepared fractions at equivalent concentrations. In addition, once 
water has bound to the gel via either the hydrophilic groups contained within the polymer network 
(known as primary bound water) or to the exposed hydrophobic groups upon polymer swelling 
(known as secondary bound water), any excess water will be imbibed towards infinite dilution 
(Piculell et al., 2011). From these analyses, it could be deduced that total bound water (primary and 
secondary bound water combined) has been transferred with the fraction of preformed 1.00% stock 
and the additional deionised water ultimately exists as free or bulk water within the agarose solution 
creating less viscous gels following dilution in comparison with freshly prepared agarose. 
The proposed mechanism for the generation of individual gel nuclei suggests a nucleation and growth 
event, whereby particles will grow to equilibrium permitted by the given shear environment. When 
molecular ordering is initiated during cooling, the sol-gel transition causes a rise in solution viscosity 
and ordered domains begin to aggregate. As shear forces cause disruption during molecular ordering, 
a phase separation event occurs via spinodal decomposition (Norton et al., 1999). The particles 
formed during this practice display a higher polymer density at the core of the particle with a 
descending gradient to the outer edge, ascribed by the weak intermolecular tension at the gelled and 
non-gelled polymer interface and the increased flow field at the particles’ surface (Fernández Farrés 
et al., 2014a). Within these lower density regions at the particles’ surface exist fewer helical domains 
and aggregates, leading to the evolution of particle hairs as described by the ‘beads on a string’ model 
(Figure 4.7).  
Another factor that plays a large role in dictating flow behaviour is the particle volume fraction within 
the fluid gel system. NMR relaxation studies have attempted to define these fractions; however, these 
methods are not applicable to systems containing hairy particles compared with those containing 
defined or absolute particles (Norton et al., 1999). Measuring particle volume fraction by means of 
centrifugation was therefore proposed (Garrec et al., 2013). Here, it may be observed that increasing 
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centrifugal force on quiescent and fluid gel agarose systems causes a reduction in solid phase volumes 
(Figure 4.8A). This is likely a consequence of larger centrifugal forces being required to attain 
maximum capacity of the supernatant rather than a reduction in the solid phase fraction itself. This 
would explain that when fluid gel particle volume fractions are normalised to that of quiescent gels, 
taking into account the fluid released from particle compressibility and syneresis, fluid gel particle 
volume fraction is relatively constant across all centrifugations. This would be expected as particle 
volume fractions would not deviate between samples of the same concentration and preparation 
method. Furthermore, particle volume fraction can be seen to increase with ascending polymer 
concentration (Figure 4.8B). This is in agreement with the particle size distribution analysis as larger 
particle populations exist within higher concentrations of agarose fluid gel and therefore contain 
higher particle volume fractions (Fernández Farrés et al., 2014a).  
Analysis of SEM micrographs of lyophilised quiescent and fluid gels displayed major dissimilarities 
due to preparation technique. Though the helical residues formed within quiescent gels is equal to 
that formed in fluid gels, quiescent gels were exposed as having more continuous networks than those 
within fluid gels at equivalent concentrations (Figure 4.9). Also, the particle volume fraction (PVF) 
and supernatant fraction from centrifuged 0.50% w/v agarose fluid gels displayed agarose gel 
particles and unbound polymer, respectively. Freshly prepared and diluted agarose fluid gels 
produced at equivalent concentrations presented contrasting network profiles. Fluid gels prepared at 
1.00% w/v exhibit much more interconnected networks compared with fresh 0.50% w/v fluid gels. 
When fluid gels are prepared following dilution to 0.50% w/v from a 1.00% w/v sample however, a 
much sparser network is exhibited. Further to these assessments, the solid fraction of each sample 
was quantified as a percentage of dry weight versus wet weight prior to lyophilisation. Quiescent gels 
comprised 0.49% dry weight, fluid gels 0.42%, PVF 1.27% and supernatant 0.02%. Further research 
would need to be undertaken to study the critical concentration at which polymer overlap occurs to 




Assessment into the characteristics of agarose fluid gels has highlighted the critical importance of 
fluid gel formulation and formation. Different concentrations of agarose fluid gels have a marked 
impact on mechanical properties, particle distribution, particle volume fraction and microarchitecture 
and are highly tuneable in directing desired gel properties. Also, the technique used for fluid gel 
formation is paramount, in that agarose must be freshly prepared to preserve the key parameters that 
are necessary for use as a supporting medium during suspended manufacturing. 
This chapter has outlined the fundamental assets within agarose fluid gels, building on previous 
research by Moxon et al., (2017) to elucidate exactly the mechanisms that have made suspended 
manufacturing so successful. Despite this success, further refinement is required, replacing hand-
printed tissue engineering constructs with a fully automated 3D bioprinter to make the potential of 
patient-specific tissue constructs more tangible. Chapter 5 is focused on integrating a commercially 
available 3D bioprinter within the suspended manufacturing technology. The potential of Suspended 
Layer Additive Manufacturing (SLAM) is reviewed by assessing the resolution of the system as well 
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Chapter 5 – Suspended Layer Additive Manufacturing (SLAM) 
5.1 Introduction 
Additive layer manufacturing (ALM) has been used for some time for the construction of human 
tissue equivalents and is constantly seeking new solutions in response to 3D printing challenges 
(Melchels et al., 2012). Currently, 3D printed constructs that are dynamic and complex in shape are 
often limited by poor print fidelity when extruding low viscosity biopolymers. Because of these 
limitations, there is often an oversight in selecting optimal print parameters, as the choice in print 
specifications such as print speed, bioink material and curing method is not at the discretion of the 
user, but instead is restricted and dictated by the 3D printing technique (Tamay et al., 2019). For 
instance, researchers have often employed high viscosity polymers in order to overcome the issues 
associated with the collapse of low viscosity materials once deposited (Duan et al., 2013). This would 
necessitate a fast print speed to be implemented and in turn, the curing of material to occur in situ 
during printing in order to limit distortion of the intended model dimensions. These criteria directly 
impact upon the successful fabrication of complex constructs that contain the biochemical and 
geometrical facets of functioning tissues. 
Suspended manufacturing, developed by Moxon et al., (2017), uses an agarose fluid gel bed and 
offers an opportunity to allow greater freedom in the selection of print parameters that are conducive 
to the production of constructs with admirable print fidelity and cell viability. The principle 
mechanisms behind this technique enable extrusion of bioinks over a range of viscosities within a 
self-healing fluid gel that acts as a temporary support prior to solidification and extraction. This is 
due to the shearing action of the dispensing nozzle upon the gel support, allowing deposition of 
printing material between the fluid gel particles by polymer disentanglement before rapidly 
restructuring to support the construct upon the removal of shear (Cooke et al., 2018). Alternatively, 
within standard additive manufacturing practices, bioinks are deposited onto a planar collector 
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platform leading to loss of structural integrity of extruded bioinks unless further intervention is 
undertaken. By utilising a supporting gel bed during layer extrusion, the geometrical dimensions of 
the print model are only limited by the dimensions of the reservoir enclosing the supporting matrix. 
Another major benefit of suspended manufacturing is that print designs require no further 
modification, such as the use of bridges or forks, that otherwise compromise scaffold architecture. 
Perhaps of upmost importance, the candidate scaffold material can be selected on a basis of 
compatibility with the native extracellular matrices being replicated as opposed to enabling print 
conduciveness. This means that the materials employed within the bioink are not limited to exhibiting 
high viscosities in order to prevent structure collapse following extrusion, but in fact can reflect the 
true mechanics of the tissue being replicated. 
Other efforts towards tissue printing have also used an embedding phase to cradle the print model 
during fabrication. Some examples include printing PDMS within a Carbopol support bath (Abdollahi 
et al., 2018), printing a supramolecular modified hyaluronic acid hydrogel within a secondary 
modified HA hydrogel of different concentration (Highley et al., 2015) and printing alginate within 
a gelatin microparticle bath (Hinton et al., 2015). These techniques enable the printing of more 
complex constructs from low viscosity precursors, yet the implications within these systems still 
require addressing. One issue lies with preserving the structural integrity of the construct during 
retrieval from the supporting bed, whilst other printed models require additional mechanical 
reinforcements using a webbed fork. These issues pose a problem regarding the suitability of printed 
constructs in tissue engineering and research contexts, with scaffold handleability and the 
manufacture of scaffolds with distinct dimensions, without the need for additional supports, being 
compromised. Another limitation is that the curing temperatures required for some of these materials 
are not conducive to cell culture conditions, and in cases where defective tissues exhibit compromised 
cellular mitotic activity, intervention through the incorporation of exogenous cells within 
biofabricated constructs is pertinent. 
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In previous studies, suspended manufacturing has been used to produce complex structures, 
demonstrated by the fabrication of a freeform helix (Moxon et al., 2017). A more comprehensive 
characterisation of the mechanisms behind extrusion within an agarose fluid gel bed was documented 
in the previous chapter of this thesis. In this chapter, hand-printing tissue constructs using suspended 
manufacturing was further refined and revolutionised by the introduction of a 3D bioprinter in a 
technique coined as suspended layer additive manufacturing (SLAM). By using SLAM, the printing 
conditions were tuned in order to assess ultimate print fidelity without compromising cell behaviour. 
Cell-laden constructs were first printed by hand to document the evolution of the process in which 
hand-extrusion was replaced by a commercially available 3D bioprinter. An alternative support 
medium was then formulated, manufactured as an agarose microparticle slurry as opposed to an 
agarose particulate fluid gel to highlight and assess the importance of support bed formulation using 
brightfield microscopy and rheology. The resolution of the system was then inspected by tailoring 
flow rate, print pressure and nozzle gauge using a diverse spectrum of different polymers, and dyes 
of differing molecular weight were extruded in order to study diffusion within the support bed. 
Finally, a range of constructs were 3D printed using SLAM technology, demonstrating that various 
dynamic model configurations and dimensions can be replicated at the human-scale in hydrogel form.  
 
5.2 Methods 
5.2.1 Fluid gel formulation 
Agarose fluid gels (type I low EEO, purchased from Sigma-Aldrich, Dorset, UK) were prepared by 
autoclaving solutions of agarose mixed with deionised water (121°C temperature and 1.4 bar 
pressure) (Prestige Medical™ bench top autoclave) at 0.50% w/v concentration and cooling to 25 °C 




5.2.2 Slurry gel formulation 
Agarose slurry gels were formed by quiescently cooling autoclaved agarose solutions to 25 °C (absent 
of shear) to give a final concentration of 0.50% w/v. Quiescent gels were then blended in a 
commercially available food-grade blender followed by homogenising using a T18 basic ULTRA 
TURRAX® homogenizer (IKA, UK).  
5.2.3 Preparation of polymer solutions for printing 
The materials used for printing were low acyl gellan gum (molecular weight 300,000 – 500,000 
g/mol) and ι‐carrageenan (molecular weight ~500,000 g/mol) (purchased from Special Ingredients, 
UK), alginate (alginic acid sodium salt, M:G ratio of 1.56, molecular weight 120,000 – 190,000 
g/mol, purchased from Sigma–Aldrich, UK), low methoxy (LM) pectin (molecular weight ~200,000 
g/mol, purchased from CP Kelco, UK) and collagen (PureCol EZ Gel, Advanced BioMatrix, 
molecular weight ~300,000, purchased from Sigma–Aldrich, UK). Gellan, ι‐carrageenan, alginate 
and pectin powders were dispersed in deionized water at concentrations of 1%, 2%, 3% and 5% w/v 
respectively and allowed to cool to 25 °C following autoclaving to form working solutions. Collagen 
solutions were stored at 4 °C prior to use. 
5.2.4 Cell culture expansion 
Mouse calvaria-derived pre-osteoblasts (MC3T3) were cultured from stock vials (passage 15) (Sigma 
Aldrich, UK). A single vial containing 1 x 106 cells was removed from storage in liquid nitrogen and 
defrosted in a water bath at 37 °C (Grant Instruments™ - Fisher Scientific, UK). Once thawed, cells 
were transferred to a centrifuge tube along with supplemented Dulbecco Modified Eagle Medium 
(DMEM) (10% FBS, 2.5% L-glutamine, 2.5% HEPES buffer and 1% penicillin/streptomycin) and 
centrifuged at 1000 rpm for 3 minutes using a benchtop centrifuge (ThermoFisher Scientific, UK). 
The supernatant was removed and fresh supplemented DMEM was added prior to transferring to a 
cell culture flask. Cells were kept at 5% CO2 and 95% air and incubated at 37 ºC (Triple Red, UK). 
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Media was aspirated and replaced every 3 days and cells were passaged at 80% confluence. 
5.2.5 Cell culture passage 
For the trypsinisation process, media was aspirated from cultures and cells were washed using 
Phosphate-Buffered Saline (PBS). TrypLE™ dissociation reagent was added and flasks were 
incubated at 37 ºC for 2 minutes. Cultures were then observed for cell lifting using a VWR IT 400 
Inverted Microscope (VWR, UK). If cells had not detached, a further 2-minute incubation period was 
provided. In order to halt the enzymatic activity of TrypLE™, supplemented DMEM was added. Cell 
suspensions were centrifuged at 1000 rpm for 3 minutes after transferring into sterile centrifuge tubes 
and the supernatant was removed. Cell counting using a haemocytometer determined the volume 
needed from the cell suspension to seed new flasks and media was added.  
5.2.6 Hand-printing tissue constructs 
Following the trypsinisation and cell counting processes, cells were suspended in sterile 1% w/v 
gellan at a density of 3 x 105 cells / mL. Agarose was then added to each well of a 6 well plate and 
the gellan / cell suspension was extruded by hand within the agarose beds into 3 defined shapes – the 
letter ‘J’, a ring and a solid disc using a 10 mL syringe and a 21 gauge needle (337 µm inner diameter). 
A VWR IT 400 Inverted Microscope (VWR, UK) was used to check for successful cell encapsulation 
without diffusion into the surrounding bed support. 200 mM CaCl2∙2H2O was then extruded around 
the perimeters of the constructs for crosslinking and DMEM was added prior to incubation at 37 ºC. 
Media was aspirated and replaced every 3 days and cells were cultured for a given number of days 
prior to cell viability assays using live/dead staining.  
5.2.7 Cell viability 
To assess cell viability, media was aspirated and constructs were washed in PBS. 7 µL of calcein AM 
was added to the constructs for the staining of live cells (green) and 25 µL of propidium iodide was 
added for the staining of dead cells (red). Photographic images of the constructs were taken prior to 
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mixing with live/dead stains. Cells were incubated for 20 minutes at 37 ºC, small sections were 
transferred onto slides and an Evos cell imaging microscope (ThermoFisher Scientific, UK) was then 
used to image live and dead cells for the analysis of cell viability within the manufactured constructs. 
5.2.8 Rheology of printing solutions 
Rheological analyses of the printing polymer solutions for assessing resolution were performed in 
triplicate at 25 °C (apart from collagen which was measured at 4 °C) using a Bohlin Gemini rheometer 
(Malvern Panalytical, UK) with a double gap cup and bob geometry (DG 24/27). Shear rate was 
ramped from 0.1 to 100 s−1 and shear viscosity (Pa.s) was recorded. 
5.2.9 Tuning print resolution 
Upon introduction of a commercially available 3D bioprinter into the suspended manufacturing 
system, giving rise to the evolution of suspended layer additive manufacturing (SLAM), the 
resolution of the technique was assessed. Dyed blue gellan rings with a diameter of 15 mm were 
printed using an INKREDIBLE 3D bioprinter (Cellink, Sweden) within an extra-depth petri dish 
filled with agarose fluid gel. Parameters that were controlled included extrusion pressure (5 – 25 kPa 
in 5 kPa increments), flow rate and nozzle internal diameter (150, 200, 250, 410 and 610 µm). The 
range of pressures and nozzle internal diameters were selected on the basis that they covered values 
considered from the lower ends to higher ends of the scale and with sufficient intermediate values to 
determine linearity. The width of the extrude was then measured using digital callipers. A flow rate 
of 3.8 µL s-1 was used as the minimum flow necessary in order to print a continuous extrude when 
operating at a print speed of 10 mm s-1. The print pressure required to achieve this flow rate using 
each nozzle gauge was then noted. To assess the effects of printing pressure on resolution, the needle 
aperture was kept at 410 µm whilst increasing pressure for each subsequent print. To assess the impact 
of internal needle diameter on printing resolution, the minimum required pressure to extrude material 
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from the smallest aperture (150 µm) was used across all nozzle gauges and the width of the extrude 
was reported. 
5.2.10 Diffusion studies 
Methylene blue (Mw = 319 g/mol) and dimethylmethylene blue (Mw = 416 g/mol) rings with a 
diameter of 15 mm were printed using an INKREDIBLE 3D bioprinter (Cellink, Sweden) within an 
extra-depth petri dish filled with agarose fluid gel. Images were taken at given time points and 
diffusion was measured by assessing the width of the extrude using digital callipers. 
5.2.11 Rheology of print beds 
Rheological analyses of the agarose fluid gel and agarose slurry were performed in triplicate at 25 °C 
using a Kinexus Ultra+ rheometer (Malvern Panalytical, UK). To investigate the shear thinning 
behaviour, the shear rate was ramped from 0.1 to 100 s−1. Three‐step thixotropic measurements were 
then performed at 0.1–100–0.1 s−1 to analyse the flowing and healing of the gels during and upon 
removal of shear. 
5.2.12 Brightfield microscopy 
For visualization of the particulate structures within fluid gels and slurry gels, small samples were 
loaded onto microscope slides and mounted with a cover slip before imaging using a VWR IT 400 
Inverted Microscope (VWR, UK). 
5.2.13 3D modelling 
3D lattice scaffolds were designed using computer‐aided design (CAD) software SolidWorks and 
saved in stl (stereolithography) file format, which describes the 3D model in a surface tessellated 
arrangement. A simple cylinder shape (10 mm diameter and 5 mm depth) was also constructed for 
printing cell / polymer solution suspensions and to confirm the viability of cells following printing (0 
hours) and culture (7 days). Models in the form of an S shape, T7 intervertebral disc, carotid artery, 
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hand, femur, foetus and spider were downloaded from thingiverse (https://www.thingiverse.com/) 
and scaled to an appropriate size (if applicable). Blood vessel and ear models were preloaded onto 
the SD card within the bioprinter, courtesy of Cellink. The stl to G‐code conversion programme Slic3r 
was then used to slice the models into layers and translate the coordinates into commands for the 3D 
bioprinter. 
5.2.14 3D printing complex shapes using SLAM 
For printing of 3D structures by SLAM, bioink cartridges were loaded with hydrogel precursor 
solutions (gellan, collagen, ι‐carrageenan, pectin or alginate), attached to a conical nozzle with an 
internal diameter (ID) of 410 µm and inserted into an INKREDIBLE 3D bioprinter (Cellink, Sweden). 
In some cases, phenol red or red/blue food dye was added to the hydrogel solutions for improved 
visualization of the printed parts. The 3D bioprinter was calibrated to a specified pressure (6 kPa) 
followed by placement of the petri dish containing the agarose fluid bed upon the z‐stage. Gellan 
gum, ι‐carrageenan, pectin and alginate were ionically crosslinked by extruding 200 mM of CaCl2 · 
2H2O solution around the structure via a hypodermic needle, whereas collagen gelation was induced 
thermally by raising the temperature to 37 °C. Finally, the constructs were retrieved from the agarose 
bed using a spatula and gently washing with deionized water. An S shape was printed with and 
without an agarose fluid gel bed for comparison. 
5.2.15 Generation of monolayer sponges 
Following the 3D printing process, 3D scaffolds destined for transformation into monolayer sponges 
were subjected to lyophilisation. Scaffolds were placed in -80 ºC conditions for 24 hours and then a 
72-hour freeze drying cycle was implemented at -76 ºC and 0.0010 mbar (Christ ALPHA 2–





5.2.16 Scanning electron microscopy 
Monolayer sponges were prepared by sputter coating with gold using a Quorum SC7620 sputter 
coater under a low bleed of argon. The internal networks within the scaffolds were then studied using 
a field emission scanning electron microscope (FEI Quanta 250 SEM) operated in high vacuum mode 
at an accelerated electron energy of 10 kV. Several images were collected at various magnifications 
using a back scattered electron detector. 
5.3 Results 
5.3.1 Hand printing tissue constructs 
Hand-printed tissue constructs of cell-loaded gellan were successfully fabricated within an agarose 
supporting bed using the suspended manufacturing method. Structures shaped as a solid disc, letter 
‘J’ and a ring shape retained structural integrity during extrusion within the agarose platform support 
prior to crosslinking of the constructs (Figure 5.1A). As neither a template nor specific dimensions 
were followed, the shapes generated were imperfect, resulting from lack of control during hand-
printing. More positively, cells remained confined to the location of extrusion without the bioink 
leaching into the supporting particulate bed (Figure 5.1B) and constructs were also successfully 
removed (Figure 5.1C). Moreover, following 8 days of culture, cell viability within hand-printed 
constructs was assessed and a high percentage of cells were viable (Figure 5.1D). 
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Figure 5.1 – Suspended manufacturing of hand printed constructs. A) Solid disc, letter J and ring-shaped 
constructs within an agarose fluid gel. B) Localisation of constructs within fluid gel at the micro-scale. C) Solid 
disc, letter J and ring-shaped constructs following removal from the fluid gel bed. D) Live / dead cell viability 
showing live (green) and dead (red) cells. 
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5.3.2 Tuning print resolution 
When engineering a tissue construct using 3D micro-extrusion printing, careful consideration must 
be taken when selecting printer operating modalities. Amongst these modalities are print speed, print 
pressure, extrusion flow rate and nozzle gauge and each criterion directly impacts upon each other as 
well as print fidelity and cell viability within a printed scaffold. Initially, the viscosities of a range of 
different biopolymers (pectin, alginate, ι-carrageenan, gellan and collagen) were measured over a 
range of shears that simulate the shear forces experienced by the materials during extrusion (Figure 
5.2A). In all cases, materials exhibited shear thinning behaviour allowing the extrusion of polymer 
with great ease. The polymer viscosity during extrusion was then compared with the pressure required 
to achieve a constant printing flow rate (3.8 µL s-1 (equating to one drop every four seconds)). As 
expected, a higher print pressure was required to extrude materials of higher viscosities and a 











Figure 5.2 - Relationships between a range of materials’ viscosities and printing pressure. A) Shear viscosity of 
pectin, alginate, ι-carrageenan, gellan and collagen solutions. B) Print pressure required in order to achieve a 
constant flow rate of 3.8 µL 
s-1






In order to assess print resolution, the effects of a range of hydrogel chemistries and viscosities, 
extrusion flow rates, nozzle gauges (internal diameters – ID) and print pressures on print resolution 
were studied while the fluid gel supporting bed was kept constant. In order to achieve this, dyed gellan 
was extruded within the fluid gel under various combinations of parameter conditions and then the 
width of the extrudes were measured with digital callipers as an indication of resolution. The same 
experiment was then repeated within an agarose slurry gel to examine the impact of supporting gel 
formulation method on resolution. 
To determine the minimum achievable extrude thickness and thus the optimum resolution within fluid 
gels and slurries for each nozzle gauge, the print pressure was adjusted for each nozzle ID accordingly 
(150, 200, 250, 410 and 610 µm) so that gellan was extruded at 3.8 µL s-1. Within both fluid and 
slurry gel systems, as the nozzle ID increased, the pressure required to extrude dyed gellan at a 
constant rate decreased due to a decrease in resistance to polymer flow. The potential resolution, 
however, decreased linearly as the nozzle ID increased when flow rate was kept constant (Figures 
5.3Ai-ii and D left). The resolution of the extrude was slightly higher in fluid gels compared with 
agarose slurries with thicker, less continuous extrudes. When print pressure increased and nozzle ID 
was kept constant (and therefore polymer flow rate also increased), resolution decreased in a linear 
fashion (Figures 5.3B and D middle). For the evaluation of nozzle ID on resolution, the lowest 
pressure required to extrude gellan material from a nozzle with the smallest ID was selected and kept 
constant across the whole range of nozzle gauges. Likewise, when print pressure was kept constant 
and nozzle ID ascended (and therefore polymer flow rate also increased), resolution decreased in a 
linear trend (Figures 5.3C and D right). In the case of gellan extruded through a needle with an ID 
of 610 µm and a pressure of 24 kPa, the gross extrusion pressure combined with minimal resistance 
to flow (due to a large needle aperture) caused excessive shear forces on the fluid gel material thus 





Figure 5.3 - Controlling print parameters for tuning 3D bioprinting resolution in SLAM. 3D printed dyed gellan 
rings with constant flow rate and varying nozzle ID and print pressure in Ai) fluid gel (FG) versus Aii) slurry gel 
(SG). B) constant nozzle ID and varying flow rate and print pressure and C) constant print pressure and varying 
flow rate and nozzle ID (scale bar = 5 mm). D) Linear plots of corresponding parameters within A, B and C. 
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5.3.3 Diffusion studies 
Two dyes of differing molecular weight (methylene blue, Mw = 319 g/mol and dimethyl methylene 
blue Mw = 416 g/mol) were 3D printed within the fluid gel print bed to characterise diffusion rates.  
This was to ascertain how different printing solutions containing different sized molecules behave 
following deposition within the fluid gel bed and also as an insight into how crosslinker solutions 
may diffuse within the suspended construct. The minimum pressure required to extrude each dye to 
form a 15 mm diameter ring was used (16 kPa and 2 kPa respectively) and the diffusion was quantified 
by measuring the thickness of the extrude over time (Figures 5.4 and 5.5). As methylene blue has a 
lower molecular weight, this dye was able to diffuse further across the fluid gel than dimethyl 
methylene blue which plateaued at around 2.2 mm after 90 minutes (Figures 5.6A and B). 
Figure 5.4 – Diffusion of a 15 mm diameter methylene blue ring (Mw = 319 g/mol) within an agarose fluid gel over 




Figure 5.5 – Diffusion of a 15 mm diameter dimethyl methylene blue ring (Mw = 416 g/mol) within an agarose 





Figure 5.6 – Diffusion of a A) methylene blue (Mw = 319 g/mol) and B) dimethyl methylene blue (Mw = 416 g/mol) 




5.3.4 Rheology of print beds 
The mechanical properties of the print bed are a crucial parameter in SLAM as they can impact on 
the resolution and complexity of the suspended construct. Freeform reversible embedding of 
suspended hydrogels (FRESH) is another embedded printing technique that uses a gelatin slurry 
support bath (Hinton et al., 2015), however the rheological behaviour of a particle slurry as a 
suspending agent has not yet been investigated. Here, the rheological behaviour of agarose fluid gels 
and slurry gels were compared. A gelatin slurry gel was not considered for inclusion within this thesis 
as its features of liquifying at cell culture temperatures renders it unsuitable for suspending cell-
loaded constructs and for these reasons is considered futile. The viscosity was measured with 
increasing shear to replicate the shear action of the cartridge needle and extruded polymer within the 
print bed (Figure 5.7A). Both formulations showed shear‐thinning behaviour which is critical in 
allowing movement of the needle through the gel during printing without causing dragging of 
previously deposited layers. Agarose fluid gels versus slurry gels exhibited lower viscosities though 
both were prepared at the same concentration of 0.5% w/v, yet a more stable recovery was featured 




Figure 5.7 – Mechanical spectra of the fluid‐gel bed and comparison with agarose slurry by shear rheology. A) 
Shear viscosity of agarose fluid gel (filled circles) and agarose slurry (blank squares) in which fluid gels exhibit 
lower viscosity. B) Shear recovery of agarose fluid gels versus agarose slurry featuring a more rapid and stable 
recovery following shear removal within agarose fluid gels. 
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5.3.5 Brightfield microscopy 
Following rheological characterisation of agarose fluid gels versus slurry gels, the particle 
morphologies within each gel were studied using brightfield microscopy. Fluid gel particles were 
formed of small subunits that interacted to form larger, hairy particles of around 100–150 µm and 
were heterogeneous and irregular in shape as a result of generation through sheared gelation (Figure 
5.8A). In contrast, agarose slurry particles generated through fracturing a solid, bulk gel exhibited a 





Figure 5.8 – Brightfield micrograph of a 0.5% w/v agarose A) fluid gel containing particles comprised of smaller 
subunits made by shear cooling and B) slurry gel showing angular particles made by fracturing a solid bulk gel 
(scale bars = 150 µm). 
5.3.6 3D printing complex shapes using SLAM 
The design and manufacture of constructs by combining 3D bioprinting and suspended manufacturing 
was successfully achieved. The generation of a G code file from an stl file was accomplished using 
Slic3r file conversion software (Figure 5.9A). An ‘S’ shape was printed using 1.0% gellan with and 
without a 0.5% w/v agarose particulate bed and crosslinked. Constructs that were printed onto a planar 
surface lost all structural integrity, collapsing under their own weight and spreading across the petri 
dish (Figure 5.9B). Constructs that were printed within the particulate bed, however, were seen to 




Figure 5.9 – Design and manufacture of a single construct using suspended manufacture with a 3D bioprinter.             
A) Stl file in Slic3r of an ‘S’ shape with dimensions 24.77 x 40.00 x 2.50 mm. B) S shape print onto a planar surface. 
C) S shape print within a supporting agarose bed. D) S shape following crosslinking and removal from the bed 
support (scale bars = 5 mm). 
After establishing that the suspended manufacture technique works concurrently with an automated 
3D bioprinting system in place of hand printing, the next crucial element that defines the success of 
the newly developed suspended layer additive manufacture method is that cells remain viable 
immediately after printing and following culture for a 7 day period. Simple cylinder shapes were 
printed using different bioinks, (gellan, ι-carrageenan, alginate and collagen) loaded with MC3T3s, 
demonstrating the large variation in material chemistries and mechanics that can be printed using this 
technology. Gellan and collagen prints reflected print model dimensions (Figures 5.10A and B left), 
whereas alginate was seen to swell, and ι-carrageenan constructs slightly sagged (Figures 5.10C and 
D left, respectively). As an alternative method to fabricating tissue engineering structures, acellular 
materials were freeze dried (Figure 5.10 middle) and rehydrated with cell-suspended media (Figure 
5.10 right) creating cell seeded sponges. Tissue engineering sponges are useful in that they can be 
stored until needed followed by cell seeding when necessary and could also be used to absorb wound 
exudate when used in dressings. The fabricated sponges lost some of their dimensional volume and 
exhibited some deformation due to the lyophilisation and rehydration process, especially in the case 
of ι-carrageenan sponges. All sponges appear pink in colour due to the colour of cell-culture media. 
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Figure 5.10 – Images of freshly printed hydrogels (left), freeze dried sponges (centre) and rehydrated monolayer 
sponges (right) using A) 1.0% gellan, B) 0.5% collagen, C) 3.0% alginate and D) 2.0% ι carrageenan (scale bar = 
5 mm). 
Upon observation of the preservation of cells within 3D printed scaffolds, live / dead staining on 
hydrogel constructs was performed to confirm cell viability following shear conditions experienced 
by cells during 3D extrusion printing and after 7-days culture (Figure 5.11). A high viability was 
seen across all material constructs both immediately following printing and after 3D culture, 
confirming that not only does SLAM enable maintenance of print fidelity, but also the conservation 
of the cell’s viable status. 
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Figure 5.11 - Calcein AM live (green) / PI dead (red) cell viability analysis on freshly 3D printed (0 days - upper) 
and 7 day cultured (lower) MC3T3 cells suspended within gellan, collagen, alginate and ι-carrageenan hydrogels 
(scale bar = 200 µm). 
As a comparison of an alternative route often employed in tissue engineering, gellan and collagen 
sponges were seeded with MC3T3 mouse pre-osteoblasts and cell viability was inspected at 0- and 
7-days culture (Figure 5.12). Two regions within each scaffold were analysed at 7 days (region 1 and 
region 2, respectively) and the placement of cells was much less heterogenous throughout the 
scaffolds attributed to the cell seeding process compared with cell-hydrogel suspensions.  
Figure 5.12 - Calcein AM live (green) / PI dead (red) cell viability analysis on freshly seeded (0 days) and 7-day 
cultured MC3T3 cells suspended within gellan (upper) and collagen (lower) sponges (scale bar = 200 µm). 
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By assessing the internal networks within freeze dried sponges, one can further understand the 
integral differences between polymer microarchitecture. Using scanning electron microscopy, 
micrographs reveal inter-material variances on the micrometre scale, showing that gellan appears to 
have a dense polymer network with fewer, larger pores in contrast to the more porous, fibrous network 
within collagen sponges (Figure 5.13). In the case of alginate, a much sparser, string like network 








Figure 5.13 - Scanning electron micrographs of 1.0% gellan, 0.5% collagen, 3.0% alginate and 2.0% ι carrageenan 
at 100x magnification. 
Following validation of integrating a 3D bioprinter within the suspended manufacturing technique 
and thus the emergence of suspended layer additive manufacturing (SLAM), a range of complex and 
biologically relevant model conformations were 3D printed to assess the capacity of the system. 
Initially, intricate lattice structures (Figure 5.14A) were printed to demonstrate that a high resolution 
of print geometry can be achieved within the fluid gel (Figure 5.14B) and that fragile constructs can 




Figure 5.14 – Suspended layer additive manufacturing of an intricate lattice. A) Stl file and 3D printed gellan 
lattice B) within and C) following gelation and retrieval from the agarose fluid gel bed (scale bars = 10 mm).  
On the other end of the scale, the potential of the system to successfully fabricate large bulk structures 
was also determined by 3D bioprinting a T7 intervertebral disc (Figure 5.15A). The fluid gel support 
bed was able to suspend the solid structure (Figure 5.15B) and crosslinking ions were able to 
penetrate the construct to initiate gelation (Figures 5.15C and D).  
 
Figure 5.15 – Suspended layer additive manufacturing of a bulk T7 intervertebral disc. A) Stl file and 3D printed 
gellan intervertebral disc B) within and C/D) following gelation and retrieval from the agarose fluid gel bed (scale 
bars = 10 mm).  
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Within conventional 3D bioprinting systems which extrude polymer material onto a planar Z-stage, 
the realisation of hollow structures can rarely be achieved. To decipher whether using a supporting 
agarose fluid gel bed could overcome this issue, hollow tubes and blood vessel-like structures with 
various lumen dimensions were fabricated (Figure 5.16A). Upon inspection, the nature of how 
polymer was deposited in an arrangement where voids were present (represented by the hollow part 
of the structure) was of no detriment to the system. Polymer was extruded within the support bed in 
a manner consistent with the 3D model file without causing dragging of previously printed material 
(Figure 5.16B). Again, scaffolds were retrieved from the supporting gel following crosslinking and 
demonstrated that the lack of chemical associations between printed gellan and the agarose gel bed 
enables suspension of hollow structures prior to solidification and extraction (Figures 5.16C and D). 
 
Figure 5.16 – Suspended layer additive manufacturing of hollow tubes and blood vessels. A) Stl file and 3D printed 
gellan tubes and blood vessels B) within and C/D) following gelation and retrieval from the agarose fluid gel bed 
(scale bars = 10 mm).  
In extension to 3D printing hollow structures and to push the boundaries of the current standard for 
manufacturing biological scaffolds, a hollow and bifurcated carotid artery was produced. An stl file 
of a carotid artery scan (Figure 5.17A) was translated into a GCODE file (Figure 5.17B) rendering 
the 3D model as a series of layers which can be printed, bottom to top, using the principles of additive 
layer manufacturing with a suspending element (Figure 5.17C and D). The carotid artery was then 
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solidified upon the introduction of calcium chloride solution (Figure 5.17E) and was extracted from 
the supporting bed (Figure 5.17F). Following this, the hollow bifurcated structure was perfused with 
a blue dye (Figure 5.17G), showing that SLAM is a suitable method for the generation of complex 
structures which would otherwise need additional reinforcements by altering the geometrical aspects 
of the model and subsequent severing following fabrication. 
Figure 5.17 – Suspended layer additive manufacturing of a human carotid artery. A) Stl file and B) GCODE print 
path of model human carotid artery. Gellan carotid artery C/D) during printing, E) following crosslinking with 
calcium chloride F) after retrieval from the agarose fluid gel bed and G) perfused to highlight channels within the 
structure using a blue dye (scale bars = 10 mm).  
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Finally, a range of bulk, biological structures that feature intricate protrusions and contours and that 
are absent a flat base were manufactured using SLAM (Figures 5.18A - E). Structures including a 
hand, ear, femur, foetus and spider were all replicated in gellan within the supporting agarose bed. 
Figure 5.18 – Suspended layer additive manufacturing of complex gellan structures. A) Human hand, B) human 
ear C) human femur D) human foetus and E) spider. Yellow graphics are stl images and red or blue graphics are 




The automation of 3D bioprinting scaffolds and constructs via the suspended manufacture method 
has been realised to a high level. The employment of a 3D bioprinter has enabled more controlled 
deposition and the generation of more refined tissue engineering parts despite the low viscosity of the 
printing hydrogel precursors. Additionally, the transition from hand printing to automated fabrication 
has seen no detriment to the viability of hydrogel-suspended cells. On the contrary, this new technique 
offers a more controlled, measurable and predictable alternative to the variable and inconsistent 
nature of hand-printing. This has seen the evolution of suspended manufacturing into what has now 
been termed as suspended layer additive manufacturing (SLAM). 
As part of this evolution, a wide range of opportunities for tuning print parameters in order to direct 
print resolution and cellular viability were created. To exploit the advantages of this feature, a range 
of biopolymer hydrogel solutions with differing mechanical properties were subjected to shear 
rheology to further understand the viscosity profiles that play an important role in extrusion 
bioprinting. Pectin, alginate, ι carregeenan, gellan and collagen all showed shear thinning 
characteristics, through a reduction in viscosity, as shear rate was increased (Figure 5.2A). The 
viscosity profiles of each hydrogel solution also correlated with the pressure required for extrusion, 
in that viscous polymers required higher print pressures to permit deposition (Figure 5.2B). When a 
single material (gellan dyed blue) was selected to assess the multifaceted relationships between flow 
rate, nozzle diameter and print pressure, it was seen that increasing each of these parameters also 
decreased the resolution of printed rings within the agarose fluid gel bed. When slurry gels were used 
as an alternative supporting gel formulation method, it was evident that the resolution was slightly 
compromised and extrudes appeared discontinuous (Figure 5.3). 
Though it has been proven that the SLAM technique is conducive to printing intricate extrudes with 
relatively high resolution, it is imperative that the shear forces experienced by the bioink during 
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deposition do not exceed the threshold of shears that impact upon cell viability and behaviour. Shear 
stress is inevitable within any extrusion-based printing procedure and is also directly influenced by 
the viscosity of the printing material, nozzle diameter and printing pressure likewise to resolution. An 
in-depth analysis into balancing printing resolution and stem cell integrity by controlling shear 
stresses in 3D bioprinting was presented by Blaeser et al., (2016). Using drop on demand (inkjet 
printing), they assessed the effects of a range of hydrogel viscosities, printing pressures and nozzle 
diameters on shear induction upon bioinks during extrusion. They found, by aid of their 
computational algorithms, that by increasing dispensing material viscosity, increasing printing 
pressure and decreasing nozzle diameter, print induced shear increased. The printing pressures and 
nozzle diameters reported during Blaeser‘s study, however, generated considerably harsher printing 
conditions than those presented using the SLAM technique (0.5 – 1.5 bar versus 0.05 – 0.24 for print 
pressure and 150 – 300 µm versus 150 - 610 µm for nozzle diameter respectively). The ranges of 
dispensing viscosities between the two systems were comparable (0.01 – 1 Pa at 10 s-1 in both cases 
(with the exclusion of ι-carrageenan at 10 Pa s)) although our group have previously demonstrated 
the capacity of SLAM to print materials with a viscosity equivalent to that of water. It must be 
acknowledged that the differences in parameters are reflective of how the two opposing printing 
techniques differ on an operating level. Inkjet printing involves dispensing of bioinks by jetting single 
droplets through electromagnetic micro-valves. Alternatively, micro-extrusion deposits bioinks as 
continuous media via pneumatic force. Due to the opposing natures of how bioinks are dispensed, the 
terms of how dispending is measured also differs. Inkjet printing is associated with deposition 
velocity as the bioink is propelled through the air onto a collector substrate, whereas the SLAM 
method measures bioink deposition within the supporting gel in terms of flow rate. It is not therefore 
appropriate to compare the two methods on this basis, however, by comparison of the more 'cell 
friendly' printing parameters used in SLAM with those used by Blasaer (which still produced 
reputable results at the gentler end of the scale), combined with the assessment of cell viability by 
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staining, it may be confirmed that a high resolution of printing may be achieved without 
compromising cellular integrity. 
As an approximate indicator of how crosslinking solutions diffuse throughout the fluid gel and within 
the construct once injected around the print perimeter, the diffusion of two dyes (methylene blue and 
dimethyl methylene blue) with different molecular weights was inspected. Interestingly, methylene 
blue required a greater extrusion pressure of 16 kPa to attain an equivalent flow rate. Of the two, 
methylene blue had the lower molecular weight (319 g/mol) and exhibited a larger range of diffusion, 
platauing much later than dimethylmethylene blue (417 g/mol). In comparison, the calcium chloride 
dihydrate crosslinking solution has a molecular weight of around 147 g/mol, whereas the polymers 
used in this study, such as alginate, gellan, ι carrageenan and collagen, have much higher molecular 
weights which generally appear in the regions of the thousands, if not tens or even hundreds of 
thousands. These values are advantageous in that the low molecular weight of the crosslinking 
solution allows it to readily traverse the fluid gel causing rapid onset of crosslinking. Conversely, the 
large molecular weights of suspended polymer within the fluid gel bed ensure that extrusion remains 
localised. In other embedded techniques, such as FRESH, a gelatin slurry forms the supporting matrix 
and is formulated with an inclusion of calcium chloride (Hinton et al., 2015). However, this may be 
unsuitable for elaborate model designs that require extended printing timeframes, as gelation may 
start to occur much too prematurely before printing has finalised. In addition, the agarose support 
bath allows for further methods of crosslinking. This includes temperature‐dependent polymers, such 
as some collagen formulations that are gelled by raising scaffold temperature to 37 °C, which would 
otherwise liquefy the gelatin slurry at cell culture and physiological temperatures. 
When comparing agarose fluid gels to agarose slurry gels, as an assessment of the importance of 
support bed formulation, shear rheology revealed that fluid gels exhibited a lower shear viscosity yet 
a more stable recovery upon the removal of shear. These results translate in that printing solutions 
may be more easily deposited following the shearing action of the needle within the supporting matrix 
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yet experience greater reinforcement from the self-healing gel before solidification. An explanation 
into the mechanical behaviour of these two gel formulations can be found when observing the inner 
particulate suspensions under a brightfield microscope. Fluid gel particles exhibited ‘hairy’ 
accessories due to the toroidal fluid motion which is generated under the shear of a magnetic stirrer 
(Halász et al., 2007). These hairy projections claim some responsibility for inter-particle associations 
due to a large surface area to volume ratio, meaning that once shear forces are removed, the particles 
interact more readily compared with the smooth, angular and irregularly sized particles within agarose 
slurry gels. 
Perhaps the most defining results that establish the success of this system is the generation of complex 
hydrogel structures whilst cell viability status is maintained. Initially, an S shape was printed with 
and without an agarose fluid gel bed using low viscosity gellan to illustrate the importance of the 
supporting matrix. Without such, the S shape was seen to deform and flow in contrast to the same 
hydrogel solution that was printed within the gel bed using SLAM. Cylindrical shapes were then 3D 
bioprinted to ensure that cells within the bioink remain live following printing and 7-day culture, in 
which a high viability was seen in both cases, throughout all four suspending materials of gellan, 
collagen, alginate and ι-carrageenan. Moreover, within 7-day cultured collagen constructs in 
particular, (the only integrin binding domain bearing material assessed) the cells appeared to have 
proliferated within the hydrogel. In comparison to the proposed method of generating hydrogel tissue 
engineering constructs, a different form of biomaterial in the conformation of a tissue engineering 
sponge was fabricated. One advantage of manufacturing sponges over hydrogel constructs is that 
sponges can be pre-made, stored and seeded with cells when necessary. Manufacturing tissue 
constructs this way, however, produces a marked difference in mechanical properties, porosity, 
diffusion rates, cell morphology and cell distribution (Zhang et al., 2013). In gellan and collagen 
sponges versus the equivalent hydrogels, cell distribution is much less heterogeneous, and cells form 
aggregates due to the seeding process, in which cells filter through the larger pores and then settle on 
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the polymer fibres. Consequentially, cells assume a more elongated morphology as opposed to more 
spherical morphologies within hydrogel constructs.  
Once print fidelity and cell viability had been established, different, biologically relevant geometries 
were printed using gellan to test the complexity and scale that can be achieved using the SLAM 
method. In order to demonstrate the resolution of the system, an intricate lattice structure was printed. 
The delicate structures could easily be removed from the fluid gel bed following gelation without 
damage to the scaffolds. These elaborate designs are often favoured in the manufacture of implantable 
scaffolds as they are conducive to diffusion and vascular infiltration, thus reducing the emergence of 
hypoxic or necrotic regions (Fantini et al, 2016; Hollister, 2005; Loh & Choong, 2013). To display 
the system’s capacity to print large bulk structures, a T7 intervertebral disc was manufactured. The 
3D printed T7 disc exhibited true-to-size dimensions and the fluid gel print matrix successfully 
allowed the addition, post-production, of crosslinking cations for solidification. The ions were able 
to diffuse throughout the fluid gel into the whole printed part despite it having relatively large 
dimensions. To test the potential of producing geometries which cannot be printed using a 2D 
collector, a range of hollow and bifurcating structures were printed. A large bifurcated structure in 
the form of a carotid artery was printed as well as smaller, tubular and perfusable structures with 
internal junctions. Following gelation, these were easily removed from the fluid gel support bed, 
residual agarose was washed away and they were sufficiently robust to be handled and manipulated. 
To demonstrate the potential to 3D print structures which combined both bulk and intricate features, 
a hand, ear, femur, spider and a foetus shape was printed. The way in which the fluid gel suspends a 
structure during manufacture has previously been likened to the way in which the amniotic fluid 
supports a developing foetus (Moxon et al., 2017). Using this suspending element, further freedom is 
granted when printing complex hydrogel shapes, in that the orientation of the print model (i.e. 
horizontal or vertical) can be selected to optimise the ALM print path, rather than to aid 
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conduciveness of printing onto a planar stage in which a particular orientation may need to be 
selected.  
5.5 Conclusions 
In summary, the SLAM technique was developed to resolve the complications related to using low 
viscosity bioinks in extrusion-based 3D bioprinting. Hand-printing 3D scaffolds by suspended 
manufacture was upgraded by introducing a robotic 3D bioprinter, thus refining the resolution of 
printed parts without impediment to construct fidelity or cell viability. A variety of biopolymer 
materials that are currently widely investigated in regenerative medicine were employed, highlighting 
the versatility of the technique. The method enabled the successful fabrication of bulk, intricate, 
hollow, and bifurcated structures as well as other elaborate scaffolds that were absent a flat base and 
featured detailed protrusions and contours. Aided by tuning flow rate, printing pressure, nozzle gauge 
and rheological properties, the physical and mechanical properties of agarose fluid gels could be 
exploited, allowing the deposition of hydrogel solutions that exhibit varying mechanical properties 
and gelation mechanisms themselves. The fluid gel also facilitates the diffusion of crosslinking ions, 
which is necessary when printing materials that gel via ionic gelation, yet the extruded precursor 
solutions that form the 3D printed model, remain stable and anchored to the region of extrusion before 
crosslinking is initiated. 
Here, manufacturing complex and human-sized hydrogel structures as potential tissue engineering 
constructs by SLAM is the first of its kind. In reality, native human tissues exhibit regional variations 
in extracellular and cellular makeup and are inherently location and function specific. These 
variations must therefore also be mirrored within a single construct during tissue replication for the 
part to successfully integrate within the human body. With this, the next chapter focuses on generating 
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Chapter 6 – 3D Bioprinting Multi-layer Constructs by SLAM 
6.1 Introduction 
Tissue engineering is a rapidly evolving interdisciplinary field that offers enormous potential towards 
the restoration, maintenance and improvement of biological function. However, there remain critical 
challenges including a lack of quantitative design of tissue scaffold architecture and engineering 
regions of the scaffolds to have distinct mechanical behaviour that is analogous to that of the desired 
tissue. When replicating tissues by generating 3D bioprinted constructs, the material environments in 
which cells are suspended should mimic their native tissue origin. In reality, the chemical and 
mechanical properties throughout human tissue are heterogeneously graded and play a crucial role in 
preventing mechanical failure between interconnecting tissues as well as maintaining cell phenotype.  
The documented sensitivity of cells to several chemical and physical cues which guide cell migration 
(known as taxis) is yet to be fully exploited in the biofabrication of tissues (Singh et al., 2008). These 
range from chemical responses of the dissolved and immobilized form (chemotaxis and haptotaxis), 
to the mediation of cell migration through physical attributes within tissues, including substrate 
rigidity (mechanotaxis), electrostatic potential (galvanotaxis) and extracellular tension (tensotaxis) 
(Haga et al., 2005; Lo et al., 2000). Addressing these phenomena within tissue engineering substrates 
could subsequently enable integration of spatially controlled gradients leading to dynamic cellular 
machineries that could enhance cell-based therapies.  
Such environments that must be recaptured within a successful tissue replica include porosity / pore 
size, substrate stiffness, surface gradients (e.g. hydrophilicity, roughness and charge) and chemical 
signalling gradients (such as growth or differentiation factors and cell adhesion molecules) (Singh et 
al., 2008). Previous studies have attempted to modulate tissue gradients by designing anisotropic 
scaffolds and constructs using interface tissue engineering. These practices predominantly focus on 
interfacing hard tissues for applications in musculoskeletal tissue repair, such as the recreation of 
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ligament-bone, tendon-bone and cartilage-bone implants (Patel et al., 2018). These include the control 
of gradients by alternative processing techniques of a single material or by incorporating multiple 
materials with varying physicochemical characteristics to recapitulate desired tissue environments. 
Fabrication techniques which have been used to achieve these goals, however, are often painstaking 
and laborious processes to undertake and can commonly be inconducive to the culture of live cells. 
In addition, many of these studies limit their research to using non-naturally occurring materials, with 
a high occurrence of PLGA, PDMS and PAA and their derivatives being cited in the literature (Sant 
et al., 2010).  
One such example of a synthetic gradient scaffold made by rigorous and complex methods is that of 
a degradable, composite bone-repair product made via 3D fabrication (Dutta Roy et al., 2003). Here, 
PLGA scaffolds containing β-tricalcium phosphate (β-TCP) ceramic were designed, containing pore 
size and porosity gradients for promoting new bone ingrowth. Initially, powdered blends of PLGA 
and β-TCP were spread onto a build bed, following which, liquid binder droplets were robotically 
deposited onto selected regions of the powder bed in a process analogous to inkjet printing. This 
subsequently generated a solid region within the 2D layer, and the process was repeated until the 
build-up of the 3D structure had been achieved. Further, between each layer, a chloroform solvent 
binder was used to consolidate the sequential layers. The gradient in porosity was achieved by adding 
87.5% by weight of sodium chloride salt to PLGA and β-TCP powder blends and decreasing to 80% 
by weight at the outermost edges of the scaffold. Salts were then leached post-fabrication by 
submerging in water, creating pores between 125–150 µm. Though sophisticated in design, this multi-
step process lacks control of pore placement and therefore a reduced potential in quantitative design. 
Towards fabricating mechanical gradients within zonally organised cartilage tissue constructs, Zhu 
et al., (2018) utilised a gradient maker in which two interconnected chambers containing polyethylene 
glycol (PEG) dithiol and chondroitin sulphate (CS) at given ratios that were mixed with isolated 
chondrocytes, were crosslinked into a single structure using photopolymerization. Although the 
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process of achieving tissue gradients within a single construct had been markedly simplified, these 
apparatuses are strictly limited by material compatibility within the system. 
3D bioprinting tissue gradients at the softer end of the scale is much less researched territory. This is 
attributed to the poor printability and shape fidelity of low viscosity solutions as well as the related 
difficulty in integrating multiple materials once crosslinking has occurred (Sardelli et al., 2019). 
Moreover, layering multiple materials with contrasting chemistries and gelling mechanisms is 
particularly hard to accomplish. With this, it is evident that there is a need for improved technology 
in generating composite scaffolds with physicochemical properties akin to soft human tissues. Within 
this thesis chapter, a range of multilayer biopolymer hydrogel structures that contain localised 
variations in physiochemical characteristics and are synonymous to that of native tissue will be 
explored. Heterogeneous tissue constructs with regional chemical, mechanical, microstructural and 
surface architecture specifications were generated using the SLAM method as established in the 
previous chapter. Multi-layer constructs containing two layers of physicochemically different 
material were printed by layering one polymer upon another or by adjacent deposition and then 
integrating by crosslinking under the principles of SLAM. Core-shell constructs were fabricated by 
encapsulating a secondary hydrogel within a pre-established cylinder extrude and were crosslinked 
to produce a phase-encapsulated construct. Further, the encapsulation of a mammary adenocarcinoma 
cell-pellet (absent a hydrogel suspending element) within a pre-established cylinder extrude was 
performed to emulate a basic model of the tumour microenvironment. Finally, polymer blends 
containing two different materials were 3D bioprinted in the form of a carotid artery, demonstrating 
the versatility of this method in recreating tissue chemistries. These 3D bioprinted structures were 
then assessed using a range of analytical techniques including brightfield and scanning electron 





6.2.1 Agarose fluid gel printbed formulation 
Agarose fluid gels (type 1 low EEO, purchased from Sigma-Aldrich, Dorset, UK) were prepared by 
autoclaving solutions of agarose mixed with deionised water (121°C temperature and 1.4 bar 
pressure) (Prestige Medical™ bench top autoclave) at 0.50% w/v concentration and cooling to 25 °C 
under a constant shear of 700 rpm using a magnetic stirrer. Fluid gels were then poured into extra-
depth tissue culture plates to form a supporting printbed. 
6.2.2 Preparation of polymer solutions for printing 
The materials used for printing were low acyl gellan gum and ι‐carrageenan (purchased from Special 
Ingredients, UK), alginate (alginic acid sodium salt, purchased from Sigma–Aldrich, UK), low 
methoxy (LM) pectin (purchased from CP Kelco, UK) and collagen (PureCol EZ Gel, Advanced 
BioMatrix, purchased from Sigma–Aldrich, UK). Gellan, ι‐carrageenan, alginate and pectin powders 
were dispersed in deionized water at concentrations of 1%, 2%, 3% and 5% w/v respectively and 
allowed to cool to 25 °C following autoclaving to form working solutions. Collagen solutions were 
stored at 4 °C prior to use. 
6.2.3 Cell culture expansion 
Mouse calvaria-derived pre-osteoblasts (MC3T3), human dermal fibroblasts (HDF) and MDA-MB-
231 epithelial mammary adenocarcinoma cells were cultured from cryopreserved vials. A single vial 
containing 1 x 106 cells was removed from storage in liquid nitrogen and defrosted in a water bath at 
37 °C (Grant Instruments™ - Fisher Scientific, UK). Once thawed, cells were transferred to a 
centrifuge tube along with supplemented Dulbecco Modified Eagle Medium (DMEM) (10% FBS, 
2.5% L-glutamine, 2.5% HEPES buffer and 1% penicillin/streptomycin) and centrifuged at 1000 rpm 
for 3 minutes using a benchtop centrifuge (ThermoFisher Scientific, UK). The supernatant was 
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removed and fresh supplemented DMEM was added prior to transferring to a cell culture flask. Cells 
were kept at 5% CO2 and 95% air and incubated at 37 ºC (Triple Red, UK). Media was aspirated and 
replaced every 3 days (or as necessary) and cells were passaged at 80% confluence. 
6.2.4 Cell culture passage 
For the trypsinisation process, media was aspirated from cultures and cells were washed using 
Phosphate-Buffered Saline (PBS). TrypLE™ dissociation reagent was added and flasks were 
incubated at 37 ºC for 2 minutes. Cultures were then observed for cell lifting using a VWR IT 400 
Inverted Microscope (VWR, UK). If cells had not detached, a further 2-minute incubation period was 
provided. In order to halt the enzymatic activity of TrypLE™, supplemented DMEM was added. Cell 
suspensions were centrifuged at 1000 rpm for 3 minutes after transferring into sterile centrifuge tubes 
and the supernatant was removed. Cell counting using a haemocytometer determined the volume 
needed from the cell suspension to seed new flasks and media was added.  
6.2.5 3D modelling 
Cylinder shapes (20 mm diameter and 5 mm depth) and cuboid scaffolds (10 x 10 x 5 mm) were 
designed using computer‐aided design (CAD) software SolidWorks and saved in stl 
(stereolithography) file format, which describes the 3D model in a surface tessellated arrangement. 
Two cylinders were stacked (one on top of the other) creating one 3D model with correlating layers 
and printheads and cuboids were to be printed laterally one after the other to determine any impact of 
print direction on shape-specificity. Shapes were scaled to an appropriate size dependent on 
application. The stl to G‐code conversion programme Slic3r was then used to slice the models into 
layers and translate the coordinates into commands for the 3D bioprinter. 
6.2.6 3D printing multi-layer constructs by SLAM 
For printing multi-layer constructs by SLAM, either MC3T3 or HDF cells were mixed with hydrogel 
solution (gellan, collagen, ι‐carrageenan or alginate) at a density of 1 x 106 cells / mL and loaded into 
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two separate printhead cartridges. Cartridges were attached to a conical nozzle with an internal 
diameter (ID) of 410 µm and inserted into an INKREDIBLE 3D bioprinter (Cellink, Sweden). In 
some cases, phenol red was added to the hydrogel solutions for improved visualization of the 
scaffolds. The 3D bioprinter was calibrated to a specified pressure followed by placement of the petri 
dish containing the agarose fluid bed upon the z‐stage. The printer was instructed by the G-code to 
print the first cylinder within the fluid gel using the bioink loaded in printhead one and extruders 
automatically changed to printhead two for printing of the secondary, upper cylinder. Multilayer 
cuboids were laterally printed by moving the petri dish following the initial print so that a secondary 
cuboid would print next to the first with a slight overlap using gellan and dyed gellan materials. 
Gellan, ι‐carrageenan and alginate were ionically crosslinked with the extrusion of 200 mM of 
CaCl2 · 2H2O around the structure through a hypodermic needle, whereas collagen gelation was 
induced thermally by raising the temperature to 37 °C. Finally, the constructs were retrieved from the 
agarose bed using a spatula and gently washing with deionized water. 
6.2.7 3D printing phase-encapsulated constructs by SLAM 
For biofabrication of core-shell constructs, a collagen cylinder was printed within a pre‐printed gellan 
or alginate cylinder to create encapsulated and encapsulating phases within a single structure. 
Scaffolds were crosslinked with 200 mM of CaCl2 · 2H2O for the polysaccharide portion of the 
scaffold whilst placing in 37 °C conditions solidified the collagen part of the scaffold before retrieving 
from the supporting gel bed. 
For fabricating a basic model of the 3D tumour microenvironment, a collagen disc was 3D printed 
within an agarose fluid gel bed followed by the placement of an MDA-MB-231 cell pellet containing 
2 x 106 cells within the centre of the collagen disc using a micropipette. Homogeneously distributed 
MDA-MB-231 cells were also 3D bioprinted within a collagen disc for comparison and both were 
cultured for 14 days prior to imaging using a confocal microscope. 
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6.2.8 Fabricating multi-layer and core-shell 3D sponges 
Multi-layer hydrogels and core-shell scaffolds were placed in −80 °C conditions for 24 h and then a 
72 h freeze drying cycle was implemented at −76 °C and 0.0010 mbar (Christ ALPHA 2–4 LD plus). 
Dry samples were stored in a desiccator prior to imaging and UV sterilised before use. In addition, 
dual layer sponges were subjected to cell seeding. Following cell trypsinisation and counting 
protocols, cell suspensions within cell culture media were created at 1 x 106 cells per mL. Dual layer 
freeze dried sponges were then hydrated with the cell-media suspension and left for no longer than 
24 hours for cells to relax. Following this period, constructs were washed in PBS and were either 
examined or cultured for a further 14 days.  
6.2.9 3D printing blended hydrogel constructs by SLAM 
For printing hydrogel constructs containing two intermixed polymers, blended solutions of pectin and 
collagen were mixed with MC3T3 cells at a density of 1 x 106 cells / mL and printed into the shape 
of a carotid artery, followed by culturing for 14 days. The cell types that are present within native 
carotid artery are smooth muscle cells and endothelial cells, however, MC3T3 cells were used in this 
case as they had previously been imaged within single collagen and pectin hydrogels and would thus 
aid as a better comparison in how MC3T3 cells behave within single matrices versus collagen / pectin 
blends. Carotid artery designs were downloaded from https://www.thingiverse.com. 
6.2.10 Brightfield microscopy 
For visualisation of the internal structure within dual-layer alginate-collagen and gellan-collagen 
sponges, samples were rehydrated in PBS, embedded in cryofluid and sectioned to 20 µm thickness 
using a cryostat microtome (Leica CM 1900). Sections were then loaded onto microscope slides and 
stained with alcian blue for polysaccharide content followed by counter-staining with Van Gieson’s 




6.2.11 Micro-Computed Tomography (Micro-CT) 
In order to assess the microstructure and porosity of intact dual phase sponges, alginate-collagen and 
gellan-collagen samples were imaged using micro-CT (Bruker Skyscan 1172, Bruker, Belgium) and 
stacked data were visualised in 3D using CTVox software (Bruker).  
6.2.12 Profilometry 
Polymer interfaces and surface texture of dual phase alginate / ι-carrageenan sponges were examined 
using a Talysurf CCI 3000 brightfield 3D surface profiler. Cylindrical dual phase sponges (20 × 10 
mm) were affixed onto a stainless-steel wafer (30 × 30 mm) and placed under the microscopic arm of 
the profiler. 800 µm2 regions of the scaffolds were scanned to obtain reliable statistics. The height 
variation in the resulting topography maps was represented by a colour scheme from which the 
topographical information could be inferred. Surface roughness was determined using Surfstand 
Software and the arithmetical mean height (Sa) and root mean square height (Sq) of the construct 
overall and within alginate, carrageenan and interface regions was calculated using the following 
equations (Equation 6.1 and 6.2 respectively).  
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6.2.13 Measuring mechanical gradients within multi-layer constructs 
Amplitude stress sweeps by shear rheology were undertaken on the 3D printed scaffolds in triplicate 
using a Bohlin Gemini rheometer (Malvern, UK) fitted with a 20 mm parallel plate geometry and a 
lower serrated plate (to prevent slippage) at 25 °C. Construct regions were sectioned to 1 mm 
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thickness prior to evaluation. Stress sweep assays were carried out to compare and characterise the 
viscoelastic behaviour within the varying regions of dual phase scaffolds. Elastic (G′) and viscous 
(G″) moduli (Pa) were measured with increasing shear stress from 1 to 1000 Pa and a constant angular 
frequency of 10 rad s-1. 
To monitor interface integrity, an 80% strain load was applied to the lateral side of a dual layer 
collagen / alginate scaffolds using a texture analyser (Stable Micro Systems, UK) and photographs 
were taken before, during and after compression to assess the region where failure occurred. 
6.2.14 Cell morphology and viability staining using fluorescence microscopy 
To assess cell morphology in 3D bioprinted dual layer constructs, media was aspirated, and 3D 
cultures washed in DPBS before 1 drop of actin and Hoechst staining (Invitrogen) was adder per mL 
of construct. To assess cell viability and morphology within cell-seeded sponges and the multi-
material blended carotid artery, 3D cultures were sectioned following the addition of 7 µL calcein 
AM for the staining of live cells (green) and 25 µL propidium iodide for the staining of dead cells 
(red) after media had been aspirated and 3D cultures washed in DPBS. Scaffold sections were 
incubated for 20 minutes at 37 ºC, washed once more with DPBS and transferred onto slides. Cells 
were then imaged using a fluorescence microscope (Evos, ThermoFisher Scientific, UK) for the 
analysis of cell viability and morphology within the manufactured constructs. 
6.2.15 3D mapping cell distribution within tumour models using confocal microscopy 
Once 3D breast cancer tumour models (both cell pellet containing models and homogenously 
distributed cell models) had been cultured for 14 days, constructs were washed in PBS, cross-
sectioned and loaded into Lumox® cell culture dishes (Sarstedt, UK). Two drops of Hoechst stain 
were added per mL of construct for staining of cell nuclei blue and two drops of phalloidin were 
added per mL of construct for staining of F-actin green (ThermoFisher Scientific, UK). Constructs 
were incubated at room temperature for 20 minutes prior to imaging using a Zeiss LSM 880 confocal 
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microscope (Zeiss, UK). 3D z-stack images were obtained using Zen black software and edited using 
zen blue software. 
6.2.16 Scanning Electron Microscopy (SEM) 
Core-shell sponges were prepared for SEM by sputter coating with gold using a Quorum SC7620 
sputter coater under a low bleed of argon. The internal networks within the scaffolds were then studied 
using a field emission scanning electron microscope (FEI Quanta 250 SEM) operated in high vacuum 
mode at an accelerated electron energy of 10 kV. Several images were collected at various 
magnifications using a back scattered electron detector. 
6.3 Results 
6.3.1 3D printing multi-layer constructs by SLAM 
Incorporation of multiple materials into a single scaffold was investigated using the SLAM method. 
Various combinations of ionotropically gelled alginate, gellan and ι-carrageenan and thermally gelled 
collagen biopolymers were successfully integrated to form dual-phase chimeric scaffolds and freeze-
dried sponges (Figure 6.1). Gradients in material could be seen with the naked eye in all cases and 
all scaffolds and constructs exhibited structural integrity throughout the part, as well as at the material 
interface, despite alternative gelation mechanisms. As with the monolayer scaffolds within the 
previous chapter, gellan and collagen closest retained the cylindrical dimensions of the G-code model, 
whereas the ι-carrageenan portions of the scaffolds sagged, and alginate swelled to a greater volume. 
All materials apart from collagen were dyed using phenol red for improved visualisation. Following 
lyophilisation of acellular 3D printed scaffolds, sponges lost some of their original volume and 
deformed further upon rehydration with media.  
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Figure 6.1 - Images of freshly printed hydrogels (left), freeze dried sponges (centre) and rehydrated (right) bilayer 
scaffolds using combinations of A) ι carrageenan / gellan, B) alginate / gellan, C) collagen / gellan, D) ι carrageenan 
/ alginate and E) collagen / alginate (upper material stated first). 
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6.3.2 Porosity gradients within multi-layer constructs by SLAM 
To confirm that materials were interfaced at the micron-scale, a series of techniques including 
brightfield microscopy and micro-computed tomography were conducted. Collagen / gellan dual 
layer scaffolds were chosen as the candidate scaffolds for observation due to achieving the best shape-
specificity and the incorporation of two materials with separate gelling mechanisms. Collagen / 
alginate scaffolds were also observed due to the swelling nature of alginate and to discern if this 
property within alginate would hinder integration at the microscale. Scaffolds were imaged using 
brightfield microscopy following Van Gieson’s staining and alcian blue staining for collagen protein 
and gellan or alginate polysaccharide respectively (Figure 6.2A and B). Collagen stained positively 
pink whilst gellan and alginate stained blue indicating positive for polysaccharide and an intermediate 
purple colour was apparent between the adjacent layers. Using micro-CT, an overall porosity of 
91.90% was achieved in freeze dried collagen / gellan sponges compared with 88.22% in collagen / 







Figure 6.2 – Imaging the interface at the microscale level. Brightfield micrographs of interfaced bilayer scaffolds 
stained with alcian blue for indication of glycosaminoglycans (gellan and alginate) and Van Gieson’s stain for the 
visualisation of collagen (left) and micro-CT scans of chimeric hydrogel sponges exhibiting A) 91.90% porosity in 
collagen / gellan scaffolds and B) 88.22% porosity in collagen / alginate scaffolds respectively (right). 
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6.3.3 Surface roughness gradients within multi-layer constructs by SLAM 
Surface texture analysis on 3D printed and lyophilised sponges was conducted using a profilometer. 
Alginate / ι-carrageenan sponges were selected for assessment due to having the largest diversity in 
material behaviour. Two surface texture parameters were calculated, namely root mean square height 
(Sq) which is equivalent to the standard deviation of heights and arithmetical mean height (Sa) which 
describes the difference in height of each point compared to the arithmetical mean of the surface. 
Looking at the construct as a whole, alginate and ι-carrageenan appeared interconnected at the 
interface with a gradient in peaks and valleys both in 2D and 3D surface texture images (Figure 6.3A 
and B). The alginate portion appeared darker pink and purple attributed to exhibiting deeper valleys 
and a rougher surface compared with ι-carrageenan which predominantly appeared white and smooth. 
These analyses are further highlighted upon revising each layer of ι-carrageenan and alginate 
separately as well as probing the interface which displayed a mixture of the two (Figures 6.3C, D 
and E). Focusing on the Sa values as the commonly accepted parameter used to evaluate surface 
roughness, overall constructs had an Sa value of 55.22 µm, whereas the highest Sa of 60.22 µm 
occurred within the alginate region, signifying the roughest texture, while the markedly lower Sa of 
16.45 µm within ι-carrageenan regions signified much smoother textures (Figure 6.3F). 
Understandably, the interface exhibited an Sa value of 50.21 µm in which both alginate and ι-
carrageenan contribute to an intermediate surface roughness. By observing the Sq values within the 
overall construct (60.6 µm), alginate region (71.22 µm), carrageenan region (20.45 µm) and interface 
(56.8 µm), it can be concluded that alginate features a much larger variation in surface height due to 
higher peaks and lower valleys, ι-carrageenan the lowest variation and the overall sponges and 





















Figure 6.3 – Surface roughness gradients within multi-layer constructs by SLAM. A) 2D and B) 3D surface texture 
images of an alginate / ι-carrageenan dual layer sponge. Surface texture of C) ι-carrageenan, D) interface and E) 
alginate alone. F) Calculated root mean square height (Sq) and arithmetical mean height (Sa) in the construct 




6.3.4 Mechanical gradients within multi-layer constructs by SLAM 
To explore the mechanical variations that can be achieved within a single construct using SLAM, two 
different combinations of mechanically contrasting materials were printed to form one whole part and 
then analysed using shear rheology. A gradual reduction in both elastic (Gʹ) and viscous moduli (Gʺ) 
were seen within alginate / collagen constructs from the alginate being the stiffest (Gʹ = 37,170 at 10 
Pa) to collagen the softest (Gʹ = 4,107 at 10 Pa) and with an intermediate consistency at the interface 
(Gʹ = 16,570 at 10 Pa) (Figure 6.4A). Additionally, the linear viscoelastic region (LVR) and thus 
shear stress required to fracture each layer reduced from the alginate layer to the collagen portion. 
Likewise, in gellan / ι-carrageenan constructs, mechanical strength was also seen to decline in a 
graduated manner from gellan (Gʹ = 10,490 at 10 Pa), to ι-carrageenan (Gʹ = 178 at 10 Pa) and with 








Figure 6.4 – Mechanical gradients within multi-layer constructs by SLAM. Amplitude stress sweeps of 3D printed 
multi-layer constructs containing A) alginate / interface / collagen and B) gellan / interface / ι-carrageenan. 
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In extension, an enquiry into the integrity of the interface following compression of an alginate / 
collagen construct was made using a texture analyser (Figure 6.5). After the set mechanical load was 
applied on the lateral side of the part, it was evident that excessive pressure to the point of fracture 
does not occur specifically at the interface, confirming that the adjoining point within the two scaffold 
materials is not the most vulnerable and susceptible point of weakness.  
Figure 6.5 - Texture analysis of interface integrity A) before, B/C) during and D) after lateral compression of a 
collagen / alginate scaffold. 
6.3.5 Chemical and cellular gradients within multi-layer constructs by SLAM 
The incorporation of multiple materials within a tissue engineering product affords the opportunity 
to introduce chemical gradients throughout the printed structure. One such example is in the 
amalgamation of two material layers, both with and without the presence of integrin binding domains 
that are conducive to cellular attachment within the matrix. Here, collagen / alginate material layers 
were unified within a dual layer construct with human dermal fibroblasts (HDF) suspended within 
each layer. Collagen is known to be an integrin binding domain-bearing hydrogel whereas unmodified 
alginates possess no cell-attachment motifs. It was hypothesised that HDF cells would attach within 
the collagen layer of the scaffold yet remain suspended and unattached within the alginate portion 
(Figure 6.6A). Cell-loaded collagen and alginate layers were successfully integrated (Figure 6.6B) 
and the hypothesis was accepted on the basis that elongated HDF cells were positively stained for 
actin within collagen, yet remained spherical and with little actin staining in alginate layers lacking 
RGD complexes which are critical for cell-matrix attachment (Figure 6.6C). 
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Figure 6.6 – Chemical and cellular gradients within multi-layer constructs by SLAM. A) Schematic of controlling 
cell behaviour with attachment motif bearing complexes in the upper collagen and no attachment motifs for cell 
suspension within a gel. B) Micro-CT showing gradient porosity within a lyophilized collagen-alginate scaffold. C) 
Confocal micrographs of Hoechst / actin cell staining of human dermal fibroblasts attached in the collagen layer 
(upper) and suspended in the alginate (lower) regions of a dual layer scaffold. 
In extension, lyophilised dual layer gellan / collagen sponges were seeded with cells, post-production, 
as an alternative method of generating tissue engineering constructs (Figure 6.7).   
Figure 6.7 – Chemical and cellular gradients within multi-layer sponges by SLAM. Sponges containing gellan and 
collagen layers were seeded with MC3T3 cells and imaged at 0-, 7- and 14 days for cell viability of live (green – 
Calcein AM) and dead (red – PI) cells (scale bar = 50 µm). 
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6.3.6 Multi-directional printing of multi-layer constructs by SLAM 
Even though embedded 3D bioprinting has been utilised to build complex, gradient-containing 
structures, some research within this field has remained limited regarding the build direction of tissue 
engineering parts, in turn, limiting optimal print-specificity. This is usually down to dragging and 
distortion of previously extruded material or the weight of each subsequent layer causing the printed 
model to flatten (McCormack et al., 2020). To challenge this issue, instead of printing stacked 
cylinders in the y direction, cuboids were interfaced in the z direction (Figure 6.8A). This was 
achieved by printing one cuboid at a time and placing the petri-dish accordingly between prints as the 
G-code is only capable of printing layer by layer from the bottom up and would require extruder 
alternation between each layer of both parts. Upon production and curing of a laterally printed doublet 
cuboid, the dyed portion of the structure was seen to blend with the un-dyed segment of gellan thus 
creating a visual gradient interface (Figure 6.8B). Multiple repeats were also demonstrated in 
laterally printed cuboid triplets without distortion of previously printed parts (Figure 6.8C).    
Figure 6.8 - Lateral printing of multi-layer constructs by SLAM. A) Stl file of a cuboid with dimensions 10.00 x 
10.00 x 5.00 mm, B) doublet of a gellan cuboid interfaced with a dyed gellan cuboid and crosslinked to give a single, 
laterally printed construct and C) triplet of interfaced gellan / dyed gellan / gellan (scale bars = 5 mm). 
6.3.7 Phase-encapsulated constructs by SLAM 
One tissue engineering product in particular which has not yet been achieved by embedded 
biofabrication is creating phase-encapsulated constructs in the form of core-shell scaffolds. These 
apparatuses contain two discrete regions that are independent of function and are used in a plethora 
of applications. For instance, various cell types and therapeutic agents may be spatially allocated 
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between these separate compartments for the enhancement of cell fate and biomolecule release within 
tissue scaffolds (Perez & Kim, 2015). To push the boundaries of the SLAM method beyond 
omnidirectional printing, a collagen-core gellan-shell scaffold (Figure 6.9A) and a collagen-core 
alginate-shell scaffold (Figure 6.9B) were made by secretion of collagen biopolymer within a pre-
extruded polysaccharide disc at different length scales. Despite gellan and alginate’s ionotropic route 
of gelation and the alternative thermal gelation mechanism of collagen, the phase-encapsulated parts 
were successfully extruded, integrated and retrieved from the supporting gel bed. Using SEM, it was 
also established that the collagen and alginate within core-shell scaffolds were successfully interfaced 
(Figure 6.9C). 
Figure 6.9 – Fabricating core-shell scaffolds by SLAM. A) collagen-core gellan-shell scaffold (20 mm diameter 
each) and B) collagen-core alginate-shell scaffold (5 mm and 10 mm diameters respectively) (scale bars = 5 mm). 
C) Scanning electron microscopy (SEM) of a cross-sectioned collagen-core alginate-shell scaffold (scale bar = 2 
mm). 
Not only does SLAM have potential in generating tissue engineering implants, SLAM could also be 
used as a tool to study drug-disease interactions. A collagen cylinder was printed as a basic 
representation of non-cancerous tissue following printing of an MDA-MB-231 breast cancer cell 
pellet in the centre (Figure 6.10A). When viewed under a confocal microscope after a 14-day culture 
period, the cell pellet remained isolated at the centre of the collagen scaffold (Figure 6.10B). In 
contrast, another construct was printed where MDA-MB-231 cells were homogeneously distributed 
throughout a collagen solution, 3D bioprinted, solidified and cultured for 14 days. Cells appeared 
globular when imaged in 3D (Figure 6.10C) and collagen fibrils were well defined (Figure 6.10D). 
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Figure 6.10 – Modelling the tumour microenvironment by SLAM. A) A basic tumour model of an MDA-MB-231 
breast cancer cell pellet suspended within a collagen scaffold (scale bar = 5 mm). B) Confocal micrograph of cell 
pellet following 14-days culture. C) 3D Z-stack of homogeneously distributed breast cancer cells. D) 2D image of 
homogeneously distributed breast cancer cells within a collagen fibre-rich matrix (micrograph scale bars = 50 µm).  
6.3.8 Multi-material blends in constructs by SLAM 
Using hydrogels for soft tissue construction by SLAM has been proven as a reputable solution in 
integrating multiple layers. When studying native tissues, most tissues are not made exclusively of 
collagen or glycosaminoglycans and instead comprise multiple ECM components to form a complex 
network. To this end, the GAG-like polysaccharide hydrogel, pectin, was blended with collagen to 
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reimagine more complex ECM environments in the form of a carotid artery (Figure 6.11A and B). 
MC3T3 cells cultured within this matrix blend showed a high percentage of viability following 
printing at 0 days (Figure 6.11C), and after 7- and 14-days culture respectively (Figures 6.11D and 
E). 
 
Figure 6.11 – 3D bioprinting multi-material blends in the form of a carotid artery by SLAM. A) Stl file of a carotid 
artery. B) 3D bioprinted carotid artery containing MC3T3 cells suspended within a pectin and collagen blend 
(scale bars = 5 mm). Fluorescence micrographs showing live cells stained with Calcein AM (green) and dead cells 
stained with PI (red) C) immediately after printing (0 days) and following D) 7 days and E) 14 days culture (scale 
bars =  50 µm).  
6.4 Discussion 
Tissues have a hierarchical structure with regional variations in ECM and mechanical stiffness that 
contribute to their function. For example, the musculoskeletal system is designed to efficiently 
transfer muscle-induced energy through the tendon and onto bone in order to perform movement 
(Merceron et al., 2015). This load must be seamlessly propagated throughout tissues in order to 
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prevent mechanical failure at distinct tissue interfaces. Hydrogels are often used as alternatives to 
extracellular matrices as they are highly manipulable in mimicking the salient elements of native 
ECM. Therefore, gradient engineering using biopolymer hydrogels is an attractive approach in 
emulating biological structures (Hartman et al., 2017). 
Extrusion-based 3D bioprinters have been recruited in pursuit of manufacturing functional tissues, 
yet the promise of engineering patient-specific tissues directly within the clinic remains at distance. 
The main hurdles in the way of realising this potential are achieving biomimicry with good 
manufacturability (McCormack et al., 2020). Here, a novel method is presented using an agarose fluid 
gel suspension bath which avoids the many inherent flaws of printing onto a flat surface in air. These 
procedures have seen the generation of multi-layered constructs that require alternative gelation 
mechanisms. 3D composite scaffolds are much more representative of native tissue environments as 
they are designed to mimic the graduated mechanical and chemical constituents of which human 
tissues are comprised. These structures are thusly much more valuable in tissue transplantation and 
drug-disease modelling perspectives compared with 2D monolayer cell cultures (Merceron et al., 
2015).   
Gradient porosity is particularly important in specific cell migration during tissue regeneration. 
Porous surfaces also facilitate mechanical interlocking between the scaffold and site of implantation, 
thus enhancing mechanical stability. The porosity, for example, in cancellous (trabecular) bone can 
range from 50% - 90% yet porosity ranges from 5% - 10% in cortical bone and can alter in response 
to loading, disease, and aging (Di Luca et al., 2016). Collagen / gellan and collagen / alginate scaffolds 
exhibited porosities of 91.90% and 88.22% respectively (Figure 6.2). Porosity gradients within tissue 
scaffolds can therefore be intelligently designed in the creation of niche bio-mimicking structures 
using SLAM techniques.  
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The surface texture and integrity of the scaffold interface was further investigated by use of a 
profilometer. Colour representations of a composite alginate / ι-carrageenan scaffold confirmed that 
two materials with large differences in material structure are inter-joinable (Figure 6.3). The surface 
microroughness of alginate and ι-carrageenan were 60.22 µm and 16.45 µm respectively and had a 
roughness of 50.21 µm at the interface, which would likely induce alternative mechanisms for cell-
biomaterial interplay as surface roughness has been seen to regulate cell response (Wu & Zhang, 
2015). Cells are prone to adapting to surface roughness in order to equilibrate internal and external 
forces, where cells existing on rougher surfaces are bound and constrained by high ridges and low 
valleys as opposed to widespread cells on smoother substrata that have established strong actin 
networks. It is therefore possible to recreate biological environments that induce desired cell 
migration by patterning surface roughness by employment of appropriate biopolymers at tuned 
concentrations. 
The variety of mechanical stimuli that cells experience includes hydrostatic pressure, shear, 
compression and tensile force and are generated locally within discrete tissues by cell–cell or cell-
ECM interactions (Butcher et al., 2009). Therefore, the behaviour of cells is inherently tissue specific. 
The mechanical influence on cell behaviour has long been interpreted by measuring their shear 
modulus (G) or Young’s modulus (E) as reported by rheological and dynamic mechanical analysis 
(Caliari & Burdick, 2016). In order to produce tissue scaffolds with corresponding elastic and 
mechanical milieus found in native tissue, the determination of hydrogel mechanical behaviour was 
assessed using shear rheology. Amplitude stress sweeps were conducted by exerting a range of shear 
stresses on each region of the multi-layer tissue scaffolds in order to measure their viscoelastic 
behaviour (Figure 6.4). The linear viscoelastic region (LVR) (and therefore the critical stress at which 
intermolecular associations are forced to collapse) reduced in a graduated manner from the gellan to 
the interface and was shortest in the ι-carrageenan region. Likewise, a gradient in LVR was exhibited 
from alginate, through the interface and shortest in the collagen layer. What is more, both of these 
123 
 
scaffolds showed a graduating reduction in elastic (Gʹ) and viscous (Gʺ) moduli throughout the 
interfaced materials. When comparing the storage modulus of the different layers within the gellan-
ι-carrageenan scaffolds to corresponding tissue elasticities found in literature, the mechanical 
characteristics of the scaffolds can be likened to those of healthy breast tissue. Gellan, ι–Carrageenan 
and interfacial regions of the scaffold had storage moduli that equated to the mechanical properties 
found in pectoral muscle, subcutaneous fat and dense glandular tissue and within muscle-fat 
interfaces respectively (Butcher et al., 2009; Cox & Erler, 2011; Gefen & Dilmoney, 2007; McKnight 
et al., 2002; Sinkus et al., 2005). During pathogenesis and the development of cancerous tissues 
within the breast, tissue stiffness can increase as much as tenfold than that of healthy breast tissue 
(Kass et al., 2007). This newly developed SLAM system holds the potential to create healthy 
transplantable tissues that mimic transplant destinations in vivo and to recreate model drug-disease 
environments in vitro in a bid to combat degenerative diseases. 
Oftentimes, when studying cell-drug interactions, cultures are propagated in 2D monolayer flasks. 
These techniques are limited to the cultivation of cells that exhibit a flattened shape, forced polarity 
and a therapeutic action that is limited to their ventral surfaces (Caliari & Burdick, 2016). The use of 
3D printed hydrogels and freeze-dried scaffolds, however, provides cells with a platform that 
recapitulates native tissue ECM, allowing for more natural phenotypes to progress. In this chapter, 
cellular morphology has been manipulated by embedding cells within hydrogels containing divergent 
chemical constituents. Within a single scaffold, cells within an alginate layer assumed a globular 
morphology when cultured over 14 days due to the lack of cell attachment motifs (Figure 6.6). When 
cells were allocated to the collagen layer, extension in three dimensions along the collagen fibres via 
focal adhesions was exhibited. Cell viability was also sustained over the 14-day period in both phases 
(Figure 6.7). By taking advantage of these contrasting mechanisms for suspending and encapsulating 
cells, scaffold systems can be designed around the application of tissue transplantation. For instance, 
when it is necessary to implant a tissue scaffold with long term functionality, a controlled-degrading, 
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slow-release gel containing cell attachment motifs would be most appropriate (Henry et al., 2007). If 
rapid neotissue formation is essential, the use of hydrogels acting as cell carriers to the intended site 
may serve as a more relevant cell vehicle. Overall, degradation rate of the scaffold should match the 
rate of neotissue formation (Ma, 2004). It has been seen previously in various studies that cellular 
morphology can be influenced by scaffold material, substrate stiffness, gelation temperature and 
presence of degradable crosslinkers (Doyle et al., 2015; Huebsch et al., 2010; Ventre & Netti, 2016; 
Wade & Burdick, 2012).  
Within the tissue engineering arena, augmentation of scaffold conformation ensues the optimum 
release kinetics of cells and therapeutic agents. The design and generation of each sophisticated 
structure is therefore unique due to scaffold-patient personalisation. This system presented here is not 
only compliant to the multitude of materials that may be exploited, but also in the way that the 
structures can be manipulated. In addition to printing multiple layers to create gradients in the z 
direction, constructs were also printed laterally (Figure 6.8), with encapsulated phases (core-shell 
scaffolds) (Figure 6.9 – Figure 6.10), and also as multi-material blends (Figure 6.11).  
Core-shell scaffolds contain two discrete regions that are independent of function and are used in a 
plethora of applications. Various cell types and therapeutic agents may be spatially allocated between 
these separate compartments for the enhancement of cell fate and biomolecule release within tissue 
scaffolds (Perez & Kim, 2015). Core-shell scaffolds are usually fabricated using co-concentric nozzle 
extrusion, microfluidics generation, and chemical confinement reactions, and the method of using an 
embedding support to extrude phases within one-another to create core-shell scaffolds, in this 
instance, is the first to be reported. In a study with Perez et al., (2014) where a collagen-core alginate-
shell cell delivery system was utilised for bone tissue engineering; a dual concentric nozzle was used. 
The inner collagen core was loaded with MSCs and was ensheathed in an alginate layer creating two 
clearly distinguished zones. During production, region thickness was controlled by tuning polymer 
concentration and injection speed, subsequently modulating the mechanical properties and 
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degradation profiles of the construct.  Compared with collagen gel positive controls, MSCs housed 
in collagen-cores of core-shell scaffolds exhibited comparable proliferative activity yet showed 
directional elongation along the fibre axis in core-shells versus randomly elongated cells in collagen 
gels alone. Cells within core-shell constructs also migrated to the outer edge of the collagen core to 
where oxygen saturation was more abundant. When studying osteogenic differentiation of the MSCs, 
expression of bone related genes BSP, OPN and OCN were significantly higher in core-shell scaffolds 
in comparison to collagen gels alone. Finally, MSCs delivered through core-shell scaffolds showed 
great potential for regenerating bone tissue in a rat calvarium model.  
To further define the system's capacity to generate tissue scaffolds not only designed for implantation, 
but also in 3D drug-disease and cosmetic modelling, the idea of fabricating basic tumour models 
using SLAM was formulated. Preliminary recapitulations of the envisaged tumour 
microenvironment contained a) an inner mass constituted of a breast cancer cell pellet representing 
the tumour portion of the model, and b) an outer, acellular stromal compartment constituted of a softer 
matrix to represent the surrounding healthy tissue (Figure 6.10). 3D tumour replicas are usually 
generated within a hydrogel suspension, using the hanging drop method, on low adhesion plates or 
micropatterned surfaces and more closely represent the 3D organisation of in vivo tumours compared 
to using cell culture plates and flasks (Costa et al., 2016). In turn, they have a greater capacity to 
mimic drug interactions within the human body more closely. MDA-MB-231 cells of mammary 
adenocarcinoma lineage were used to create a potential drug-disease model using SLAM as they are 
notoriously difficult to encourage spheroid formation. Cell pellets were cultured within a 3D collagen 
matrix and were compared with homogenously dispersed cells (Figure 6.10). Whilst cell pellets 
remained in the closely associated formation in which they were seeded, cell cultures appeared as 
compact aggregates rather than tumour spheroids. Alternatively, a liquid overlay technique using a 
cell-repellent surface and 3.5% Matrigel has been developed which successfully induced spheroid 
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formation in MDA-MB-231 cells (Froehlich et al., 2016), however potential remains in the SLAM 
method following further refinement. 
The last of the studies on constructs containing regional variations in physicochemical properties 
were those on 3D bioprinting multi-material blends to create ECM-like scaffolds. Using multi-
material blends compared with layering different materials is another way of structuring the ECM 
microenvironment, yet with consistently changing properties at the microscale level compared with 
a uni-directional gradient from one material to another. Polymer blending modifications are of great 
interest as they can lead to the development of a new range of biomaterials with a full set of desired 
properties (Doulabi et al., 2014). The main reason of blending is to widen the range of properties 
while obviating their drawbacks. Collagen pectin blends printed in the form of a carotid artery 
simulated the collagen and GAG-like material environments within native carotid artery (Figure 
6.11). The collagen and pectin materials used within the blend have also been seen to exhibit good 
processability, printability, antibacterial activity, low toxicity, cell interaction, biocompatibility, 
water solubility, biodegradability, tuneable porosity and mechanical properties, pH stability and are 
easily crosslinked (Dong & Lv, 2016; Kulikouskaya et al., 2019). Although native carotid artery 
contains smooth muscle and endothelial cells, MC3T3 cells were used to confirm that cells remain 
viable throughout the printing of 3D constructs that contain material blends. 
6.5 Conclusions 
Gradients in porosity, surface texture, mechanical properties, material chemistry, cell morphology 
and cell distribution within a single 3D bioprinted construct have been demonstrated using the SLAM 
method. Different build conformations were manufactured by layering materials in multiple 
directions, by lyophilisation, with encapsulated phases and by blending multiple materials to achieve 
tissue-synonymous chemical and architectural variations. Indeed, examples of hydrogels at fixed 
concentrations have been presented, yet there is unlimited potential in achieving particular tissue-
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synonymous gradients by modulating the materials to be incorporated and equally, their 
concentrations and gelation mechanisms. This technology outlined here has the potential to assist in 
overcoming the issues associated with donor waiting lists, immune rejection, and animal testing by 
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Chapter 7 – Design and Manufacture of a Tri-layer Skin Model 
Native human skin is comprised of numerous cell types and extracellular matrix (ECM) components 
which are organised into hierarchical layers. As the largest organ of the human body, it serves a range 
of different purposes, however, disease, trauma and infection of the skin can lead to compromised 
skin integrity and impaired function. A comprehensive understanding of normal skin tissue anatomy 
and physiology is therefore critical when attempting to restore damaged tissue and its roles. This 
chapter will focus on the complex architecture and mechanisms of the skin and how the acquisition 
of wounds may be established. Furthermore, the current clinical advances towards repairing damaged 
skin tissue shall be outlined and the design and manufacture of a tri-layer skin model will be 
investigated.  
7.1 Introduction - Anatomy and Function of Human Skin 
Covering the complete exterior of the human body, the skin and its cutaneous appendages constitute 
the integumentary system, defined by its ability to protect the body from external influences. Skin 
can vary in colour, thickness and elasticity depending on a number of factors such as genetics, 
lifestyle, age and body region. For instance, skin located at the eyelids, prepuce, and inguinal regions 
measure around 500 - 600 µm whereas skin in the upper back region is up to 5,000 µm (Y. Lee & 
Hwang, 2002). Skin may also be characterised as either hirsute (thin and hair bearing), which is 
distributed across the majority of the body’s surface, or glabrous (thick and hairless), which is present 
on the palms and soles (Westgate, Botchkareva, & Tobin, 2013). 
Skin exists as a compartmentalised yet graded complex structure containing two main layers that are 
intimately associated: the epidermis and its appendages and the dermis (Figure 7.1). Underlying these 
layers exists the hypodermis or subcutaneous layer and muscle layer, however it is disputed whether 











Figure 7.1 – Anatomy of the skin including epidermis and dermis and underlying hypodermis and muscle layers. 
7.1.1 Cutaneous Appendages 
The epidermis exhibits a range of accessories in the form of hairs, pores, ducts and nails that aid in 
the protection of the body’s internal environment against potentially harmful external substances and 
artefacts. Hair shafts made of dead, keratinised epidermal cells that are connected together with 
extracellular proteins that protrude from the surface of the epidermis are anchored deep in the dermis 
or subcutaneous layer. Each hair follicle is connected to arrector pili muscles that, when contracted, 
causes the hair to stand on end (McLafferty, Hendry, & Farley, 2012). Some of these hair follicles 
have associations with sebaceous glands which secrete sebum - an oily substance containing 
triglycerides, cholesterol, proteins and organic salts – onto the surface of the skin. These secretions 
protect hair follicles from becoming dry and brittle, inhibit excessive evaporation of moisture from 
the skin and have also been seen to harbour antimicrobial and properties (Penzer, 2002). 
Overproduction of sebum as a result of sebaceous gland over-activity that is induced by hormones 
during puberty can result in open comedones (blackheads) or closed comedones (whiteheads). 
Eccrine and apocrine glands are amongst the other types of secretory apparatus within the skin. The 
purpose of these glands is to deliver sweat to the skin’s surface during thermoregulation processes 







Derrickson, 2014). Another appendage of the skin’s surface are the nails located at the end of each 
digit. They are made of tough keratin sheets and grow from the germinal layer at the nails root. The 
pink appearance at the nail’s bed is causative of the extensive capillary network within the underlying 
layers of skin. They capacitate the protection of the finger ends during dextrous movements. The 
conservation of skin at the distal portion of the digits is further facilitated by the hyponychium –  a 
thickened portion of epithelium where the nail plate and nail bed integrate (Penzer, 2002).  
7.1.2 Epidermis 
The outermost region of the skin is termed the epidermis and is primarily constituted of stratified 
keratinised squamous epithelium. The most prominent of cells in this layer are keratinocytes (90%) 
as well as populations of melanocytes, Langerhans and Merkel cells. The cell subtypes within the 
epidermal environment function as a barrier, in pigmentation, immune response and somatosensation. 
The epidermis is an avascular unit and is therefore reliant upon dermal vasculature for the provision 
of oxygen and nutrients (Abdo et al., 2020). 
Multiple epidermal strata comprise the epidermis in which a base layer of mitotic cells migrate 
upwards whilst differentiating to constantly replace and replenish keratinocytes at the surface. 
Keratinocytes are typically replaced between 45 to 75 days, dependent on epidermal thickness and 
age amongst other internal and external factors. Disease status of the skin is also a contributing factor 
to keratinocyte turnover rate where in psoriasis, the rate can be as little as 3 to 7 days and 
subsequently, keratinocytes cannot fully differentiate before reaching the surface (Rajguru et al., 
2020). The bottom-most layer of the epidermis is the stratum basale which is highly abundant in 
keratinocyte-producing stem cells. Moving up the epidermal layers are the stratum spinosum, stratum 
granulosum, stratum lucidum and finally, the stratum corneum (the most superficial portion of the 











Figure 7.2 – Anatomy of the epidermis containing stratum corneum, lucidum, granulosum, spinosum and basale 
































The bottom-most epidermal layer separated from the dermis by the basal 
lamina within the basement membrane. Predominantly comprised of 
epidermal stem cells and keratinocytes as well as melanocytes and 




8 – 10 layers of mature polyhedral cells, also known as the prickle cell layer 
due to cytoplasmic processes or spines which interlock with one-another 




3 – 5 cell layers composed of diamond-shaped cells containing keratohyalin 
crystals which initiate keratinisation (the dying process of cells) and 




2 – 3 cell layers found only in glabrous skin made of flat translucent dead 
cells and eleidin protein (transitional substance between keratohyalin in 




20 – 30 cell layers that form the outermost cornified layer and is made of 
keratin embedded in filaggrin and dead keratinocytes. Cells are anucleate 











7.1.3 Basement Membrane – Basal Lamina and Reticular Lamina 
The basement membrane of the epidermis is made of two different layers: the basal lamina 
comprises the upper portion and is attached to the stratum basale, and the reticular lamina 
interfaces the dermal connective tissue. Epithelial cells within the epidermis require a connection 
to the dermis through the basement membrane so that cells can be appropriately supplied with 
necessary growth and proliferation mediators. 
 
7.1.3.1 Basal lamina – lamina lucida and lamina densa 
The basal lamina is further split into two separate regions, namely the lamina lucida which exists 
on the periphery of the stratum basale, and the lamina densa which is located adjacent to the 
reticular lamina. The lamina lucida is filamentous and granular in appearance attributed to the 
heparan sulphate, proteoglycan and laminin macromolecules which reside within this layer. The 
lamina densa houses a network of type IV collagen, fibronectin and various other proteoglycans. 
Overall, the basement membrane controls the passage of certain macromolecules from the dermis 
to the epidermis, helps regulate keratinocyte differentiation and mechanically stabilises the 
epidermis (Standring, 2016).  
 
7.1.4 Dermis – Papillary Dermis and Reticular Dermis 
Dermis connective tissue is much more abundant in extracellular matrix, lying beneath the 
epidermal epithelial tissue and constituting the main bulk of skin. Studded throughout the dermis 
ECM are mainly fibroblast cells along with fewer endothelial cells, smooth muscle cells and 
mast cells. The network of interlacing connective tissue is made up of collagen and some elastin 
and features important structures such as blood vessels, lymphatics, sweat glands and nerves. 
The dermis provides a durable base that can absorb mechanical forces to prevent shear, 
functioned by glycosaminoglycan and proteoglycan molecules which allow a high water-binding 
capacity such as hyaluronic acid (Abdo et al., 2020). The anatomy of the dermis can be further 
134 
 
sub-sectioned into two parts: the papillary layer being the most superficial layer beneath the 
epidermis, and the deeper reticular layer.   
The papillary layer is classed as a loosely packed connective tissue ascribed by the sparse 
bundles of collagenous fibres it contains. This layer exhibits small structures called papillae 
which interdigitate with recesses (or rete ridges) within the epidermis, providing anchorage in 
the form of a dermo-epidermal junction. Double rows of papillae protuberances within glabrous 
skin are responsible for each individual fingerprint. The role of this layer is to provide 
mechanical anchorage, metabolic support and trophic maintenance to the epidermal tissue 
overhead and accommodates a complex network of blood vessels and sensory nerve endings 
(Hicklin, 2014). 
In contrast to the papillary layer, the underlying reticular layer within the dermis is manifested 
as a dense connective tissue, containing more closely packed elastic fibres and thicker collagen 
bundles which run parallel to the skin’s surface. This feature provides skin with most of its 
strength, elasticity and flexibility. In addition, this layer is less abundant in dermal fibroblasts 





The hypodermis (also known as the subcutis or subcutaneous tissue) is placed between the dermis 
and an apparatus called the fascia, which acts as a stabiliser and separator from muscles and internal 
organs. This specialised loose connective tissue supports cells called adipocytes organised in lobules 
and, like the other layers of skin, varies in thickness depending on body region as well as individual 
body habitus. It plays a role in acting as a gliding plane, thus protecting internal components of the 
body from acute and chronic trauma, as well as storing fat, contributing to temperature control and 
secreting various hormones and cytokines (Diegel et al., 2018; Valle & Zamorani, 2007). 
Mesenchymal stem cells (MSCs) within this layer have a remarkable influence on skin 
microenvironment as a whole, coordinating keratinocyte and fibroblast proliferation, regulating 
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angiogenesis and contributing to inflammatory response. These mechanisms ensure normal skin 
tissue homeostasis, regeneration and wound healing, and for this reason, have very recently been 
thrust into the limelight as crucial components in wound repair and therapeutics (Gaur et al., 2017). 
The hypodermis also features deeper adnexal structures (such as hair follicles), pressure sensors 
(Ruffini and Pacinian corpuscles) and a subdermal plexus of blood vessels that orchestrate 
thermoregulation and blood flow (Findlay & Gurtner, 2017). 
7.1.6 Physiological Functions of the Skin 
In its most basic description, skin (or the integument) is an organ which covers almost the entire 
human body and acts as a large biological shield. In fact, skin has an extensive number of roles as 
well as protection from the environment, including immunologic, endocrine, metabolic and even 
psycho-social considerations in its biologic enterprise. The part skin plays in protection from the 
environment is perhaps its most critical function for survival. For the body to act accordingly to 
external stimuli either through somatic or autonomic movement, however, the role of the skin in 








Figure 7.3 – Summary of the physiological functions of the skin – sensory, protection, regulation and synthesis 
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7.1.6.1 Sensory reception 
Skin is embellished with a series of receptors for the detection of touch, pressure, temperature and 
pain. Mechanoreceptors called Merkel cells within the stratum basale are responsible for sensing low 
frequency vibrations, whereas deep pressure and vibration is sensed and transduced by lamellated 
Pacinian corpuscles found deeper within the dermis or hypodermis. These lamellated corpuscles, or 
neurons with encapsulated nerve endings, also respond to touch stimuli via Meissner corpuscles and 
to hair movement at the surface of the skin by the hair follicle plexus. The nociceptors (pain receptors) 
and thermoreceptors (temperature receptors), in contrast, have free nerve endings. Stretch receptors 
named Ruffini corpuscles (or bulbous corpuscles) are responsible for identifying stretching of the 
skin (Betts et al., 2013). 
7.1.6.2 Protection from the environment 
Covering the entire of the human body, the skin’s most critical function is to protect the rest of the 
body from the natural elements as well as foreign, harmful substances and microorganisms. The 
epidermis is the region within skin that is most predominantly associated with protection and defence 
as it comprises the outermost portion that most frequently comes into contact with the environment. 
Keratin and glycolipids within the waxy stratum corneum prevent water loss and also acts as the first 
line of defence against skin abrasion and harmful chemicals. Additionally, Langerhans cells are most 
prominent within the stratum spinosum and play a crucial part in cellular defence - whereas 
melanocytes within the stratum basale aid in the protection of skin against burning from UV sunlight 
radiation (Betts et al., 2013). 
7.1.6.3 Regulation and homeostasis 
Because skin harbours multiple roles, these functions are often manifold in their purpose, in that while 
skin-water balance can be seen as a protection mechanism, it can also be viewed as a water 
homeostasis mechanism by using aquaporins. Likewise, once changes in temperature are perceived 
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by the skin during sensory reception, the skin and its cutaneous appendages act accordingly to such 
stimuli through temperature homeostasis. This phenomenon is governed by the rate in temperature 
change as opposed to the change in temperature itself. When the temperature reduction rate is 
sufficient, the arrector pili muscles contract causing the hairs to stand on end and subsequently trap 
warm air at the surface of hirsute skin. When temperature increases at a sufficient rate, hair follicles 
relax allowing body heat to escape. Another process in which skin regulates body temperature is via 
vasoconstriction and vasodilation mechanisms. When the rate of cooling exceeds threshold, arterioles 
constrict to minimise heat loss and to concentrate body heat towards vital organs. The opposite occurs 
when the rate of temperature increase triggers dilation of arterioles and subsequent escape of heat to 
cool down the body. The sweat and sebaceous glands which are allocated to the dermis and 
hypodermis are responsible for the secretion of sweat and sebum. Approximately 0.5 L of sweat is 
unnoticeably secreted per day and can increase to as much as 1.5 L per hour for an active person, 
where heat is dissipated with evaporation of sweat from the skin’s surface. Furthermore, the pores 
that allow perspiration also allow the excretion of urea and nitrogen waste products (Betts et al., 2013; 
Carola et al., 1990). 
7.1.6.4 Synthesis 
The epidermal layer of human skin screens out most of the earth’s UV radiation with the exception 
of small quantities required for vitamin D synthesis. When sunlight is present, cholecalciferol 
(vitamin D3) is synthesised from dehydrocholesterol and is further converted to calcidiol and calcitriol 
(active form) by the liver and kidneys, respectively. Vitamin D is vital for normal absorption of 
calcium and phosphorus in bone maintenance, and lack of such can lead to serious complications such 






7.1.7 Clinical Demand for Skin Replacements  
Under normal circumstances, the skin has a regenerative capacity in response to injury or impairment. 
In the case of partial-thickness and acute healing wounds, skin will assume its usual wound healing 
cascade, however, when wounds are infected, deep, chronic, and non-healing, medical intervention 
is pertinent. These types of wounds can arise from trauma, congenital defects or pathogenesis, or via 
the emergence of chronic wounds as a result of non-healing (Dhasmana et al., 2018). 
7.1.7.1 Trauma of the skin 
Trauma of the skin can occur in the form of contusion, hematoma, abrasion, blisters, burns, puncture, 
incision, laceration or avulsion and in severe cases can lead to significant skin loss (Figure 7.4).  
Figure 7.4 – Examples of different types of wounds resultant of trauma (adapted from Biodermis, 2018). 
The most prevalent of these cases are burns due to thermal compromise of the skin and can occur at 
varying degrees; namely first-degree (superficial), second-degree (partial thickness) and third-degree 
(full thickness) burns. First and second-degree burns are defined where only the epidermis or both 
epidermis and partial dermis, respectively, are affected and may be able to heal naturally, although 
most cases will cause scarring. In third-degree burns, not only are the epidermis and dermis damaged, 
but trauma can also extend down to the hypodermis, muscle, bone and tendon. In cases such as these, 
medical intervention in the form of a graft is necessitated as missing tissue, lack of vasculature and 
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necrotic cells residing at the wound’s outer edge render the natural wound healing process defective 
(Stone et al., 2018). 
7.1.7.2 Pathogenesis and congenital diseases of the skin 
Pathogenesis and disease due to congenital disorders within skin can compromise its ability to 
undergo usual function and repair. A common example of how skin can require replacement due to 
pathogenesis is following the establishment of skin cancer. Non-melanoma skin cancers include basal 
cell skin cancer (BCC) and squamous cell skin cancer (SCC) and usually occur on areas of skin that 
are often sun-exposed (Figure 7.5). Other, rarer types include Merkel cell carcinoma, Kaposi’s 
sarcoma, T cell lymphoma and sebaceous gland cancer. Melanoma, on the other hand, tend to develop 







Figure 7.5 – Non-melanoma (SCC and BCC) and melanoma skin cancers (adapted from Mayo Clinic, 2020). 
Inherited epidermolysis bullosa describes a group of genetically transmitted skin diseases in which 
spontaneous blistering can occur within the skin. Epidermolysis bullosa simplex (EBS) is 
characterised by intraepidermal blistering due to mutations in K5 and K14 genes. These genes within 
keratinocyte cells, under usual circumstances, are responsible for keratin type I and II production, yet 
cause intraepidermal cleavage when EBS is observed. Junctional epidermolysis bullosa (JEB) causes 
separation of the lamina lucida in the dermo-epidermal junction and is often due to mutations in 
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LAMB3 gene encoding laminin-5.  The third and final subtype of epidermolysis bullosa is categorised 
as Dystrophic (DEB) where mutations occur in the type VII collagen-encoding gene, compromising 












Figure 7.6 – Illustration of the differences between A) healthy skin and B) recessive dystrophic epidermolysis 
bullosa (adapted from Vanden Oever et al., 2018. 
7.1.8 Wound Healing Cascade 
The wound healing process is a complex milieu of regulated pathways in reaction to tissue injury. 
Human foetal skin is capable of regenerating skin without issue, however, adult skin repairs by 
forming scar tissue. It is understood that the four main orchestrated events of wound healing are 
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(minutes / hours) 
 
At the onset of injury, fibrinogen leached from severed blood vessels is 
cleaved by thrombin to form a fibrin mesh for blood clot formation. The fibrin 
mesh captures platelets which enables attachment to the capillary walls. 
Coagulation factors are then upregulated, forming a clot consisting of 
platelets, red blood cells and ECM matrix molecules which causes the rapid 
release of various growth factors and chemokines, including platelet-derived 
growth factor (PDGF), vascular endothelial growth factor (VEGF), and 




(hours / days) 
 
The inflammatory phase constitutes the invasion of white blood cells called 
phagocytic neutrophils and macrophages to the wounded site. Foreign 
particles, bacteria and necrotic cell components are phagocytosed, and 






(days / weeks) 
 
When stimulated by VEGF and TGF-β, endothelial cells release matrix 
metalloproteinases (MMPs) that digest the basement membrane and liberate 
endothelial cells from parent vessels, initiating angiogenesis from pre-existing 
vasculature. Newly formed capillary sprouts enter the collagenous network 
and form highly vascularised granulation tissue. 
Fibroblasts proliferate and differentiate into myofibroblasts which 
subsequently cause wound contraction and closure, while keratinocytes 
migrate over the wound surface during reepithelialisation.  
 
Remodelling 
(weeks / months) 
 
Granulation tissue transitions into a relatively acellular collagen-rich scar and 
blood vessel density starts to reduce to previous abundancies.   
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7.1.8.1 Chronic wounds 
Chronic wounds are pathological extremes of abnormal healing processes and present themselves in 
the form of diabetic foot ulcers, venous leg ulcers, pressure ulcers and arterial insufficiency ulcers 
and can therefore be classified as having a combination of disease and trauma elements. Although 
they do not usually cover an extensive area of skin, they are a major healthcare problem, associated 
with poor prognosis, having excessive and prolonged inflammation, lack of re-epithelialisation and 
are absent of sufficient vasculature. In turn, a strict regime of wound care is vital for treatment and 
infection control, including debridement of dead tissue, slough, biofilm, debris and exudate from the 
wound bed, administration of therapeutic agents and antimicrobials and compression bandaging of 
the wound (Frykberg & Banks, 2015). In more severe cases, treatment is focused on addressing the 
cause rather than treating the wound, where complete excision of the affected area is performed and 
grafting of partial-thickness, full-thickness or artificial skin is used to address time-consuming 
nursing care, cost-effectiveness and psychological distresses associated with the prolonged treatment 
of chronic wounds (Snyder et al., 2012). Chronic wounds are associated with impaired ECM 
synthesis, fibroblast migration and angiogenesis, delayed epithelialisation, prolonged inflammation, 
poor mobilisation of progenitor cells, increase in MMPs and infection and decreased levels of VEGF, 





















Figure 7.8 – Key differences between acute (healing) and chronic (non-healing) wounds (adapted from Turner & 
Badylak, 2015). 
7.1.9 Advances in Skin Repair 
The current treatment for dermal wounds is very much dependent upon the nature of the wound itself. 
For non-healing wounds that are greater than 4 cm2, either implanting a split-thickness autograft 
(typically harvesting skin from the patient’s thigh or buttock) or implementing tissue flap surgery 
(whereby skin adjacent to the wound is lifted and placed over the wound) is routinely practiced. 
Within recent years, however, a greater understanding of the wound healing process has allowed for 
the development of alternative therapies that use hydrogels, foam hydrocolloids, and skin substitutes 
incorporating live cells (Vig et al., 2017).  
Current skin substitutes that are commercially available on today’s market vary on permanency 
(permanent, semi-permanent and temporary), anatomical structure (epidermal, dermal, and dermo-
epidermal), composition (cellular / acellular) and type of material (biological / synthetic). The 
Acute (healing) wound Chronic (non-healing) wound 
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biological nature of the skin substitute is also crucial, in that autologous cells and tissues tend to be 
more successful compared with substitutes from allogenic or xenogenic sources.  
Acellular skin substitutes became available in later 1970s and were commonly used for superficial 
and partial-thickness wounds. The use of human acellular dermis such as Alloderm® has been 
documented in donor sites and epidermolysis bullosa wounds (Özkaya et al., 2016; Sinha et al., 2002) 
(Figure 7.9Ai). Biobrane® is another acellular skin substitute which, instead, incorporates an 
overlying silicone epidermis atop a nylon mesh / collagen dermis and has been used to dress split-
thickness skin grafts in paediatric burns (Farroha et al., 2013) (Figure 7.9Aii).  
In other skin replacement therapies, substitutes are delivered as a keratinocyte cell suspension, 
allowing the complete coverage of contoured wound voids (Magnusson et al., 2007) (Figure 7.9Bi). 
Epicel™ also utilises autologous keratinocytes but are delivered on top of a petrolatum gauze support 
and is detached approximately 7 days after grafting onto patients with extensive, full thickness-burns 
(Carsin et al., 2000) (Figure 7.9Bii). 
Dermal tissue substitutes can be categorised into autologous grafts (i.e. Hyalograft 3D (Figure 7.9C)) 
or allogenic grafts (i.e. Dermagraft (Figure 7.9D)). The main difference between the two is the source 
of cells, where Hyalograft uses patient-derived fibroblasts and Dermagraft uses neonatal fibroblasts 
and both have been used in chronic wounds and diabetic ulcers (Li et al., 2015; MacNeil, 2007). 
Likewise, epidermal / dermal tissue engineering apparatus can also be split into autologous or 
allogenic cell-bearing constructs. The scaffold matrices also differ, with TissueTech autograft system 
containing hyaluronic acid (HA) and Apligraf® containing collagen as their main components 


















Figure 7.9 – Tissue engineering skin substitutes. A) Acellular: i) Alloderm ii) Biobrane. B) Epidermal autologous: 
i) Cell spray ii) Epicel. C) Dermal autologous Hyalograft 3D. D) Dermal allogenic Dermagraft. E) Epidermal / 
dermal autologous TissueTech autograft system. F) Eipdermal / dermal allograft apligraf (adapted from Vig et al., 
2017). 
7.1.10 Current Challenges in Skin Repair 
Chronic wounds that are resultant of trauma, surgery or disease pose a major healthcare problem, 
with around 2.2 million people requiring treatment for chronic wounds in the UK alone (Guest et al., 
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however, issues remain with this technique including donor site morbidity and an imbalance between 
donor availability and demand. Additionally, harvested grafts are not always sufficient in thickness 
in order to compensate for the extent of tissue trauma down to the subcutaneous hypodermal layer. 
Engineering of skin substitutes has seen remarkable progress in addressing the physical, 
psychological and economical burdens that come with wound healing therapies over the past four 
decades (He et al., 2018). 3D bioprinting skin substitutes, in particular, is currently at the forefront of 
research as it has the potential to produce intelligently designed skin models with greater precision. 
Even so, most skin equivalents manufactured using 3D bioprinting are typically limited to containing 
only dermal and epidermal layers and lack a hypodermal layer. However, in vitro studies have shown 
that adipose derived mesenchymal stem cells (ADSC) within a model hypodermal layer can 
contribute to epidermal morphogenesis, neovascularisation and accelerate wound healing (Huang et 
al., 2012; Lu et al., 2012). The true, complex, hierarchical nature of native skin is therefore seldom 
recapitulated in dermo-epidermal constructs alone. Furthermore, current 3D printed skin equivalents 
that do feature a hypodermal layer are limited in thickness due to poor print fidelity when extruding 
low viscosity biopolymers with relatively deep dimensions. Because of these limitations, there is 
often an oversight in selecting optimal print parameters, as the choice in print specifications such as 
print speed, bioink material and curing method is not at the discretion of the user, but instead is 
restricted and dictated by the 3D printing technique. For instance, researchers have often employed 
high viscosity polymers to overcome the issues associated with the collapse of low viscosity materials 
once deposited. This would necessitate a fast print speed to be implemented and in turn, the curing of 
material to occur in situ during printing to limit distortion of the intended model dimensions. These 
criteria directly impact upon the successful fabrication of tissue substitutes that contain the 
biochemical and geometrical facets of functioning skin. 
Suspended layer additive manufacture (SLAM), as developed in previous chapters, allows greater 
freedom in the selection of print parameters that are conducive to the production of multi-layered 
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constructs with admirable print fidelity and cell viability. The principle mechanisms behind SLAM 
enable extrusion printing of bioinks over a range of viscosities within a self-healing fluid gel that acts 
as a temporary support prior to solidification and extraction.  
Here, it is proposed that SLAM offers a potential solution to the issues associated with producing 
skin substitutes for chronic wound repair. By using SLAM, printing conditions can be tuned in order 
to gain ultimate print fidelity without compromising cell behaviour. Tri-layer skin models complete 
with epidermis, dual compartment dermis and hypodermis could potentially be fabricated with 
substantial depth as seen at the human scale. The resolution of the skin layers would be enhanced 
accordingly by adjusting printing specifications including printing pressure, flow rate and nozzle 
gauge whilst also maintaining cell viability and phenotype. Using these methods, one is not limited 
by the characteristics of the printing material i.e. chemical composition, viscosity and method of 
gelation. This means that the true nature of native skin can be captured within a single construct, 
featuring gradients in material chemistry, cellular phenotype and density, microarchitecture, and 
mechanical characteristics.  
In attempt to achieve this, first, human skin tissue was obtained from an elective human 
abdominoplasty for the isolation of human epidermal keratinocytes (HEK), human dermal fibroblasts 
(HDF) and stromal vascular fraction (SVF). Cells within SVF were homogenised to obtain adipose 
derived mesenchymal stem cells (ADSC), which were subsequently characterised by flow cytometry 
to confirm the success of homogenisation. As an investigation into the differentiating capacity of 
ADSC, cells were cultured under osteogenic and adipogenic conditions and stained with specific 
solutions to confirm the differentiation. Using SLAM technology as previously described, human-
scale skin equivalents were 3D bioprinted and cultured for a period of 21 days at the air-liquid 
interface. Skin tissue constructs were analysed using shear rheology, cell viability and morphology 
staining, histology and immunohistochemistry (IHC) staining and by incorporating within a porcine 




7.2.1 Preparation of human skin samples  
Human skin tissue (25 cm2) complete with subcutaneous adipose was obtained from an elective 
human abdominoplasty (previously belonging to a 36-year-old caucasian female of Fitzpatrick 
classification type 3) (Genoskin, France). Samples were shipped at 4°C in transportation culture 
media within 4 hours of excision. The subcutaneous portion of the tissue sample was then separated 
from the dermal / epidermal skin layer and placed in saline solution for washing in preparation for 
processing and ex vivo expansion. Dermo-epidermal tissue was sectioned and submerged in Dispase 
II solution at 4 °C overnight followed by separating the dermal and epidermal counterparts.  
7.2.2 Isolation of Human Dermal Fibroblasts (HDF)  
Fibroblasts were released from the dermal portion of skin by incubation in collagenase D solution 
overnight followed by submerging in trypsin and mechanically agitating the dermis using a scalpel. 
Released cells were centrifuged, re-suspended in basal media, filtered through a 100 µm cell strainer 
and plated in a T25 flask. Basal media was changed every 3 days (Dulbecco’s modified eagle medium 
(DMEM) supplemented with FBS (10%), HEPES (2.5%) and penicillin/streptomycin (1%). 
7.2.3 Isolation of Human Epidermal Keratinocytes (HEK)  
Keratinocytes were released from epidermal matrices by using trypsin and mincing using a scalpel. 
Keratinocyte growth medium (KGM, Lonza, UK) was used to halt enzymatic action of trypsin 
followed by centrifugation, re-suspending, filtering through a 70 µm cell strainer and plating onto 
HDF feeder layers. KGM media and detached feeder cells were replaced every 3 days or as necessary 





7.2.4 Isolation of Stromal Vascular Fraction (SVF) 
The stromal vascular fraction was isolated from adipose tissue by mincing using a scalpel, passing 
through a cell dissociation sieve (size 100 mesh) and incubating in collagenase type I. Media was 
added to halt the reaction and samples were then sequentially filtered through 100 and 40 µm filters. 
Solutions were then centrifuged and the lipid, mature adipocyte and aqueous layers were discarded 
leaving behind the SVF cell pellet. The pellet was suspended in erythrocyte lysis buffer followed by 
a further centrifugation step prior to plating in basal media. Extracted SVF were sub-cultured as per 
standard trypsinisation protocols for 21 days until a homogenous ADSC population emerged and 
media was changed every 3 days or as necessary. 
7.2.5 Cell characterisation by flow cytometry 
Phenotypic analysis was undertaken using flow cytometry (Millipore Guava Easycyte Flow 
Cytometer, Merck Millipore, UK) in order to confirm the heterogeneity of freshly isolated SVF 
populations at week 0 and the homogeneity of 3-week-old in vitro cultured ADSC populations. Cells 
were trypsinised and 1 x 105 cells of each population were re-suspended in PBS in separate Eppendorf 
tubes. Antibody cocktail (anti-human CD34 PE / CD45 FITC, BD Biosciences) was added and 
incubated at room temperature absent from light. Control antibody was added to a further two 
Eppendorf tubes of each cell population to determine nonspecific binding (mouse IgG1 PE and mouse 
IgG1 FITC, BD Biosciences) and cells with no antibody were used for flow cell counting. PBS was 
added to each tube, vortexed and centrifuged (600 g for 5 mins), the supernatant was removed and 
each cell pellet was re-suspended in PBS prior to analysis. The fluorescence intensity was then plotted 
against cell count and mean fluorescence intensity was calculated accounting for non-specific binding 





7.2.6 Adipocyte differentiation  
ADSC cultured for 21 days were washed in PBS and adipogenic differentiation medium was added. 
Adipogenic media included basal media supplemented with 500 µM isobutyl-methylxanthine 
(IBMX), 50 µM indomethacin and 1 µM dexamethasone. Cultures were maintained for a further 21 
days and culture medium was changed every 3 days or as necessary. 
7.2.7 Oil red O staining of adipocytes 
Following a 21-day culture period, media was aspirated and cells were fixed in 10% formalin 
followed by washing with PBS and distilled water. Cells were stained with 60% Oil Red O solution, 
washed thrice in PBS and counterstained with Harris’ haematoxylin diluted 1:2 in deionised water 
prior to visualisation under an inverted microscope. ADSC were also stained as a control population. 
7.2.8 Osteogenic differentiation 
ADSC were trypsinised and plated at a density of 5 x 103 cells / cm3 in ADSC media. The following 
day, ADSC media was aspirated and replaced with osteogenic differentiation media. Osteogenic 
differentiation media contained basal media supplemented with 10 mM β-glycerophosphate, 200 µM 
ascorbic acid and 0.1 µM dexamethasone. Cultures were maintained for a further 21 days and culture 
medium was changed every 3 days or as necessary. 
7.2.9 Alizarin red S staining of osteocytes 
Following a 21-day culture period, media was aspirated and cells were fixed in 10% formalin 
followed by washing with PBS and deionized water. Cells were stained with 2% Alizarin Red S 
solution and washed thrice in deionised water prior to visualisation under an inverted microscope. 




7.2.10 Fluid-gel print bed preparation  
For formulation of the print bed, agarose fluid gels were prepared by cooling autoclaved agarose (type 
1 low EEO, purchased from Sigma–Aldrich, UK) dispersed in deionized water at 0.5% w/v 
concentration to 25 °C under a constant shear of 700 rpm. Fluid gels were then loaded into extra‐
depth tissue culture plates. 
7.2.11 Preparation of polymer solutions for printing  
The materials used for replicating skin ECM were LM pectin (purchased from CP Kelco, UK) and 
collagen (PureCol EZ Gel, Advanced BioMatrix, purchased from Sigma–Aldrich, UK). Pectin 
powders were dispersed in deionized water at concentrations of 5% w/v and allowed to cool to 25 °C 
following autoclaving to form working solutions. Collagen solutions were stored at 4 °C prior to use. 
For the hypodermal layer, collagen and pectin were mixed at a ratio of 1:1 (1Col:1Pec) and for both 
the papillary and reticular dermis layers, collagen and pectin were mixed at a ratio of 2:1 (2Col:1Pec). 
7.2.12 Rheological characterisation of polymer printing solutions 
Rheological analyses of the printing polymer solutions for the hypodermal and dermal layers were 
performed in triplicate using a Bohlin Gemini rheometer (Malvern Panalytical, UK) fitted with a 
double gap cup and bob geometry (DG 24/27). Collagen (0.5%) and pectin (5%) alone were also 
subjected to rheological shear for reference. Collagen was measured at 4 °C, pectin at 25 °C, 
hypodermis solution at 15 °C and dermis solution at 11 °C to reflect the temperatures of which the 
solutions would experience during printing. Shear rate was ramped from 0.1 to 100 s−1 and shear 
viscosity (Pa s) was recorded.  
7.2.13 Design of 3D skin models 
Tri-layer skin models were designed using computer aided design (CAD) software SolidWorks® and 
saved in stl (stereolithography) file format. The model hypodermis (15 x 15 x 7 mm), papillary dermis 
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(15 x 15 x 1 mm) and reticular dermis (15 x 15 x 1 mm) layers were stacked and the stl to G-code 
conversion programme Slic3r® was then used to slice the models into layers and translate the 
coordinates into commands for the 3D bioprinter. 
7.2.14 Fabrication of 3D skin models 
For the printing of 3D skin models by SLAM, printing cartridges were loaded with bioink, attached 
to a conical nozzle with an internal diameter (ID) of 410 µm and inserted into an INKREDIBLETM 
3D bioprinter (Cellink, Sweden). For the simulated hypodermis bioink, collagen was mixed with 
pectin at a ratio of 1:1 and ADSC were suspended at a density of 5 x 105 cells / mL. For the simulated 
reticular dermis bioink, collagen was mixed with pectin at a ratio of 2:1 and HDF were suspended at 
a density of 1.5 x 106 cells / mL. For the simulated papillary dermis bioink, collagen was mixed with 
pectin at a ratio of 2:1 and HDF were suspended at a density of 3.0 x 106 cells / mL. The 3D bioprinter 
was aligned and calibrated to a specified pressure followed by placement of the petri dish containing 
the agarose fluid bed upon the z-stage. The printer was then instructed to commence fabrication of 
the tri-layer skin model and automatically switched cartridges upon each successive layer. Following 
scaffold fabrication, 200 mM of CaCl2·2H2O was injected around the structure through a hypodermic 
needle in order to solidify the pectin portion of the blends and collagen gelation was induced thermally 
by raising the temperature to 37 ºC. Structures were cultured overnight in an incubator (Triple Red, 
UK) at 37 ºC, 5% CO2 and 95% air with the addition of adipogenic media and were removed from 
the agarose fluid gel bed the following day. Submerged in adipogenic media, scaffolds were then 
cultured for 14 days, followed by forming an air-liquid interface at the surface of the scaffold, seeding 
2 x 106 HEKs atop the scaffold and culturing for a further 7 days prior to sectioning and analysis. 
Separate cultures of singular hypodermis, reticular dermis, papillary dermis and epidermis (HEK 





Acellular 3D printed skin equivalents were cross‐sectioned and placed in −80 °C conditions for 24 h 
followed by implementing a 72 h freeze drying cycle at −76 °C and 0.0010 mbar (Christ ALPHA 2–
4 LD plus). Dry samples were stored in a desiccator prior to imaging. 
7.2.16 Scanning Electron Microscopy (SEM) 
Lyophilized skin equivalents were prepared for SEM by sputter coating with gold using a Quorum 
SC7620 sputter coater under a low bleed of argon. The internal networks within the samples were 
then studied using a field emission SEM (FEI Quanta 250 SEM) operated in high vacuum mode at 
an accelerated electron energy of 20 kV. Images were collected using a backscattered electron 
detector. 
7.2.17 Rheological characterisation of 3D printed skin models 
Rheological analyses of acellular skin model layers were performed in triplicate at 37 °C using a 
Bohlin Gemini rheometer (Malvern Panalytical, UK) with a parallel upper plate (PP 20) and serrated 
lower plate to prevent slippage. Model hypodermis (1Col:1Pec) and dermis (2Col:1Pec) ECM layers 
were printed in a cylindrical format (20 mm diameter and 1 mm depth) within an agarose fluid gel 
bed and solidified before retrieving and loading onto a rheometer. Shear stress was ramped from 10 
to 100 Pa and elastic modulus Gʹ (Pa) was recorded. 
7.2.18 Porcine wound model studies 
Freshly slaughtered porcine cheeks sourced direct from the abattoir (Medcalf J & E Ltd, UK) were 
sterilized by submerging in absolute ethanol before forming a simulated wound throughout the 
epidermal, dermal and hypodermal layers using a scalpel. An acellular skin equivalent was then 3D 
printed to fit the dimensions of the porcine wound model followed by solidification and placement of 
the implant within the wound cavity.  
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7.2.19 Paraffin embedding 3D printed skin models 
3D printed skin equivalents and human skin samples were sectioned and mounted within cassettes 
prior to processing. Samples were subjected to immersion within a fixing solution of 10% formalin 
followed by a series dehydration within graded ethanol (30%, 70% and absolute). Samples were then 
placed in xylene prior to embedding in paraffin (Leica EG 1150C Tissue Embedder, Leica 
Biosystems, UK).  
7.2.20 Haematoxylin and Eosin (H&E) staining 
Paraffin embedded samples were sectioned to 7 µm thickness using a microtome (Leica EG 1150C 
Tissue Embedder, Leica Biosystems, UK) and mounted onto adhesion coated slides. Slides were 
immersed in xylene followed by a series rehydration within graded ethanol (absolute, 70% and 30%). 
Slides were then rinsed under running tap water between treatments firstly with haematoxylin 
followed by counterstaining with eosin. Slides were dehydrated in a series of ethanol (30%, 70% and 
absolute) and submerged in xylene before the addition of mounting solution and a cover slip prior to 
analysis under a Leica CTR 6500 confocal microscope (Leica microsystems, UK). 
7.2.21 Fluorescence microscopy 
3D printed skin equivalents and singular scaffolds were sectioned and stained with Hoechst nuclear 
blue and phalloidin actin green fluorescent reagents (Fisher Scientific, UK) for visualization of 
suspended cells. All 3D cell culture scaffolds were then visualized using a fluorescent microscope 
(EVOS FLoid Cell Imaging Station, ThermoFisher Scientific, UK).   
7.2.22 Cryoembedding 3D printed skin models 
3D printed skin equivalents and human skin samples were embedded in frozen section media within 





Cryoembedded samples were sectioned to 7 µm thickness using a cryostat microtome and mounted 
onto adhesion coated slides. Slides were then brought to room temperature and fixed in -20 °C acetone 
followed by washing in PBS. After placing specimen slides in a wet chamber, slides were treated 
with blocking solution (PBS/BSA/FBS), then primary antibody diluted in blocking solution (rabbit 
Anti-Cytokeratin 10 at concentration of 1 in 500, and mouse Anti-Cytokeratin 14 at 1 in 400, 
ABCAM Plc, UK) (mouse TGase 1 at 1 in 100, Santa Cruiz Biotechnology, USA), with an overnight 
incubation at 4 °C. Primary antibody was removed from each specimen followed by washing thrice 
in PBS / Tween and once with PBS. Secondary antibody was diluted in blocking solution absent from 
light (0.6 in 500 or 0.75 in 400 Goat anti-rabbit IgG respectively or 3 in 297 Goat anti-mouse IgG, 
ThermoFisher Scientific, UK) added to samples and left to incubate at room temperature for 45 mins. 
Following incubation, slides were washed with PBS / Tween, stained with DAPI for 3 mins, washed 
again thrice with PBS / Tween, twice with PBS and once with deionized water. Finally, slides were 
embedded with mounting medium, a coverslip was placed on top and samples were visualized using 












7.3.1 Design and preparation of a human skin equivalent 
In order to recapitulate the true nature of human skin, it is important to try and capture the cellular 
makeup as well as the extracellular environment within the skin model as closely as possible. Native 
human skin components were therefore used as the basis for the design of the 3D bioprinted skin 
(Figure 7.10A).  The hypodermal portion of the model contained adipose derived mesenchymal stem 
cells (ADSC) (Figure 7.10B) embedded within a matrix comprised of collagen and pectin at a ratio 
of 1:1. The reticular dermis consisted of a low-density population of human dermal fibroblasts (HDF) 
(Figure 7.10C) embedded in a more collagen-rich matrix (Col 2:1 Pec) and papillary dermis exhibited 
a higher density population of HDF cells as found within human skin. Human epidermal keratinocytes 
(HEK) (Figure 7.10D) were to be seeded atop the 3D model following printing. 
Computer aided design (CAD) software was used to generate the hypodermal (152 x 7 mm), papillary 
dermal (152 x 1 mm) and reticular dermal (152 x 1 mm) layers, followed by integration of the three 
structures (Figure 7.10E left) and generation of the 3D print path (Figure 7.10E right) to create the 
print geometry for the tri-layer skin equivalent. Final preparation for printing the skin model included 
rheological characterisation of the collagen / pectin blend printing materials (Figure 7.10F). Both 1:1 
and 2:1 collagen to pectin ratio blends exhibited shear thinning behaviour with increasing shear rate 
similarly to collagen and pectin alone. Interestingly, material blends had higher viscosities under 
simulated static conditions (low shear rates) compared with collagen and pectin alone yet 
demonstrated intermediate viscosities between singular pectin and collagen under simulated printing 






Figure 7.10 - Design and preparation of a tri-layer skin model. Illustration of a tri-layer skin model (15.0 x 15.0 x 
9.1 mm) featuring a hypodermis, dual compartment dermis and epidermis. Adipocytes differentiated from adipose 
derived mesenchymal stem cells (ADSC), human dermal fibroblasts (HDF) unattached and attached to collagen 
and human epidermal keratinocytes (HEK) are specifically localised within the layered scaffold and encapsulated 
within a graded collagen / pectin matrix blend in an arrangement that is synonymous to native tissue. 2D culture 
of B) ADSC C) HDF and D) HEK for integration within the 3D skin model (scale bar = 200 µm). E) G code of skin 
model layer configuration containing hypodermis (yellow), reticular dermis (red) and papillary dermis (green) 
(left) and print path (perimeter in yellow, infill in red) (right) F) Viscosity profiles of hypodermal layer (1Col:1Pec) 
and dermal layer (2Col:1Pec) printing materials including single collagen and pectin for reference.  
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7.3.2 SVF isolation and ADSC expansion and characterisation 
Upon microscopic inspection, freshly isolated SVF at day 0 predominantly contained erythrocytes 
along with stromal cells (Figure 7.11A). When cultured under defined conditions, ADSC emerged 
exhibiting a spindle-like morphology at day 7 (Figure 7.11B) and were almost completely fusiform 
by day 14 at passage 1 (Figure 7.11C). One further passage at day 21 showed complete expansion of 
SVF to ADSC procuring a homogenous cell population (Figure 7.11D).  
In order to confirm mesenchymal status of expanded ADSC versus the hematopoietic nature of 
freshly isolated SVF, flow cytometry was undertaken. SVF were positive for hematopoietic marker 
CD34 (difference in mean fluorescence intensity (δMFI) between control IgG isotype and human 
variant of 56.6) and was downregulated at day 21 (δMFI = 23.29) showing elimination of 
hematopoietic cells and homogenization of cells with a mesenchymal lineage (Figure 7.11E). CD45 





Figure 7.11 - Homogenisation of cells obtained from the stromal vascular fraction within adipose tissue for 
expansion of adipose derived stem cells. A) SVF at day 0, passage = 0, B) SVF at day 7, passage = 0, C) SVF at day 
14, passage = 1 and D) ADSC at day 21, passage = 2 (scale bar = 200 µm). E) Characterisation of SVF and ADSC 
by flow cytometry. Freshly isolated SVF exhibit greater expression of haematopoietic marker CD 34 and is 
downregulated in ADSC (upper). Expression of haematopoietic marker CD 45 remained relatively constant 
(lower). Red corresponds to control IgG isotype and green to the specific antibody. 
 
To satisfy proper characterisation of ADSC, both phenotype and differentiation capacity criteria 
require fulfilling. ADSC have a multi-lineage differentiation capacity giving rise to mesodermal 
lineages, namely adipogenic, osteogenic and chondrogenic cell species. To determine the 
differentiation capacity of ADSC incorporated within the hypodermal skin model, ADSC were 




Figure 7.12 - ADSC differentiation potential. A) ADSCs obtained and cultured from SVF were subjected to B) 
adipogenic and C) osteogenic differentiation media in vitro for 21 days. D) Oil Red O lysochrome dye stains lipids 
indicative of adipocyte-like cells. E) Alizarin Red S dye stains calcium deposits indicative of osteocyte-like cells. 
Undifferentiated ADSC staining is shown as a negative control (scale bars = 200 μm).   
When adipocytes were stained with Oil Red O, lipid deposits became visible while ADSC controls 
remained unstained thus confirming dye specificity to in vitro cultured adipocytes from the ADSC 
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population. Likewise, osteocyte specific staining using Alizarin red revealed calcium deposits when 
ADSC were in vitro cultured under osteogenic differentiating conditions compared with ADSC 
controls. These results therefore demonstrate the multi-lineage differentiating capacity of isolated 
ADSC for culture of adipocytes within a human skin model.  
 
7.3.3 Characterisation of 3D printed skin models 
Hypodermis and dual compartment dermis layers were 3D printed within an agarose fluid gel bed 
prior to formation of the epidermis by seeding the surface with keratinocytes, ultimately forming a 
single, graded skin replica (Figure 7.13A). Upon visual inspection, the graduation of material content 
within each layer went from clear pink to translucent white attributed to the higher collagen content 
within the upper dermal layers. A gradient in material architecture could also be seen at the 
microstructural level using scanning electron microscopy (SEM), which demonstrated porosity 
gradients with a likeness to human skin (Figure 7.13B).   
With gradients in microstructure within a tissue scaffold also comes gradients in mechanical strength. 
When subjected to mechanical testing using shear rheology, the collagen to pectin ratio of 1:1 which 
simulated hypodermal ECM was stiffer (higher elastic modulus) compared with the 2:1 ratio 





Figure 7.13 - Characterisation of an acellular tri-layer skin model. A) 3D printed construct (scale bar = 5 mm). B) 
Scanning electron micrograph of a 3D printed construct following lyophilisation (scale bar = 500 µm). C) 
Mechanical behavior of a 3D printed construct by shear rheology. 
 
A B C 
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7.3.4 Histology and immunohistochemistry of 3D bioprinted skin equivalents 
Histological evaluation of the bioengineered skin equivalent using H&E staining further illustrated 
the architecture of the construct, revealing the apparent similarities to human skin (Figure 7.14A and 
B). Each layer of the 3DP skin, including epidermis (E), papillary dermis (PD), reticular dermis (RD) 
and hypodermis (H) was consistent with that of native skin. Additionally, the skin model hypodermis 
appeared vacuolated, in agreement with human skin, due to the large lipid droplets that dominate 
adipocyte cell volume being removed during routine tissue preparation and leaving spherical voids.  
 
Figure 7.14 - Histological analysis of a 3D printed trilayer skin model manufactured by SLAM. A) Haematoxylin 
and Eosin staining of a human skin sample (left) compared with a 3D printed model (right) complete with 
epidermis (E), papillary dermis (PD), reticular dermis (RD) and hypodermis (H) (scale bars = 100 µm). 
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Further to culturing HEK, HDF and ADSC within the tri-layer skin model, separate cultures of cells 
in each respective material environment were also examined (Figure 7.15). In all cases, the 
proliferative behaviour and appearance of cells were identical between single and tri-layer cultures. 
It was also evident that cells remained viable, made possible by the gentle printing conditions despite 
a high resolution being accomplished. The densities of cells within each distinctive layer of the 
methodological model design were successfully reimagined within the 3D printed model although 
HEK were not as abundant as anticipated. 
Figure 7.15 - Fluorescence micrographs of HEK, high density (HD) HDF, low density (LD) HDF and ADSC each 
within the skin model (upper) and separate 3D culture (lower) (scale bars = 100 µm). 
 
Upon immunohistological staining of the skin model epidermis, there were indications of 
keratinocytes terminally differentiating through the layers (Figure 7.16). Cytokeratin 10 staining was 
indicative of stratum corneum apparatus (Figure 7.16A), transglutaminase expression suggested a 
formation of an intermediate stratum spinosum or granulosum layer (Figure 7.16B) and finally 
cytokeratin 14 as expressed in the basal layers of the epidermis was highlighted within both human 
and model skin samples (Figure 7.16C). It is likely that, had more time been given for keratinocytes 







Figure 7.16 - Immunohistological analysis of epidermal differentiation within human skin (upper) and skin model 
(lower) for the indication of A) Cytokeratin 10 within the stratum corneum, B) Transglutaminase within the 
stratum granulosum and C) Cytokeratin 14 within the stratum basale. Scale bar = 50 µm. 
 
7.3.5 Implantation of a 3D printed skin equivalent within a porcine wound model 
In order to validate the model as a transplantable scaffold, the skin equivalent was transplanted within 
a simulated porcine wound model (Figure 7.17A-C). The scaffold retained structural integrity with 
all layers remaining interconnected and intact whilst also filling the dimensions of the wound void 
preventing sagging and caving of the lesion (Figure 7.17D). In extension, the aesthetics of the 
scaffold were relatively consistent with those of the porcine skin and was structurally and visually 
similar to that of human skin. 
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Figure 7.17 - Implantation of a 3D printed construct within a porcine wound model. A) Arial and B) lateral view 
of freshly slaughtered porcine skin, C) 15 cm3 simulated wound void and D) wound containing implanted 3D 
printed skin equivalent (scale bars = 15 mm).   
7.4 Discussion 
In chronic wounds, replacement skin is necessary as the wound itself is unable to re-epithelialize, 
leading to problematic scarring and in some cases, impaired function.  Though many skin equivalents 
have been manufactured in attempt to meticulously mimic human skin for implantation, few have 
managed to represent the hypodermal portion of skin tissue (Kim et al., 2019). Here, a tissue-
engineering skin model has been fabricated which incorporates three compartments consisting of 
epidermis, dermis and hypodermis within a single 3D printed structure (Figure 7.10A). 
In preparation for 3D bioprinting skin equivalents, cells were isolated from a single human 
abdominoplasty. In this study, the chosen method for obtaining an ADSC population was to isolate 
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the heterogeneous stromal vascular fraction (SVF) from the subcutaneous adipose tissue of an elective 
patient abdominoplasty. Following culture under defined conditions over a 21-day period, ADSC 
emerge having multi-lineage differentiation capacity, including the ability to differentiate into 
adipocytes. Obtaining ADSC from adipose is more accessible, allows harvesting of greater numbers 
of progenitor cells and harbours a larger expansion potential compared with other tissues such as bone 
marrow, making high-dosage treatments readily available, relatively simple and also more cost-
effective (Araña et al., 2013). It was clearly demonstrated, using flow cytometry and specifically 
formulated cell culture medias, that ADSC could be homogenised from SVF within subcutaneous 
tissues and subsequently directed towards specific cell phenotypes (Figure 7.11 – 7.12). ADSC were 
also successfully encouraged to assume a lipid-secreting cell lineage, highly like adipocytes, 
confirming their appropriate inclusion within the model hypodermal layer. The final step for 3D 
printing preparation was to simulate the shear experienced by bioinks during printing by exposing 
solutions to rheological shear (Figure 7.10F). Interestingly, combinations of collagen and pectin 
exhibited higher shear viscosities under simulated static conditions (low shear rates), yet lower 
viscosities under simulated dispensing conditions (high shear rates) compared with collagen and 
pectin solutions alone. These properties are largely advantageous in that cell suspensions within 
polymer blend solutions are more stable prior to printing, yet much lower shear forces are exerted on 
cells during deposition thus preserving cell viability. 
Following cell and solution (bioink) preparation, the 3D bioprinting process commenced. The printed 
scaffold exhibited true-to-size dimensions and demonstrated the system’s capacity to achieve a high 
resolution by following the designed print pathways and specifications (Figure 7.13A). Due to the 
gentle suspending nature of SLAM, the model could be cured using divalent cations for the pectin 
portion of the blend whilst an ambient temperature of 37 °C gelled the collagen element of the blend. 
Each layer of skin is naturally highly anisotropic, however, hypodermis is generally stiffer compared 
to dermis with a decreasing graduated stiffness between the two (Geerligs, 2010). This 
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microarchitectural and mechanical graduation was successfully demonstrated within the tri-layer skin 
equivalent by scanning electron microscopy and shear rheology (Figure 7.13B-C), while 
fluorescence micrographs exampled how cell density and phenotype can be heterogeneously 
distributed to mimic native skin (Figure 7.15). Despite the gradients exhibited within the multi-
layered construct, layers remained intact during manipulation and placement within a porcine wound 
model, exemplifying that the scaffold is fit for purpose (Figure 7.17). 
Within the hypodermis, not only do ADSC play a part in repair and regeneration within the wound 
environment, they also have a stimulatory effect on human dermal fibroblast (HDF) proliferation and 
migration as well as contributing to the secretion of growth factors, collagens and fibronectin through 
HDF (Kim et al., 2011). Naturally occurring hypodermis is classed as loose connective tissue and is 
rich in ground substance made of polysaccharide that fill the voids between collagenous, elastic and 
reticular fibres and cells (Mathieson & Watkins, 2009). Pectin, also a polysaccharide, is a hydrogel 
which has strong structural similarities to ground substance such as glycosaminoglycan (Neves et al., 
2015) within adipose ECM and thus acts as an ideal alternative within the model hypodermal layer. 
Pectin has also been associated with having wound healing properties based on its hydrophilicity, 
antibacterial action and for its role in scaffolding within the wound void preventing premature 
contraction, excessive scarring and skin distortion (Giusto et al., 2017). Collagen was incorporated 
into the hypodermal layer at a ratio of 1:1 due to its role within natural hypodermis during wound 
repair. 
Within the dual dermis compartments, the collagen / pectin blend ratio used was altered to 2:1 due to 
the higher abundance of collagen within native dermal dense connective tissue (Marieb & Hoehn, 
2015). Predominantly secreted by HDF, collagens contribute to dermal ECM by allowing attachment 
and migration of resident cells and are also a large contributor to the wound healing process (Kanta, 
2015). The density of residing HDF from the lower reticular dermis to the upper papillary dermis, 
however, is twofold (Sorrell & Caplan, 2004) and is thus reflected within this model. During 
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histological evaluation of human skin, sebaceous and sweat glands could be identified (Figure 7.14). 
Although these features were not present within the 3D bioprinted skin model, they still held 
structural similarities by comparison. These findings were significant in that the scaffold has the 
potential capacity to support structures such as these. This means that, once a fundamental 
understanding of the tri-culture of cells had been established, further cells such as sebocytes, hair 
follicle cells and other associated stem cells could also be incorporated within the system.  
Finally, this model exhibited a layer of keratinocytes seeded atop the dermal compartment for 
representation of the epidermis. Much like naturally occurring epidermis, the fabricated epithelial 
layer was much more abundant in cells, distributed within a sparse ECM compared with ECM-rich 
connective tissue within the dermal and hypodermal regions. A further benefit to this model is that 
the calcium used to crosslink pectin serves an additional purpose. Calcium has an established role in 
mammalian skin tissue homeostasis and is known to modulate keratinocyte proliferation and 
differentiation, playing a vital role in epidermal regeneration and dermal reconstruction in wound 
healing (Zhang et al., 2018). Despite the successful placement of HEK cells above the 3D bioprinted 
papillary dermis, HEK were not as abundant as anticipated. This could be down to several reasons 
which are commonplace in surface seeding cells, such as HEK cells simply sliding off from the model 
during seeding, failure of HEK cells attaching and loss of epidermal apparatus during tissue 
preparation and examination. In this case, it is likely a combination of the three as models were left 
to propagate for 7 days following seeding of HEK and the number of cells seeded do not reflect those 
shown during imaging. Precise placement of polymer material-suspended cells using 3D printing is 
a much more efficient method, however, it is unsuitable in recapitulating epithelial tissues that exhibit 
minimal ECM compared with HDF and ADSC-containing connective tissues. The fact that cell 
proliferation appeared to cease whilst suspended within the scaffold could suggest that the cells within 
each layer remained viable yet were mitotically inhibited. In a transplant setting, this feature may be 
beneficial in that the scaffold is given time to vascularise prior to consequential degradation and 
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release of its cell cargo. This means that once vascularisation has been established, cell proliferation 
may resume upon release and the demand for oxygen and nutrients supplied by the blood can be met. 
Although cells assumed a non-proliferating state, there was evidence of regulated gene expression 
and protein secretion. Upon immunohistological staining of the skin model epidermis, there were 
indications of keratinocytes terminally differentiating through the layers (Figure 7.16). Cytokeratin 
10 staining was indicative of stratum corneum apparatus, transglutaminase expression suggested a 
formation of an intermediate stratum spinosum or granulosum layer and finally cytokeratin 14 as 
expressed in the basal layers of the epidermis was highlighted within both human and model skin 
samples. 
7.5 Conclusions 
The results presented here on manufacturing a tri-layer skin model using suspended layer additive 
manufacture are the first of its kind. A skin equivalent complete with a tri-culture of cells distributed 
throughout hypodermal, dermal and epidermal regions was successfully designed and fabricated by 
optimising print resolution without compromising cell viability. ADSC were propagated from SVF 
populations and demonstrated both stem-cell-ness and a multi-lineage differentiation capacity within 
both adipogenic and osteogenic culture conditions. HDF and HEK were also extracted and cultured 
from the same patient sample prior to incorporation within a 3D skin equivalent. Aided by tuning of 
flow rate, printing pressure, nozzle gauge and rheological characterisation, scaffolds were printed 
with high precision within a supporting agarose fluid gel matrix prior to solidification and extraction. 
The careful placement of simulated dermal and hypodermal ECM through ranging collagen and 
pectin blend ratios resulted in biochemical, microstructural and mechanical gradients as seen in native 
human skin. Scaffolds also demonstrated their implantable capacity within an ex-vivo porcine skin 
wound, exhibiting admirable aesthetics and dimensional compatibility. On the micro-scale level, skin 
models featured native skin apparatus such as epidermal layer and nucleated matrix resultant of 
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adipocyte lipid removal as well as the presence of collagen and gradients in cell density. Furthermore, 
there was evidence of epidermal terminal differentiation on the model’s surface evidenced by the 
formation of markers indicative of the stratum corneum, stratum granulosum / spinosum and stratum 
basale. Despite this, cells within the lower regions of the scaffold appeared to halt mitotic activity 
whilst suspended within the collagen / pectin blend – a feature which is highly advantageous for 
allowing vascularisation of the scaffold following implantation. It is envisaged that the 3D skin 
bioprinting techniques used in this research could be made readily available within the clinic setting. 
Potentially, following scanning of a patient’s wound or lesion, a patient-specific scaffold may be 
printed once the wound dimensions had been characterised and a complementary geometry to fill the 
wound void had been computed. This scaffold could then incorporate the patient’s cells thus reducing 











































SUMMARY, CONCLUSIONS,    
AND FUTURE DIRECTIONS 
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Chapter 8 – Summary, Conclusions and Future Directions 
 
This research was intended to explore novel methods in manufacturing multi-layered tissue 
engineering constructs. Building on previous suspended manufacturing protocols, the theory behind 
fluid gel formulation and suspension within the supporting matrix was elucidated with greater detail. 
The incorporation of a 3D bioprinter further refined tissue construct resolution and enabled the 
generation of layered structures of greater complexity and with more accurate dimensions. This work 
was then used to mould a strategy for designing, fabricating and assessing a tri-layer skin model, 
which could have future applications in wound healing, drug / disease modelling and cosmetics 
testing. 
8.1 Characterisation of the Agarose Fluid Gel Bed 
The supporting fluid gel bed was initially studied to describe how it behaves during formulation, 
handling and extrusion of material within it. Using a series of analytical techniques, ranging from 
mechanical testing, through to particle sizing and microscopic evaluation, and also by employing 
centrifugation procedures for extraction of fluid gel phases, an improved understanding of suspended 
manufacture function was met. It was deduced that the way in which agarose supporting matrices are 
formulated play a pivotal part in the mechanical properties they harbour. Freshly prepared agarose 
fluid gels had markedly increased mechanical properties compared with their diluted fluid gel 
counterparts of equivalent concentration. Deeper exploration into defining the particle sizes and 
particle volume fractions within fluid gel systems of differing concentrations gave further explanation 
into the support-bed mechanism of action. Fluid gels with concentrations above 0.5% exhibited 
greater particle size heterogeneity, attributed to the modified local shear environment on particles 
within more viscous solutions. In turn, the high viscosity of fluid gels over 0.5% proved difficult to 
allow material deposition and construct formation. Although particle size distribution was more 
homogenous within fluid gels below 0.5% concentration, sufficient particle volume fractions were 
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lacking, leading to poor mechanical properties and the inability to uphold deposited material. Taken 
together, these data were applied toward optimum formulation conditions for the research to follow. 
Despite these advances, the highly complex nature of agarose fluid gel systems dictates that much 
more research requires undertaking. Many parameters must be tightly controlled and regulated for a 
specified outcome during fluid gel formation. Indeed, formulation method and concentration have 
both been seen to impact upon fluid gel mechanics, yet there are other parameters which also 
modulate the behaviour of fluid gels. For instance, cooling rate influences fluid gel particle formation 
and subsequently dictates the overall status of fluid gel viscosity. Even though all agarose solutions 
were autoclaved under identical conditions of temperature and pressure, and an end temperature of 
25 °C was implemented for all formulations, it would be advantageous if the rate of cooling was also 
controlled in order to reduce batch-to-batch variability. Likewise, different shear rates and shearing 
methods (using a magnetic flea, rheometer cone and plate geometry, jacketed pin stirrer or overhead 
impeller) have all been seen to generate rheological and particle morphological variances within fluid 
gels. Achieving an understanding of all of these aspects combined for fluid gel formation would 
require an extensive project in itself, yet ample research was conducted, in this thesis, to successfully 
manipulate fluid gel characteristics for the fabrication of complex hydrogel scaffolds and constructs. 
8.2 Suspended Layer Additive Manufacturing (SLAM) 
Following the transition from printing by hand to the installation of a commercially available 3D 
bioprinter, Suspended Layer Additive Manufacture (SLAM) was born. System methodology was 
further characterised and consolidated by describing the printing resolution within the support bed 
using a combination of different printing parameters, and the diffusion of dyes within the fluid gel 
bath was also monitored. Other avenues for agarose support bath formulation were explored in the 
form of an agarose microparticle slurry as referenced in the literature, and it was concluded that fluid 
gel formation is critical to the behaviour of the supporting matrix. A series of cell-containing disc-
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shaped constructs made of different materials were manufactured which were diverse in their 
chemical and mechanical natures. Alternative tissue engineering structures were also compared by 
freeze drying and cell seeding tissue engineering sponges. Research into a range of different 3D 
printed geometries was then conducted to define the potential of the system to generate intricate, bulk, 
hollow and bifurcating features within a 3D tissue mimic.  
Two different dyes of differing molecular weights were extruded within the agarose bed to examine 
dye diffusion over time. To better study the diffusion timescales of the calcium chloride dihydrate 
crosslinker, from injection within the support bed to total crosslinking of scaffolds, a calcium-specific 
marker could be used to trace the diffusion rate. Although dye diffusion offered some insight into 
how crosslinker would traverse across the support bed and throughout the printed construct, 
methylene blue, dimethylmethylene blue and calcium chloride all exhibit different chemical 
structures and molecular weights and more work would need to be done to assess their mechanisms 
of diffusion within an agarose fluid gel. Reagents arsenazo III and o-cresolpthalein complexone have 
previously been used for the detection and quantification of serum calcium using colorimetric assays 
(Janssen, 1991; Stern, 1957). Further research into characterising calcium chloride dihydrate 
diffusion within agarose fluid gels by exploring the suitability of these reagents could aid in defining 
and characterising crosslinker diffusion as used in the SLAM system.  
Other future recommendations for this chapter include further research into different hydrogels, cell 
types and geometrical shapes that are compatible within the SLAM technology. 
8.3 3D Bioprinting Multi-Layer Constructs 
Different cells were successfully combined with biopolymer solutions and then crosslinked, 
following printing, to create cell-loaded biopolymer hydrogel constructs. It should also be possible to 
load scaffolds and constructs with drugs, growth-factors and other bioactives toward therapeutic 
intervention in the form of tissue engineering implants. Some work towards this end was conducted 
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by loading ibuprofen and IgG antibodies within discrete regions of hydrogel and sponge core-shell 
scaffolds (data not included in this thesis). The release profiles and dissolution rates of the bioactives 
and also the degradation rates of the scaffolds were then measured in-vitro, although further testing 
and statistical analyses would be required to acquire sufficient data and establish conclusions. 
Another preliminary study using PCR was conducted as a quantitative measure for reviewing cell 
suspension or attachment in dual layer scaffolds (data not shown). During fluorescence microscopy, 
it appeared evident that cells within collagen were attached to the matrix, whereas cells within gellan 
or alginate layers were suspended rather than attached due to the lack of attachment-conducive 
structures within these materials. Integrins α1β1 and α2β1 gene expression levels were measured in 
each layer and were found to be markedly upregulated in cells within the collagen layers compared 
to cells within gellan or alginate layers. A greater number of constructs would require testing in order 
to gain enough sample data to validate and deduce a statistically significant difference in future work. 
8.4 Design and Manufacture of a Tri-Layer Skin Model 
By amalgamating previous research on interpreting fluid gel behaviour, defining SLAM resolution 
and producing complex, multi-layer constructs, the fabrication of a tri-layer skin model for 
implantation within chronic wounds was proposed. The model was designed so that epidermis, dual 
compartment dermis and hypodermis all existed within a single tissue engineering construct by 
carefully selecting cells and biopolymer hydrogels to mimic the salient ECM environments within 
each layer. Initially, human epidermal keratinocytes (HEK), human dermal fibroblasts (HDF) and 
stromal vascular fraction (SVF) cell populations were extracted from a human abdominoplasty. 
Erythrocytes, hematopoietic stem cells and smooth muscle cells were eliminated from SVF fractions 
so that only ADSC remained for propagation. This was confirmed by evaluating cell marker status 
using flow cytometry and the differentiation capacity of ADSC was demonstrated by culture within 
adipogenic and osteogenic conditions. For the printing process, collagen / pectin blends of defined 
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ratio were mixed with cell populations at controlled densities to reflect native skin. Hypodermis was 
printed, followed by printing of reticular dermis and then papillary dermis before crosslinking with 
calcium chloride crosslinker for the pectin element of the construct whilst the collagen element 
underwent thermal gelation at 37 °C. Constructs were cultured for two weeks within adipogenic 
media to allow differentiation of ADSC into lipid-secreting cells. Keratinocytes were then seeded 
atop the cultured part and was cultured for one further week at the air-liquid interface. Following a 
total culture period of 21 days, constructs were vertically cross sectioned into three parts and 
processed using either paraffin embedding, cryosectioning or leaving unprocessed. Paraffin 
embedded construct sections were stained with Haematoxylin and Eosin for identification of the 
major layers in both human and 3D printed skin, revealing the strong similarities between the two. 
Cryosectioned constructs underwent immunohistochemical analysis for determining the presence of 
CK10, CK14 and tranglutaminase as a result of terminally differentiating keratinocytes within the 
epidermis. IHC staining showed indications of keratinocyte maturation within the epidermal portion 
of the construct, however further culture periods would be needed to further verify this. Unprocessed 
construct sections were stained with Hoechst and actin to observe cells within constructs and also in 
separate 3D cultures under a confocal microscope. The designed cell density within the 3D bioprinted 
layers were successfully re-imagined within the 3D model although the number of keratinocytes was 
not reflective of the seeding density. Further validation of the success of the construct was presented 
in the form of shear rheology and the graduated mechanical properties within the part, scanning 
electron microscopy and the graduated microarchitectural properties within the part and also by 
implantation within a porcine wound model. 
The SLAM method holds vast amounts of potential within the tissue engineering arena and therefore 
many possible avenues for future research. Whilst it has been shown that multiple bioinks can be 
layered to assemble a 3D trilayer skin model, longer culture periods could allow the emergence of 
more mature and better-substantiated skin equivalents. Once this has been established, it would be 
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possible to incorporate other types of skin cells, including merkel cells, Langerhans cells, 
melanocytes and sebocytes, as well as additional ECM components, such as elastin and fibronectin, 
to better restore the function of defective skin. In addition, exploration into loading therapeutics 
relevant to wound healing by loading gold nanoparticles within the construct was made (data not 
shown), yet more characterisation into the effectiveness of this feature would be required to justify 
its use within the implant.  
Other areas of research requiring attention are those of defining and recapitulating the mechanical 
properties in native skin within the tissue engineering construct and the subsequent degradation 
profile of the printed part as the potential patient’s endogenous tissue infiltrates the lesioned area. 
As a whole, this work has demonstrated the scope of the SLAM system in creating complex, multi-
layered tissue engineering parts with limitless potential in reimagining human tissues and organs. 
This kind of research is key for future innovation and could drastically reduce the need for animal 
testing in cosmetics research and drug / disease modelling, and relieve the pressures of organ-donor 
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